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Abstract 
 
This work presented in this thesis details efforts towards understanding what factors control the 
formation of the myriad of architectures in calix[4]pyrogallolarenes, leading towards biological 
application. A variety of C-alkyl-calix[4]pyrogallolarenes have been synthesised and their solid-
state and in-solution behaviour has been studied by diffusion NMR spectroscopy and single 
crystal X-ray diffraction.  
 
It has been found that calix nano-capsules can be formed by calix[4]pyrogallolarenes in polar 
protic solvents when the alkyl chain is substituted with bromine at its terminus. This is 
speculated to be due to formation of a dipolar interaction between the bromine atoms of adjacent 
calix[4]pyrogallolarene molecules. 
 
Calix[4]pyrogallolarenes with pendant chains bearing hydroxyl and cyano groups have been 
synthesised, and their behaviour in the solid state have been investigated by single crystal X-ray 
diffraction. They have been shown to form head-to-tail packing interactions in the solid state. As 
the hydroxyl functional group offers opportunity for further synthetic manipulations, in future 
investigations these molecules will provide a key intermediate in the synthesis of therapeutic 
delivery vectors.  
 
Preliminary investigation of cellular toxicity of the calixarenes has also been performed and 
indicates that this class of molecules does not appear to possess a high degree of toxicity towards 
dendritic cells and peripheral blood mononuclear cells which are the envisioned target of this 
delivery vector.  
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1 Supramolecular chemistry 
 
Calixarenes are cup shaped molecules whose cavity can accommodate smaller guest molecules.  There 
have been many calixarene derivatives synthesized with a diverse range of applications in mind. This 
includes their use as drug delivery vectors,1 gas storage media,2 memory for computing applications 3 
and in catalysis.4 This thesis focuses on the potential applications of functionalised calixarenes as drug 
delivery vectors, with details of work which will underpin the use of these molecules in a therapeutic 
setting. 
 
The first section of the introduction gives an overview of the principles of supramolecular chemistry, 
which form the basis of the synthetic work carried out for this thesis. 
 
Jean Marie Lehn, Donald J. Cram and Charles J. Pedersen shared the 1987 Nobel Prize in chemistry for 
their pioneering work on supramolecular chemistry. In his Nobel lecture, Lehn describes supramolecular 
chemistry as: 
 
“The chemistry of the intermolecular bond, covering the structures and functions of the entities formed 
by association of two or more chemical species.” 
Jean Marie Lehn 5 
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2 Inter- and intramolecular interactions 
 
Chemists working in supramolecular science seek to design and control the formation of intermolecular 
bonds which Lehn refers to, in order to produce materials with novel structures and properties. 
 
The intermolecular bond may take several different forms which are relevant to the construction of 
functional supramolecular species. In complex molecules there may be many different types of 
interaction which give rise to the molecular structure and therefore the bulk function. This interrelation 
between structure and function is best exemplified in nature by its ability to form functional 
macromolecules which catalyse chemical reactions. Urease (shown in Figure 1) is an enzyme which 
catalyses the hydrolysis of urea to ammonia and carbon dioxide, accelerating the reaction by 106 times.6 
The complex 3D structure shown below arises from multiple hydrogen bonds, hydrophobic interactions 
and metal to heteroatom bonds.6 
 
 
Figure 1 - Cartoon of Urease enzyme structure 
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2.1 Hydrogen bonds 
 
A hydrogen bond is an interaction (which may be inter or intra-molecular) between a hydrogen atom 
and another atom bearing an opposite partial charge. These dipoles arise as a result of differences in the 
Pauling electronegativity of the constituent atoms in a heteromeric covalent bond.7 
 
“The nature of the hydrogen bond depends on the nature of the donor and acceptor groups” 
Jeffrey 7 
 
Hydrogen bonds can have a wide variety of bond strengths (4 – 120 kJmol-1) which in neutral molecules 
is proportional to the distance between the two interacting atoms (in the range of 1.2 Å to 3.2 Å).8 
Hydrogen bonds are directionally dependent, which means that the strongest hydrogen bonds are formed 
between atoms arranged at 180° to each other. From the strongest to the weakest, hydrogen bonds can 
have a range of bond angles from 180° to 90°. The deformation of hydrogen bonds is entropically 
favoured and compromises between the angle formed and other packing forces are often reached.7 
 
Hydrogen bonding is one of the most important intermolecular interactions in nature; the genome of 
every living organism is contained in strands of DNA which are held together in its characteristic double 
helix by hydrogen bonding (Figure 2). The complementarity of hydrogen bonding between the base 
pairs allows faithful transcription and translation of the genetic code from DNA to produce proteins. 
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Figure 2 - Structure of DNA, showing hydrogen bonds between base pairs 
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2.2 Cation – pi interactions 
 
The interaction between a cation and the pi electrons of an aromatic system are among some of the 
strongest non-covalent inter-molecular interactions found, having energies of interaction in the range of 
160 kJmol-1 to 60 kJmol-1.9 The electrostatic model which describes the interaction between the cation 
and the cloud of electrons which reside above and below the plane of the aromatic ring has been 
validated.10 However, inconsistencies between the standard model and reality do exist, for example the 
cation is treated of as a point charge 4 Å from the plane of the ring in the model, when in reality there 
are only the van der Waals radii of the atoms between the two interacting species.11 
 
The concept of a cation to pi interaction was developed after binding studies of cations with synthetic 
cyclophane hosts were carried out.12 Cyclophanes, the general structure of which is shown below 
(Figure 3), are water soluble and monomeric between pH 7 and 9. The distance between the solubilising 
carboxyl groups and the binding cavity allowed electrostatic interactions between the carboxyl anion 
and any potential guest cation to be minimised in aqueous solution.11 The hydrophobic effect may give a 
false positive of the binding of a cation by the cavity, therefore experiments using organic solvents have 
also been performed.12-14 
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Figure 3 - Cyclophane host molecule (X = C6H4) 
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Cation to pi interactions are important in nature because amino acids containing aromatic residues such 
as tryptophan, phenylalanine, and tyrosine (Figure 4) are able to interact with a variety of biologically 
significant cations. 
 
 
Figure 4 - Amino acids with aromatic side chains 
 
Another illustration of the importance of cation to pi interactions is the transmission of nerve impulses 
between neurons in vertebrates. For example, the active site of the enzyme acetylcholine esterase has 
been characterised by X-ray diffraction studies and shows a deep cavity with 14 aromatic amino acid 
residues in the active site.15 
 
 
Figure 5 - Acetylcholine 
 
The toxin from the green mamba (Dendroaspis angusticeps) blocks the hydrolysis of acetylcholine by 
strong inhibition of the acetylcholine esterase enzyme.16 Inhibition of this enzyme prevents termination 
of a nerve impulse.15 One of the toxins is a polypeptide of 61 amino acids, known as fasciculin.17 This 
polypeptide is cationic overall due to the presence of many lysine and arginine residues. When these 
residues are functionalised there is a reduction of 70% in the inhibitory activity of fasciculin.17 This is 
due to a blockage of the interaction between the lysine and arginine residues of the toxin and the 
aromatic amino acid residues of the active site. Therefore the strong binding between the toxin and the 
enzyme can be attributed to cation to pi interactions.  
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2.3 Van der Waals interactions 
 
Van der Waals interactions arise from the polarisation of an atom’s cloud of electrons, but unlike 
hydrogen bonding they are non-directional and are a result of non-permanent polarisation.18 This 
polarisation of a molecule’s electron cloud may be the result of the proximity of another non-polar 
group. If the molecules are close enough the fluctuations may become synchronised and produce an 
attractive force which is strongly dependent on the intermolecular (or inter-atomic) distance. The 
strength of the interaction decreases as a function of distance to the negative 6th power. 8, 19 
 
Van der Waals interactions are important interactions between the alkyl chains in a wide variety of 
mesogens. The odd-even effect in calamitic liquid crystals is due to the disruption of the van der Waals 
interactions between long alkyl chain substituents. When there is an even number of carbon atoms in the 
chain the interactions are disrupted because the alkyl chains cannot come into close enough proximity 
for the van der Waals interactions to take place. This results in a destabilisation of the mesogenic 
phase.20 
 
Another example of the importance of van der Waals interactions is that of the phospholipid membrane 
which surrounds cells and organelles in biological systems.21 Biological membranes are not fully 
understood in vivo and are the subject of intense investigation.22 The physical properties of the 
membrane (fluidity, thickness and lateral mobility of the constituent molecules) determine the 
conformation of proteins which are embedded in or pass through the membrane. This has important 
implications for drug delivery and anaesthesia which involve small lipophilic molecules causing 
changes in the cell membrane.22, 23 
 
Pabst et al. modelled a lipid bilayer and demonstrated that it may be disrupted by the presence of 
ethanol.24 Normally the lipid bilayer is twice the thickness of an individual phospholipid molecule.21 
However when ethanol is added, the hydroxyl group of the ethanol molecules coordinate to the polar 
phosphate head groups of the membrane, so the alkyl chain of the ethanol molecules reside in the more 
lipophilic area of the membrane. This inclusion of a guest into the bilayer causes the packing of the 
alkyl chains of the lipid to be disrupted, and to compensate for this and to prevent formation of a void in 
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the membrane, the chains begin to interdigitate to stabilise the membrane with increased van der Waals 
interactions.24 
 
This interaction is put to use by geckos (Gekko gecko) which can climb a smooth glass surface at high 
speed.25 This is possible because a gecko has approximately 500,000 keratinous hairs known as setae 
which measure 0.2-0.5 µm long, on the pad of each foot.26 The van der Waals interactions between the 
setae and the surface on which the gecko is standing produce up to 20 N of adhesive force per foot.27 
The interaction can be rapidly applied and removed, allowing the gecko to quickly attach and detach its 
foot from a surface and move rapidly.28 This is achieved because a small change in the angle between 
the hair and the surface allows the bond to be broken, since the interaction relies on intimate contact 
between the setae and the surface.27 
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2.4 The hydrophobic effect 
 
The hydrophobic effect is an entropically driven phenomenon which causes non-polar groups to 
aggregate together in aqueous solution. The increase in entropy on formation of aggregates is due to the 
liberation of water molecules which would otherwise be rigidly associated around the non-polar groups. 
This liberation of water molecules is caused by a reduction in surface area when non-polar groups 
associate together. 29  
 
Lipid Transfer Proteins (LTP) transport hydrophobic molecules between membranes in plants. It has 
been discovered by Schramm et al. using X-ray diffraction data that oleic acid can interact with lipid 
transfer protein in two different ways.30 The cavity of the LTP is smaller than oleic acid’s molecular 
volume, therefore both the conformations of the bound guest which have been discovered possess non-
staggered methylene interactions. These gauche interactions are thermodynamically unfavourable but 
this is compensated for by the hydrophobic effect, because when associated with lipid transfer proteins 
the oleic acid is shielded from the aqueous medium.30 
 
In addition to natural systems, it has been shown by Trembleau et al. that the hydrophobic effect can 
negate energetically unfavourable interactions in synthetic systems.31 When an alkene-based surfactant 
is introduced to a synthetic receptor molecule with a hydrophobic cavity in aqueous solution, a 
supramolecular complex is formed. If the guest in its linear form has a molecular volume greater than 
the cavity of the host, the complex will still form. This is because the entropic gain caused by the 
liberation of water molecules to the bulk solution will overcome the energetic cost of the unfavourable 
gauche interactions caused by folding the alkyl chain into a helix.31 
 
21 
 
3 Host-guest chemistry 
 
Intermolecular interactions are the founding principle of supramolecular chemistry, and as shown above 
there are many different types of interaction possible. In order for a supramolecule to be formed, 
complementarity of these molecular interactions is required. This is achieved by manipulation of the 
molecular structure to effect changes in molecular shape. Complementarity of shape is as essential to 
formation of a supramolecule as the interactions themselves. This is because the strongest 
intermolecular interactions (ion-dipole, dipole-dipole and hydrogen bond) are directionally dependent 
and the forces which support the supermolecule (van der Waals forces and hydrophobic effect) rely on 
very close proximity of the interacting groups. 
 
Perhaps the most elegant demonstration of complementarity has been provided by nature in the 
functioning of enzymes and metalloproteins. These molecules make life possible by accelerating 
physical and chemical processes, which are achieved by intricate combinations of inter- and intra-
molecular interactions. That enzymes and their substrates fit together like a lock and key was first 
proposed by Emil Fischer in 1894.32 This was further developed by Koshland et al. in 1960 by their 
suggestion that the protein can modify its shape to fit around its guest when the two are associated. This 
theory became known as the induced fit model.33 
 
The induced fit model can be applied to one of the most closely studied metalloproteins, haemoglobin, 
which is responsible for the transport of oxygen in red blooded animals. Haemoglobin comprises four 
subunits, each responsible for transport of a single dioxygen molecule using their haem iron centre 
bound to a porphyrin macrocycle.34 Haemoglobin demonstrates all of the interactions described in the 
section above in order to maintain its quaternary structure and therefore its function. 35 
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Figure 6 - Oxygen binding to haemoglobin 
(taken from M. F. Perutz, Trends in Biochemical Sciences, 1989, 14, 42-44.) 
 
When dioxygen binds to the haem iron, a conformational change takes place and the iron moves further 
towards the plain of the macrocycle.36, 37 The position of the proximal imidazole ring of a histidine 
residue coordinating to the iron is also altered, causing a conformation change in the quaternary 
structure. 36 This conformation change on binding O2 makes the haemoglobin convert to its ‘relaxed’ 
form and increases the affinity for further oxygen binding by the remaining sites. 35 
 
This cooperation between subunits allows oxygen to fully occupy haemoglobin’s four binding sites 
when in a high oxygen environment (such as the lungs). When the oxygen concentration falls (i.e. in 
tissues) the removal of oxygen from an O2 saturated haemoglobin molecule renders it in a “tense” state, 
where the binding of oxygen is energetically less favourable. Therefore haemoglobin readily unloads it 
remaining oxygen molecules and shows a sigmoid saturation curve illustrated by Figure 7.38-40 
 
Figure 7 - Oxygen partial pressure vs. haemoglobin saturation 
Taken from R. M. Winslow, M. L. Swenberg, R. L. Berger, R. I. Shrager, M. Luzzana, M. Samaja and 
L. Rossi-Bernardi, Journal of Biological Chemistry, 1977, 252, 2331-2337. 
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The affinity for oxygen by haemoglobin can be affected not only by cooperative binding but also its 
local environment. The Bohr Effect describes the pH dependence of haemoglobin’s oxygen affinity, 
which is observed due to modification of the quaternary structure as a result of changes in inter- and 
intra-molecular interactions. The sigmoid curve moves to the left or right depending on the pH of the 
local environment. In the bloodstream an acidic environment is usually due to the presence of high 
concentrations of dissolved carbon dioxide characteristic of high metabolic activity. This low pH causes 
a decrease in the affinity of haemoglobin for binding oxygen, thus the oxygen cargo is delivered to 
tissues where it is most needed.41 
 
“Evolution is a brilliant chemist” 
Perutz 36 
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3.1 Calixarenes 
 
Calix[4]arenes are macrocyclic condensation products of 1,3-dihydroxybenzene (resorcinol) or 1,2,3-
trihydroxybenzene (pyrogallol) with an aldehyde. Alternatively 4-tert-butylphenol may be reacted with 
formaldehyde to produce t-butyl-calix[n]arenes. Figure 8 below shows on the left 
calix[4]pyrogallolarene when X = OH and  calix[4]resorcinarene when X = H. On the right of the 
Figure: t-butyl-calix[4]arene. There may be either alkyl or aryl substituents of the macrocycle denoted 
by R. 
 
 
Figure 8 - Calix[4]arene molecules  
 
The calix- prefix was applied to this class of molecules because t-butylcalix[4]arenes, which were the 
first to be synthesised, were found to have a shape resembling a cup.42 The bowl shape is no longer a 
prerequisite for the calix- prefix (derived from the Greek: calix = cup) and all macrocyclic condensation 
products of aldehydes with resorcinol or pyrogallol are now included in this class. This expansion of the 
class of molecules given the prefix was necessary because tert-butylcalix[4]arenes were subsequently 
found to be conformationally flexible, and a large number of calixarene derivatives have been shown to 
have alternative conformations.43 
 
In calix[4]pyrogallolarenes and resorcinarenes, the upper rim bearing the hydroxyl groups has a wider 
diameter than the lower rim (or annulus). The groups positioned axially at the macrocyclic methylene 
position are known as the pendant chains. These structural features are highlighted in the image 
generated from single crystal X-ray diffraction data in Figure 9 below.  
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Calixarene molecules (pyrogallolarenes, resorcinarenes and t-butylcalixarenes) are cavitand molecules 
which can act as hosts to a surprising variety of guests. The cavity formed by a calixarene is 
hydrophobic, yet it has been proven that they can de-solvate a variety of alkali metal cations, as the aryl  
rings offer the potential to form a strong cation to pi interaction. This interaction has been exploited in 
the use of calixarenes as simplified molecular models of complex biological systems such as sodium 
channels.44 The coordination of a cation to a cavity of a calixarene inhibits the conformational flexibility 
exhibited by t-butylcalix[4]arenes. Coordination of a caesium ion to the cavity of the calixarene has 
been demonstrated in the solid state by X-ray crystallography and in the solution phase using NMR.45, 46 
The coordination of cations to calix[4]pyrogallolarenes has also been published by Ahman et al.47  
 
The cation to pi interactions have been shown to take different forms for the two calixarene species. 
When the t-butyl derivative is coordinated to the cation it holds the cation in the centre of its cavity.45 
The pyrogallolarene adopts a distorted boat-like conformation, allowing η6 coordination to the cation by 
two equatorially positioned aromatic rings from neighbouring molecules. The distortion of the 
macrocycle allows the axial phenyl rings to come into close proximity and form pi - pi interactions.47 
 
It is not only cations which can be bound to the cavity of the calixarenes, a wide variety of guest 
molecules have been coordinated to the interior of the cup, by either the hydrophobic effect or stacking 
interactions such as pi - pi stacking. 
  
Figure 9 - Main structural features of calix[4]pyrogallolarenes 
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A variety of calix[n]arenes have a high affinity for buckminsterfullerenes. Atwood et al. and Suzuki et 
al. demonstrated that calix[8]arene selectively forms an inclusion complex with C60 
Buckminsterfullerene.48, 49 The supramolecular complex increased the solubility of C60 in a variety of 
organic solvents, allowing its separation from fullerene soot to a purity of 98%. It has subsequently been 
shown that other calix[n]arenes and cavitands form complexes with the fullerenes.50-53 
 
Unfunctionalised calix[4]resorcinarenes have a wide cavity which allows rapid exchange of a range of 
guest molecules. However functionalisation of the upper rim creates deeper hydrophobic cavities, with 
the advantage that specificity for guests is increased and exchange rates are slowed. This extension of 
the cavity has allowed large steroid molecules to be encapsulated; a phenomenon driven by the 
hydrophobic effect.54, 55 Cave et al. demonstrated that the cavity of calix[4]pyrogallolarenes can be 
extended by non covalent interactions of 4,4’-bipyridines to the upper rim.56 
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3.1.1 Conformations of calix[4]arenes 
 
Calix[4]arenes possess four stereo-centres at the bridging points of the macrocycle. Different isomeric 
arrangements at these points produce a different conformation in the macrocycle. Figure 10 shows a 
cartoon of the possible conformations, with each square block representing a phenyl ring:  A – cone, B – 
partial cone, C – 1,3-alternate, D – chair 
 
Figure 10 - Conformation of calix[4]arenes 
 
Only t-butylphenyl-calix[n]arenes synthesised from formaldehyde and 4-tert-butylphenol have been 
reported in the literature.43 There are no pendant chains attached to the bridging methylene position of 
the macrocycle present in these molecules. The macrocycle is therefore conformationally flexible and 
can convert between cone and chair via the intermediate forms. When the phenolic hydroxyl groups on 
the lower rim of the t-butylcalix[4]arenes are functionalised this locks the macrocycle in a single 
conformation. Unlike the t-butylphenyl-calix[n]arenes, calix[4]pyrogallolarenes and 
calix[4]resorcinarenes are conformationally locked. The conformation interconversion is sterically 
impossible because the pendant chains are blocked passage through the annulus, therefore conversion of 
conformations is only possible by ring-opening and re-formation of the macrocycle.57  
 
The conformation which predominates in a reaction mixture (during the synthesis of resorcinarenes and 
pyrogallolarenes) is dependent on the reaction conditions and the substituent on the pendant chains. The 
greater steric bulk at the α-position to the aldehyde, the greater yield of the chair conformation (D) is 
isolated; when benzyl aldehydes are used, the chair conformation is exclusively isolated.58 It has been 
shown that cone conformation (A) has the greatest thermodynamic stability when alkyl 
calix[4]pyrogallolarenes are synthesised due to the greater number of intramolecular hydrogen bonds 
which can form.59 Since much research has been undertaken on the cone conformation, syntheses have 
been optimised to yield higher quantities of this isomer.57, 60 
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3.1.2 Synthesis of calix[4]resorcinarenes and calix[4]pyrogallolarenes 
 
Calixarenes are synthesised by the condensation of resorcinol or pyrogallol with an aldehyde under 
acidic catalysis as shown in Figure 11 below. There are currently three methods in use to access these 
molecules: reflux in mineral acid, transition metal catalysed condensations and grinding of the reactants 
are discussed in section 4.1.2. 
 
 
Figure 11 - General synthetic scheme for calix[4]arenes 
 
Calix[4]resorcinarenes (see Figure 11 where X = H, R = CH3) were first synthesised by Niederl and 
Vogel by the condensation of resorcinol and acetaldehyde in acidic solution.61 However, it was a further 
40 years before C-alkyl resorcinarenes were fully characterised by Högberg et al. 62 
 
The conditions of the synthesis determine which conformer and ring size product is formed.63 Högberg 
extended the work of Niederl and Vogel to include C-alkyl-calix[4]resorcinarenes. He described the 
reflux of resorcinol with acetaldehyde in ethanol and hydrochloric acid, and found that changing the 
composition of the solvent and concentration of the hydrochloric acid produced varying amounts of the 
cone and chair isomers. The length of the alkyl chain also affects the solubility of the macrocycle and 
thus the distribution of products produced from the reaction.57 This method became the standard 
technique which has been widely applied to the synthesis of C-alkyl-calix[4]resorcinarenes and C-alkyl-
calix[4]pyrogallolarenes with minor adjustments made to the conditions to optimise the production of 
the desired product.64-66 
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3.1.2.1 Green methods for the synthesis of calix[4]pyrogallolarene derivatives 
 
The technique of refluxing the reactants to prepare calixarenes is very time consuming and produces the 
product in only moderate yields.64-66 As the cone conformation is often the desired product, long 
reaction times (up to 6 days) are used to exploit the low solubility of the thermodynamic product, 
causing its precipitation.67 Coupled with the long reaction times the large solvent volumes required to 
synthesise calix[4]arenes prompted development of novel “green” techniques for their synthesis.  
 
The use of microwave irradiation has been widely applied in synthetic chemistry in recent years to 
reduce reaction times, solvent volumes required and to increase the yield of a reaction.68 This method of 
heating a reaction has been applied to the synthesise calix[4]resorcinarenes by Hedidi et al. and 
calix[4]pyrogallolarenes by Yan et al. 69, 70 It was reported in these articles that the use of microwave 
irradiation considerably shortened the reaction time and reduced the volume of solvent required to 
synthesise the macrocycles by up to 90%.  
 
Hedidi et al. synthesised resorcinarenes as a single conformer, using microwave irradiation in 2-
ethoxyethanol solution. 12-Tungstophosphoric acid (8 mol%) was used as catalyst, however this does 
not significantly increase the isolated yield over use of concentrated hydrochloric acid as the catalyst 
(HCl catalysed the synthesis of six of the nine compounds reported in the article in higher yield). There 
is no mention of recycling the tungsten catalyst or the isolation procedure which was used to separate 
the tungsten catalyst and the product. A claim in the article is that the technique is tolerated by a range 
of functional groups, yet the only functionality published aside from alkyl and benzyl groups was an 
aryl ether.69 
 
Yan et al. employed the method developed by Hedidi et al. to synthesise a range of aryl 
pyrogallolarenes using a solution of concentrated hydrochloric acid. The range of functionality on the 
pendant phenyl rings which tolerate the conditions include aryl rings bearing ethers, halogens and esters, 
demonstrating an extension to the work of Hedidi. Due to the steric bulk at the alpha position below the 
macrocycle ring the chair conformation is formed exclusively.70 
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The ‘green’ methodology of using metal catalysis rather than mineral acids has been extended by the use 
of ytterbium (III) triflate as a Lewis acid catalyst in the reaction of resorcinol with a variety of aldehydes 
in ethanolic solution.71 The catalyst was recovered from the reaction mixture and reused. This technique 
gives yields comparable to the standard reflux in mineral acid but is more atom efficient and therefore 
more environmentally friendly since there are only reactants, and the catalyst (which is recoverable and 
reusable) in absolute ethanol. 71 
 
Most recently a novel technique for synthesizing calix[4]pyrogallolarenes was developed by 
Antesberger et al.72, 73 The reactants are mixed in equimolar amounts in the presence of a catalytic 
quantity of para-toluenesulfonic acid and ground together using a pestle and mortar. This process gave 
C-aryl and C-alkyl-calix[4]arenes in excellent yield. In contrast to the results of Högberg et al.62 the 
equilibration between the cone and the chair isomer was not observed on prolonged standing. This 
supports the earlier theory that strong mineral acids and vigorous conditions are necessary for conformer 
interconversion.63  
 
3.1.2.2 Green techniques for the synthesis of terpyridines 
 
Terpyridines have been co-crystallised with calixarenes to form a variety of supramolecular systems. It 
was found by Cave and Raston that terpyridines can be synthesised by grinding together an aryl 
aldehyde and aryl acetates in the presence of sodium hydroxide to give Kröhnke type pyridines (2,4,6 
substitution pattern). The reactants form a eutectic melt and undergo an aldol reaction followed by a 
Michael type condensation. The intermediate di-ketone is then reacted in acetic acid with ammonium 
acetate which cyclises the intermediate to a pyridine, as shown in Figure 12. 
 
 
Figure 12 - Terpyridine synthesis 
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3.1.3 Capsules formed by calix[4]pyrogallolarenes and calix[4]resorcinarenes 
 
Aoyama first postulated that calix[4]resorcinarenes self-assemble into aggregates in 1988. The mass 
spectra indicated a hexameric arrangement of calix[4]resorcinarene molecules in both chloroform and 
benzene solution but gave no indication of the nature of the structure that was formed.74 It was a further 
nine years before MacGillivray and Atwood published an image generated from single crystal X-ray 
diffraction data showing the formation of a spherical hexameric molecular capsule in the solid state.75 
This C-methyl-calix[4]resorcinarene crystallised from nitrobenzene self-assembles into a nanometer 
scale-sphere with an external diameter of 24.3 Å, held together by 60 hydrogen bonds. Its central cavity 
was unprecedented in size (diameter = 17.7 Å) and volume (approximately 1375 Å3) which was four 
and a half times larger than the capsule reported earlier that year by Kang and Rebek.76  
 
 
Figure 13 - Nanometer scale-capsule formed by C-alkyl-calix[4]pyrogallolarenes 
 
A capsule formed by calix[4]pyrogallolarene was reported two years later by Gerkensmeier et al. who 
proposed that due to a lack of reproducibility of formation, the assembly of six calix[4]pyrogallolarene 
molecules was less stable than the previously reported resorcinarene capsule.77 It has been subsequently 
shown that the pyrogallolarene capsule is in fact more stable due to the extra hydrogen bonding which 
the additional four phenolic hydroxyl groups allow.78, 79 
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The difficulty that Gerkensmeier had in reproducing the capsule formation was recently shown to be due 
to the acetonitrile solvent from which the crystals were grown. When crystallised from acetonitrile, C-
alkyl-calix[4]pyrogallolarenes are capable of forming both bi-layers and dimeric or hexameric capsular 
packing motifs. The resulting packing arrangement is dependent on the degree of hydration of the 
solvent.79 
 
The unequivocal determination of structure by single crystal X–ray crystallography allows the study of 
the interactions which lead to the formation of the various nanometer scale-architectures and packing 
motifs. From data gathered using this technique, it was found that the capsule formed by C-methyl-
calix[4]resorcinarene is a spherical arrangement of six monomer molecules. The capsule is held together 
by 60 hydrogen bonds, 36 of which are intermolecular with each capsule having a seam of eight water 
molecules.75 C-alkyl-calix[4]pyrogallolarenes have been shown to not require this belt of water 
molecules for capsule formation.80 The nanometer scale-capsule itself can have different packing motifs 
in the solid state. The calix[4]pyrogallolarene molecules show varying degrees of interdigitation of 
pendant chains, with perturbation of the sphere observed in one of the polymorphs. 67, 79, 81 It has been 
recently shown by Dalgarno et al. that the formation of capsular architecture by calixarene derivatives is 
not limited to resorcinarene and pyrogallolarene molecules. An upper rim sulphonated and carboxyl 
functionalised calix[4]arene has been shown to enclose 700 Å3 of space.82 The symmetry that the 
carboxyl substituted calixarene possess in the 1,3-alternate conformation allows each calixarene to form 
the walls of two capsules. 
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3.1.3.1 Synthesis of capsules 
 
Currently there are three techniques available for the synthesis of calixarene-derived nanometer scale-
capsules. The technique used by MacGillivray of dissolution in a suitable solvent in the presence of an 
appropriate guest is still widely used for generating hydrogen bonded architectures. More recently it has 
been shown that the capsule can be held to together with metal to ion bonds and covalent bonds. For 
example, the capsule may be synthesised by dissolution of C-methyl-calix[4]resorcinarene in boiling 
nitrobenzene and slow evaporation of the resulting solution. This method of production exploited the 
self assembly of calix[4]resorcinarenes into hexameric spheres in solution when an appropriate guest 
molecule is present, and in this case the solvent proved to be a suitable guest for inclusion. The exact 
location of the guest molecules could not be determined by single crystal X-ray diffraction owing to 
their extensive disorder.75 
 
In subsequent work, resorcinarene capsules have been shown to spontaneously self-assemble in 
chlorinated solvents saturated with water.80 Dissolution of pyrogallolarenes and resorcinarenes in 
chloroform leads to spontaneous formation of nanometer scale-capsules which are stable enough to 
crystallise from solution when slow evaporation is allowed. If a methanolic solution is heated in a sealed 
tube within appropriate guest (to 150°C) and then allowed to slowly cool, crystals suitable for X-ray 
diffraction studies form.83 The capsules have been shown to form in-situ during the macrocyclisation 
reaction when the grinding method is employed.84 In order to speed capsule formation, solutions of 
calixarene may be sonicated in an ultrasonic bath which provides the additional energy required. 
 
Calix[4]resorcinarene derived capsules may be held together by covalent linkers. This has been shown 
by Liu et al. who synthesised an imine link between resorcinarenes which had been functionalised with 
aldehyde groups on the upper rim of the molecule.85 The 18 components of the reaction mixture came 
together to form a nanometer scale-sphere of unprecedented interior volume of approximately 1700 Å3. 
In subsequent publications Liu et al. describe the synthesis of  covalently bound dimeric and tetrameric 
capsules derived from upper rim substituted resorcinarenes.86  
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3.1.3.2 Metal fringed capsules 
 
Orr et al. 87 showed that addition of a lanthanide salt and pyridine-N-oxide changed the molecular 
architecture formed by p-sulfonatocalix[4]arene from a bilayer to a sphere.88 There are significant 
differences between the capsules formed by the resorcinarenes and pyrogallolarenes to those formed by 
p-sulfanatocalix[4]arenes. The capsules derived from p-sulfanatocalix[4]arenes are held together by a 
combination of van der Waals interactions, coordination to metals and the hydrophobic effect, while the 
resorcinarene capsules employ solely hydrogen bonding. Despite the greater number of constituent 
molecules which make up the p-sulfanatocalix[4]arene capsule (12 vs. 6), the molecular volume 
enclosed (1000 Å3) is smaller than that reported for the resorcinarene capsules (1300 Å3). The decrease 
in volume enclosed is due to the lower rim of the calixarene forming the interior surface of the capsule. 
The lower rim of these molecules bears four hydroxyl groups which offer coordination sites to the guest 
molecules, which causes ordering of the guest molecules. It is possible to determine the atomic positions 
of the guest molecules within the capsule by single crystal X-ray diffraction. This is not the case in the 
resorcinarene capsules because the interior of the capsule is formed by the cavity of the macrocycle. The 
upper rim hydroxyl groups are largely involved in hydrogen bonding to the other molecules which form 
the capsule, so the opportunity for coordination within the capsule is limited to cation to pi interactions. 
This results in disorder of the guest molecules.59 Perhaps most importantly the capsules are not discrete 
because the lanthanide ions which hold the capsules together are also coordinated to the capsule 
adjacent so each capsule is coordinated to 6 others which come into contact with it.89 
 
It has been shown that the phenolic hydroxyl groups of the upper rim of calix[4]pyrogallolarenes offer a 
coordination site for a metal ion. Therefore capsules which were held together by hydrogen bonds can 
be synthesised by metal to oxygen bonds to form discrete metal bound nanometer scale-capsules.90-92 A 
hexameric capsule formed by the coordination of copper (II) ions  to six calix[4]pyrogallolarene 
molecules did not show significant changes in volume or shape compared to the hydrogen bonded 
structure.93 The hexameric gadolinium capsule shows significant distortion of both the spherical 
arrangement of the capsule and of the individual calixarene molecules. Unusually for the 
pyrogallolarene capsule, four water molecules are included in the seam of the capsule. This inclusion of 
water is a result of the distortion providing a suitable gap in the hydrogen bonding network. The 
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distortion of the capsule and the larger ionic radius of gadolinium reduces the capsule volume to 
1150Å3. 94 
 
There are two possible capsular architectures when zinc (II) ions are coordinated to 
calix[4]pyrogallolarenes. Firstly a dimeric capsule forms when two calix[4]pyrogallolarene molecules 
are arranged with their upper rims coordinated to a belt of eight zinc ions.91 Secondly, if the calixarene 
is manipulated by substituting a central hydroxyl group of the upper rim for a carboxyl group, this 
provides sites for coordination to metal ions. Single crystal X-ray diffraction data has been collected 
showing hexameric capsule formation with 16 zinc (II) ions coordinating to six calixarenes.95 
 
Following the discovery that pyridines can coordinate to the upper rim of calix[4]resorcinarenes 96 and 
that therefore the dimensions of the cavity can be expanded, a nanometer scale capsule formed by the 
co-crystallisation of 4’-(4-octyloxyphenyl)-4,2’:6’,4’’-terpyridine and C-methyl-calix[4]pyrogallolarene 
was published by Cave et al. 56, 97 
 
Kobayashi et al. combined covalent extension of the upper rim and the use of non-covalent interactions 
to form space enclosing architectures.98 A hydrogen-bonded capsule forms when C-methyl-
resorcinarene functionalised with carboxyl groups on the upper rim is co-crystallised with 2-
aminopyrimidine. This capsular arrangement is stable in solution as well as the solid state because the 
amino-pyrimidine and carboxyl groups are complementary, and the capsule is held together by 16 
hydrogen bonds.  
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3.1.3.3 The interior of the capsule  
 
The interior of the capsule has been likened to a new phase of matter and therefore has been an area of 
interest for a variety of groups over the past 20 years since capsular arrangements of molecules were 
first discovered. 99, 100 
 
A study carried out by Mecozzi et al. led to the development of the 55% rule which states that the 
optimum volume of a host’s cavity which a guest can occupy is 55% ± 9%. If the host capsule is tightly 
held together by hydrogen bonds the occupancy can rise to 70% however this degree of occupancy is 
infrequently observed. The remaining 45% of volume is required for thermal motion of the guest 
molecules. Constriction of these motions is thermodynamically unfavourable as it is effectively freezing 
the molecule out of solution. When solvent molecules are encapsulated (as in the sphere formed by 
pyrogallolarenes in chloroform) the concentration of solvent within the capsule is similar to the external 
concentration.101 In synthetic systems it has been shown that it is possible for guest molecules to be 
contorted by intermolecular interactions into conformations which would be unfavourable in free 
solution, in order to compress its volume to occupy 55% of a cavity.31 
 
The discovery of the 55% rule not only has implications for synthetic systems because it has been 
recently applied to enzymes and their active sites and the design of inhibitors which is of interest in the 
drug development process.102 Zurcher et al. reported that a series of enzyme inhibitors were synthesised 
differing only in the alkyl chain length and that after modelling of the enzymes’ active site they 
discovered that the most effective inhibitors occupied 55% of the volume of the active site.102 
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3.1.3.4 Capsules in solution 
 
The spontaneous formation and stability in solution of capsules consisting of calix[4]arenes was 
independently proven by the groups of Cohen and Rebek within a few months of each other, using 
diffusion NMR spectroscopy to show both the large capsule and their encapsulated guests have the same 
diffusion coefficient. While robust, in solution the capsule is in dynamic equilibrium; individual 
calixarenes comprising the walls of the capsule can be exchanged and while the calixarenes are being 
exchanged the guests can enter and leave, without the complete destruction of the capsule.78, 80, 103-109 
 
It has been recently shown that in the solution phase the resorcinarene capsule does not always have a 
seam of water molecules which is ubiquitous in the solid state structures.75 The inclusion of water 
molecules into the structure of the sphere is dependent on the guest entrapped in the interior of the 
capsule. When solvent molecules or tetraalkylammonium halide salts are encapsulated the belt of water 
is present in agreement with the solid state structure published,110 but if the counter ion of the 
tetraalkylammonium is changed to PF6- or BF4- the belt of water molecules is no longer observed.111 
 
It has also been proven that in solution there is no formation of heteromeric capsules when 
calix[4]pyrogallolarenes and calix[4]resorcinarenes are mixed.112 Cohen et al. discovered that C-alkyl-
calix[4]resorcinarenes formed heteromeric capsules comprising of resorcinarene monomers with 
pendant chains of different lengths. The exchange between two discrete species and a mixture of 
capsules was shown to take seven days at ambient temperature or 2 hours at reflux. 78 
 
It has been shown that the calixarene molecules are capable of showing high degrees of self recognition 
in the formation of spheres. This capacity for self recognition has been tested by the synthesis of 
calixarenes containing both pyrogallol and resorcinol ring units. A statistical distribution of cyclic 
monomers precipitated from the reaction mixture containing equal quantities of pyrogallol and 
resorcinol. When dissolved in a non-polar solvent, homomeric nanometer scale capsules are formed. 
These contain a single heteromeric macrocycle which can be crystallised, showing extreme degrees of 
self recognition as the macrocycles differ only by a single hydroxyl group.113 
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To study the behaviour of nanometer scale capsules in solution at concentrations below the sensitivity 
limit of NMR, Fluorescence Resonance Energy Transfer (FRET) analysis was applied to the calixarene 
system by Barrett et al. FRET is the transfer of energy from one molecule to another by fluorescence. 
The fluorescence of the original molecule (donor) is absorbed and then re-fluoresced by another moiety 
(acceptor). The transfer of energy from donor to acceptor and re-fluorescence by the acceptor can be 
monitored by ultra-violet-visible spectroscopy. FRET can only be achieved by molecules which are in 
very close proximity, so if the donor and acceptor moieties are on different monomers which constitute 
the nanometer scale-sphere, FRET will only be observed in spherical arrangements of nanometer scale-
capsules which hold donor and acceptor species together. FRET is achieved in calix[4]arene systems by 
mono-functionalisation of the pendant chain of calix[4]arene molecule with pyrene or perylene 
substituents. The FRET occurs between the pyrene moiety which absorbs light at 346 nm (the donor) 
and the perylene substituted calix[4]arene (the acceptor), causing its fluorescence. A reduction in the 
pyrene and increase in the perylene fluorescence is therefore observed only when the molecules are 
arranged in a nanometer scale capsule. The FRET studies have demonstrated high levels of self 
recognition in the formation of nanometer scale spheres, because mixtures of calix[4]pyrogallolarene 
and calix[4]resorcinarene monomers do not form. Also shown is the enhanced stability to polar protic 
solvents of the pyrogallolarene spheres over the resorcinol derived derivatives.114, 115 
 
In contrast Ajami et al. used NMR to characterise a calix[4]resorcinarene which had been extended on 
its upper rim with an imido group forming a heteromeric dimer with a calix[4]resorcinarene.116 This 
type of non-self recognition in calixarene systems was unprecedented, showing flexibility in the 
recognition which will lead to capsule formation. In solution there was equilibrium between the three 
capsular species; hexameric capsule of resorcinarene, heteromeric capsule of extended species and 
calixarene and dimeric capsule of extended calixarene. The heteromeric capsule was templated by the 
encapsulation of an appropriate guest. Different guests had different affinities for the capsules and the 
presence of 1,4-diethylbenzene shifted the equilibrium in favour of the hetero-capsule, while addition of 
4,4’-dimethyl-trans-stilbene favoured the formation of the homomeric capsules. 
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3.1.3.5 Capsules in the gas phase 
 
It has been shown in the literature that obtaining mass spectra of supramolecular capsules is possible for 
smaller assemblies such as Rebek’s softball 117 and urea functionalised calixarenes.118 Larger hexameric 
capsules have proven more troublesome to detect in the mass spectrum but recently it has been shown 
that the hexameric capsule formed by calix[4]pyrogallolarene is stable in the gas phase.119 The presence 
of a cationic guest molecule of appropriate size to template the formation of the capsule is required to 
observe the hexamer. If smaller guest molecules are used (e.g. tetramethylammonium tetrafluoroborate) 
dimers and trimers are observed. 
 
In contrast to the work of Cohen et al.104 and Rebek et al.112 Beyeh et al. found that mixed hexamers of 
pyrogallol and resorcinol derived calixarenes were formed in a near statistical distribution when a 
pseudo-octahedral ruthenium(II)tris(2,2’-bipyridine) complex (Figure 14) is the guest molecule. It was 
also found that when solutions of pyrogallolarenes and resorcinarenes were mixed an equilibration 
towards a statistical distribution of calixarene molecules comprising nano-spheres occurred rapidly (<30 
seconds).119 
 
Figure 14 - Ruthenium(II)tris(2,2'-bipyridine) complex 
 
Molecular modelling of the supramolecular nano-capsule shows that the di-cation is the correct size for 
the cavity of the sphere and that the deviation from octahedral geometry of the guest is tolerated. There 
may be a strong cation to pi interaction driving the formation of the sphere but this is not considered by 
Beyeh. The discovery that capsules are stable in the gas phase and that heteromeric capsules can be 
formed if the association to the guest is favourable enough, indicates that the formation of a sphere is 
driven very strongly by the presence of a guest molecule and that the forces which control capsule 
formation can be manipulated with an appropriate guest. 
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4 Drug Delivery 
 
4.1 Historical perspective 
 
In the UK over the past 150 years modern healthcare has more than doubled life expectancy from 39 to 
79 years, and in the past 50 years has reduced infant mortality by 80%.120 Pharmaceuticals developed 
over the past 100 years are a significant weapon in the armoury of healthcare professionals, rendering 
treatable, diseases once considered fatal. The following discussion shows why pharmaceuticals are 
important, how they are developed and used and how this development and use can be improved by 
novel drug delivery techniques. 
 
Treatments available from local apothecaries, unchanged for many hundreds of years, have been 
replaced relatively quickly by a pharmaceutical industry which in its early days was closely linked to 
companies specialising in petrochemicals. Today, pharmaceuticals are a multi-billion dollar industry.120 
This transformation began with the extraction of “active principles” from a variety of plants traditionally 
used in the treatment of illness. One of the earliest examples of this extraction and purification was 
morphine’s extraction from opium in 1803. Once the active ingredient was isolated, the dosage could be 
controlled and treatment could be given in a precise, repeatable fashion.121 This repeatability was 
improved by the invention of tablets which gave further control over the dosage of medicines. The 
industrial tablet compression machine was introduced in England in 1843 and gelatine capsules 
followed in 1875.120 
 
The movement away from the use of plant extracts towards synthetic chemicals can be attributed to Paul 
Ehrlich, who can be described as the originator of antibacterial chemotherapy. While studying azo dyes 
produced by the chemical industry in Germany, Ehrlich noticed that certain dyes stained only bacteria. 
This led to the idea that bacteria could be selectively targeted with a chemical which was toxic only to 
the bacterium like a “magic bullet”.  
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Methylene Blue, a dye which selectively stained the malaria protozoan was used by Ehrlich to 
successfully treat a malaria case in 1891, but due to its renal toxicity and difficulty in producing an 
animal model for malaria (the mosquito vector was unknown at the time) the treatment was not 
developed further. 120, 121 
 
 
Figure 15 - Methylene Blue 
 
Ehrlich continued to screen a variety of dyes and organometallic complexes for antibacterial activity. 
The bacterium which caused syphilis (Treponema pallidum) responded successfully to the 606th 
compound to be synthesised. This compound became known as Salvarsan, the first antibacterial 
chemotherapy available. While offering a cure for syphilis, Salvarsan did require a series of painful 
injections and due to a sulphur impurity from the synthesis, a variety of side effects were observed.122 
The molecular structure of Salvarsan was undetermined until 2005 when mass spectroscopy gave 
conclusive evidence to show that the drug was a mixture of a trimer and pentamer, as shown in Figure 
16 below.122 
 
 
Figure 16 - Structures of Salvarsan 
 
Those studying disease have refined the paradigm developed by Ehrlich by targeting specific receptor 
molecules rather than the whole cell. This advance has been made possible by the use of computers in 
the development of combinatorial chemistry and modelling of receptors which are the desired targets.123 
 This helps chemists design molecules with an appropriate molecular shape (
discussed earlier) and size (
The use of computers and receptor screening has helped to increase the number of 
Entities (NCEs) synthesised, yet there still needs to be five thousand 
which makes it to market.
 
Scientists involved in health research have made great progress in reducing mortality and morbidity 
using chemotherapy but 
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4.2 The drug development process
 
In order to facilitate the discussion of why new chemical entities fail to become drugs a very brief 
overview of the current method of drug development is required
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great challenges remain, including; cancer, coronary heart disease, Human 
V) and malaria. 
 
 (Figure 17). 
Figure 17 - Overview of drug development process 
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Medicinal and combinatorial chemists synthesise a series of molecules which are screened for activity at 
the desired receptor.127 From this initial screening process a candidate having activity towards the 
receptor is taken forwards for further development.128 
The toxicity of the candidate drug is tested on progressively more complex organisms requiring larger 
quantities of active ingredient. If the testing on animal models show no significant toxicity, the drug 
progresses onto double blind clinical trials.129 
 
In the development of a new drug, clinical trials are the most time consuming and expensive phase for 
the company. Phase I trials are on healthy male volunteers and are designed to assess any side effects 
and determine the metabolism of a drug. 126 If Phase I is successful, the drug can pass on to Phase II and 
be tested on a small cohort of patients, to assess its efficacy and dosage against the current gold standard 
of treatment. If efficacy and potency is proven, a large cohort of patients is recruited for phase III trials 
and testing is undertaken. Only when large clinical trials are completed will the relevant agencies 
(Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK and the Food and Drug 
Administration (FDA) in the USA) allow the drug to be marketed. If the number of eventually 
unsuccessful candidate drug molecules which make it clinical trial can be reduced, this will make the 
drug development process significantly quicker and cheaper.121, 123, 124, 130 131, 132 
 
4.3 Why drugs fail 
 
The process of bringing a new drug to market is both lengthy (taking up to 15 years) and costly (more 
than $800 million US dollars per drug125). The improvement of efficiency of this process would benefit 
both the company which develops the drug (in terms of cost reduction and an increase in the time which 
the drug can be marketed under patent protection) and patients, because more treatments may be 
available. In order to improve the efficiency of a process how it can fail must be understood. Below is a 
discussion of why drugs fail and what can be done to improve the process. 
 
An analysis of the reasons for failure of candidate drugs which have undergone clinical trials between 
1964 and 1988; Prentis et al. showed that adverse drug metabolism and pharmacokinetics were the main 
cause of failure to progress (89.9%). The remaining 11.1% of candidates failed to meet commercial 
interests.133 Since this report was published, the pharmaceutical industry has undergone massive 
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changes, with the introduction of automation and computational elements to the drug development 
process. The integration of disciplines has also been helpful in reducing the failures from lack of 
commercial interest by improving communication between the departments.132 
A more recent analysis of why candidate drugs fail was undertaken by Schuster et al.125 Their analysis 
showed that between 1992 and 2002, a drug’s potential efficacy and toxicity could not be determined in 
pre-clinical phases. This is because toxicity and lack of efficacy remain the major reasons for drug 
withdrawal once clinical trials have begun. Their data is in greater detail than that of Prentis et al.133 and 
gives a phase by phase breakdown on the reasons for withdrawal. In Phase I the major reason for 
withdrawal was toxicity, this is because this is the first time that a new chemical entity is given to man, 
and animal models can not predict exact toxicity in man. In Phases II and III the major reason for 
withdrawal was a lack of efficacy. Since these Phases include administration of a candidate drug to 
patients with the targeted condition, accurate measurements of the effect of the drug are possible. The 
proportion of drugs which are discontinued due to toxicity increases from phase II to phase III, this has 
been reasoned to be due to the increased number of patients receiving the drug, allowing rare side 
effects to be observed. 
 
Pharmaceutical companies are making major investments into in vitro and in silico methods to 
determine a candidate drug’s efficiency and toxicity before it is brought to clinical trial, in the hope of 
reducing the number of costly animal and human trials which result in failure.125, 129 
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4.4 Pharmacology and Formulation 
 
Bioavailability is critically important to the efficacy of a drug. Bioavailability is defined as: 
 
“The rate and extent to which the active drug ingredient or therapeutic moiety is absorbed from a drug 
product and becomes available at the site of action.” 134 
 
Pharmacologists and medicinal chemists jointly design a drug with an appropriate drug delivery system. 
A drug delivery system may involve chemical or physical manipulation of the active principle to control 
the bioavailability and prevention of premature drug excretion, inactivation and the Active 
Pharmaceutical Ingredient (API) inducing an immune response. 
 
The provision of accurate, reproducible dosage by the selected route of administration is critical: it is 
known that identical drugs in different formulations give different plasma concentrations.130 The plasma 
concentration which a drug achieves after administration is important because the therapeutic index 
shown below is variable between drugs. Some drugs have small therapeutic indexes therefore making 
control of the plasma concentration of the drug is critical.135 
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In order for the drug to reach the site of action (and cause an effect) the drug can be administered via the 
following routes: 135 
• Oral 
• Sublingual 
• Rectal 
• Application to epithelial surfaces 
• Inhalation 
• Injection – subcutaneous, intramuscular, intravenous, intrathecal 
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With the exception of intravenous injection, the majority of drugs must be taken from the site of 
administration into the bloodstream. This process of transporting a drug to its site of action offers 
challenge for both the pharmacologist and medicinal chemist. 
 
Small, hydrophobic drugs may enter the bloodstream by the trans-cellular route which means passing 
through the cell membrane. This transport may be active (involving carrier proteins or endocytosis) or 
passive (directly through the lipid membrane). The transport of drugs is partially dependent on its 
partition coefficient and therefore its solubility in water and organic solvents. Solubility of the API is of 
critical importance it has been estimated by Fahr et al. that approximately 40% of drugs on the market 
are poorly water soluble.136 
 
Current techniques employed in the pharmaceutical industry for dealing with low solubility APIs are : 
• Micronisation – grinding the drug so the final particle size is between 100 – 200 nm 
• Crystal engineering – changing particle size / (pseudo)polymorphic forms 
• Co-crystals can be formed by slow evaporation of mixtures, growth from melts, 
sublimation, and slurry preparation. 
• Use of different counter ions which affect the solubility 
• Solublisation of drugs in co-solvents 
• Use of micelle / liposome systems. 
• Use of cyclodextrins 
• Use of carrier proteins 
 
Physical methods for drug delivery such as acid resistant tablet coatings and transcutaneous routes, will 
not be covered in further detail in this review, which will concentrate on methods of encapsulation. 
Physical methods such as the micronisation and dispersible tablets rely on increasing the rate of 
dissolution and not increasing the solubility of a drug.136 
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4.5 Pro-drugs, Early Antibiotics and Nitrogen Mustards 
 
One of the earliest techniques for improving the pharmacokinetics of a drug was to functionalise the 
molecule with a biodegradable group which renders it inactive, but when metabolised releases the active 
drug known as pro-drug formation. Addition of the biodegradable group can improve solubility, add 
specificity to the localisation of a molecule in the body,130 prevent metabolism 124 or allow controlled 
release of the drug over a long period of time.130 
 
Pro-drugs may be inadvertently discovered, a good example being the discovery of Prontosil Rubrum in 
1932 by Domagk from the screening of a range of azo dyes. When further investigations into the 
mechanism of Prontosil Rubrum’s bacteriostatic action took place in 1935 by Forneau, they showed that 
in vivo the azo bond was hydrolysed and the 4-aminobenzenesulfonamide was the product had the same 
bacteriostatic action as Prontosil Rubrum, and therefore must be responsible for the efficacy of the 
administered drug. 120, 121 
 
 
Figure 18 - Metabolism of Prontosil Rubrum 
 
This was revolutionary because systemic bacterial infections were generally regarded as untreatable so 
only supportive measures could be taken for a patient. This prompted further derivatives to be 
synthesised and in 1938 Sulfacetamide was synthesised. The greater acidity which the acetyl group gave 
to the nitrogen of the sulphonamide meant that the drug was rapidly excreted through the kidneys to the 
bladder, where it would exert a bacteriostatic action. This side effect is particularly useful in patients 
with urinary tract infections. 
 
The use of pro-drugs is exemplified by early DNA alkylating agents used in antineoplastic 
chemotherapy. It was known that nitrogen and sulphur mustard gas used during the First World War 
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damaged the bone marrow, however they were too toxic to be administered directly as they had a strong 
vesicant effect.120 When the molecular structure was modified, their toxicity was reduced and on 
administration to patients suffering from non-Hodgkin’s lymphoma dramatic remissions were 
observed.124  
 
Nitrogen mustards work by alkylating DNA and therefore preventing cell division, their general 
structure is shown by the first structure of Figure 19. There are two delivery systems at work in this 
treatment; firstly the pro-drug (formation of the active agent within the cancerous cells) and secondly 
the variation of the R group. The general form of a nitrogen mustard is shown in the Figure below. 
Variation of the R group allows tuning of the reactivity of the molecule due to the biologically active 
component of the mustard is an aziridinium cation which the N-7 of guanine is reactive to. It is formed 
by the nucleophilic substitution of a chlorine atom with the lone pair of the nitrogen. The R group can 
exert an effect on the availability of the lone pair of the nitrogen and therefore the rate at which the 
aziridinium ion is formed. 
 
Figure 19 - Mechanism of action for nitrogen mustards 
 
In an example of rational pro-drug design phosphoramidases were found to be over produced in tumour 
cells, and so a phosphoramide containing mustard was synthesised (Endoxana) in order to boost the 
reactivity of the nitrogen mustard in the tumour cell. The increase in reactivity is due to the increased 
availability of the lone pair of the nitrogen atom once hydrolysed. Endoxana was found to have 
improved pharmacological properties over mustine R = CH3. 130 
 
 
Figure 20 - Endoxana metabolism 
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4.6 Microemulsions, Protein Carriers and Taxol 
 
Taxol is an antineoplastic drug approved for use in 1992 by the FDA to treat advanced metastatic breast 
and ovarian cancer.137 The active ingredient was found in the bark of the Pacific yew tree (Taxus 
brevifolia) with yields for its extraction at 0.04% wt/wt meaning a single cycle of treatment would 
necessitate the sacrifice of 4 fully grown trees.137 The drug can now be prepared semi-synthetically from 
the needles of the more common English yew tree (Taxus Baccata). Despite its high tumour response 
rates (51% in metastatic breast cancer 138) Taxol has very low aqueous solubility (0.34 µg/ml) which 
makes both formulation and administration problematic.137 
 
 
Figure 21 - Taxol 
 
Currently Taxol is administered as a Cremophor® / ethanol microemulsion, in order to solubilise 
sufficient quantities of the drug. Cremophor® is a derivative of castor oil which has been developed to 
form micro-emulsions. Unfortunately there are problems associated with the formulation, as micelle 
formation in the bloodstream leads to non-linear dose – anti-tumour activity. It has been shown that the 
delivery method may cause a severe hypersensitivity reaction in 20 – 30% of patients.139 In addition 
significant side effects are nephrotoxicity, neurotoxicity and leaching of Poly(vinyl chloride) (PVC) 
from the infusion apparatus, which may be caused by the delivery method. The majority of the side 
effects can be managed by pre-medication with corticosteriods and antihistamines before each cycle of 
treatment. 140 
 
Taxol has been found to be tightly bound(>90%) to serum proteins in-vivo. These proteins are the 
natural carriers of hydrophobic molecules around the body.137 A formulation was subsequently 
developed in 2002 139 formulating taxol with Human Serum Albumin (HSA) in order to overcome the 
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difficulties in using taxol. A phase III clinical trial (454 patients) found that HSA formulated taxol has 
significantly benefits over the Cremophor® formulation. A higher maximum tolerated dose was found 
to be possible and therefore a higher response rate to treatment was observed. The formulation was 
diluted in a saline or dextrose solution allowing a shorter administration time (30 minutes versus 3 
hours) preventing leaching of the plasticisers from the administration kit removing the requirement for 
pre-medication.141 
 
4.7 Liposomes and Doxorubicin 
 
Liposomes are nanometer sized spherical assemblies of amphiphilic molecules which self assemble into 
a lipid bilayer in the solution phase. They can thereby entrap guest molecules, either within the central 
aqueous cavity (shown in blue in Figure 22) or the lipophilic inter-membrane zone (shown in yellow 
below). This method of drug delivery has been an area of intense scientific endeavour since the mid 
1970’s.142, 143 
 
Liposomal drug delivery is not without problems: their primary method of excretion is by 
reticuloendothelial cells scavenging the vesicles and transporting them to the liver and the spleen for 
metabolism and excretion. This obviously leads to an accumulation of liposomes (and their cargo) in 
these organs.144 As a result there may be hepatotoxicity observed due to increased concentrations of both 
drug and carrier molecules.145  Short shelf life,146 limited drug capacity, use of aggressive conditions for 
their preparation and problems with sterilisation are other problems which it has been necessary to 
overcome.147 Therefore it is only recently (2005) that liposomes have been available in pharmaceutical 
formulations.148 
 
 
 
 
Figure 22 - Schematic representation of a mono-lamellar liposome 
 
  
51 
 
The FDA granted approval for the first formulation to use liposomes as a carrier system in November 
2005. It consisted of mono-lamellar vesicles ≤100 nm diameter containing doxorubicin.149 Doxorubicin 
is an anthracycline antibiotic which is used for treating a variety of solid malignant tumours.150 The total 
maximum cumulative dosage of doxorubicin is limited to 450 mgm-2 due to its severe cardiotoxicity 
which can cause congestive heart failure.151 
 
 
Figure 23 – Doxorubicin 
 
It has recently been shown that doxorubicin is cytotoxic in vitro to glioma (a tumour of the non-nervous 
cells in the nervous system 152) but the free drug has poor blood-brain barrier penetration, preventing its 
use in treatment of brain tumours. A recent clinical trial has shown that PEG-ylated liposomal 
doxorubicin can cause stabilisation of disease in 50% of patients with glioma.148 
 
Other clinical trials have shown that encapsulation of doxorubicin in liposomes increases the 
concentration of drug in the tumour (by up to 10 times in advanced Kaposi’s sarcoma) and also 
increases the drug’s half life, allowing penetration of the blood-brain barrier and reduction in the drug’s 
toxicity over the free molecule. These combined improvements in the pharmacology have been shown 
to result in improvement in the overall survival times for ovarian cancer patients in comparison to those 
receiving platinum based chemotherapy. Patients suffering from Kaposi’s sarcoma are shown to have a 
longer mean survival rate and an increase in health-related quality of life than those on the standard 
ABV (Bleomycin, Vincristine & Doxorubicin) regimen.153  
 
The improvement in pharmacological properties of the liposomal formulation has been attributed to the 
increase in time spent within the body’s circulation over the un-encapsulated drug. The extension to half 
life is thought to be caused by the PEG reducing the attachment of plasma proteins to the liposome 
which would otherwise result in clearance from the circulation.154 The increased circulation time allows 
increased concentration of the drug in solid tumours. This is due to the enhanced permeability and 
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retention effect (EPR effect) in solid tumours. A tumour has different pathophysiological characteristics 
from normal tissue.130 This includes leaky vasculature within tumours which allows the tumour cells 
access to sufficient oxygen and other nutrients. This leaky vasculature allows drug delivery systems to 
leave the general circulation and become concentrated in the tumour.155 
 
4.8 Cyclodextrins and Itraconazole 
 
Cyclodextrins are cyclic oligosaccharides discovered in 1891,156 whose arrangement of hydroxyl groups 
means that the interior of the torus shape is less polar than the exterior.136 This difference in polarity of 
the interior and exterior allows the water molecules coordinated within the cyclodextrin to be liberated 
and replaced by lipophilic guest molecules.157 
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Figure 24 - β-Cyclodextrin 
 
Cyclodextrins have been investigated for drug delivery applications and have been shown to increase 
solubility of lipophilic drugs without changing their molecular structure.147 In 1976 the first cyclodextrin 
drug formulation was approved for use in Japan.158 Currently cyclodextrins are marketed in over 30 
pharmaceutical products.157 
 
Due to their high hydrophilicity cyclodextrins show poor penetration of biological membranes and 
therefore act by increasing the concentration at a membrane surface.159 When a drug is encapsulated, it 
is masked from the external environment, so cyclodextrins have found use in reducing local drug-
induced irritation.158, 160 
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Itraconazole is a wide spectrum antifungal agent which is used to treat infections caused by organisms 
resistant to the standard treatment of fluconazole. Unfortunately it has a very low aqueous solubility 
(1 µgml-1) which limits its clinical utility. It has been formulated with PEG but recently a cyclodextrin 
formulation for oral administration has been approved by the FDA.161 It has been determined that the 
drug is released when the complex comes into contact with the gastric lumen, and once released follows 
the same pharmacokinetics as the un-encapsulated preparation. The cyclodextrin is not absorbed in large 
quantities (0.5% excreted intact in urine), but the majority of the undesirable side effects can be 
attributed to the cyclodextrin rather than Itraconazole.161 The major advantage of the cyclodextrin 
formulation over the PEG capsule is the increased serum concentration achieved, which in clinical trials 
leads to a higher efficacy of treatment.161 
 
 
Figure 25 - Itraconazole 
 
While there are significant advantages to the use of cyclodextrins in pharmaceutical formulation there 
remain some significant disadvantages. For example, β-cyclodextrin shows low water solubility and 
nephrotoxicity 161 and so is unsuitable for intravenous injection. and also the rate of formation / 
dissociation is very close to the diffusion limit so the guest molecules are only weakly held within the 
cavity.158 
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4.9 Summary of drug delivery 
 
The recent progress in improving the pharmacokinetics of doxorubicin has confirmed that there is great 
potential in the field of drug delivery to improve existing treatments and potentially make viable 
chemical entities which were previously too harmful for therapeutic use. These recent developments 
demonstrate that significant progress being made to improve the treatments already available on the 
market by using novel drug delivery systems. 
 
Ideally a new drug delivery system must be cheap to synthesise, be applicable to a variety of therapeutic 
agents, have good stability and improve the pharmacokinetics and efficacy of the drug it carries. Most 
importantly it must be non-toxic and have no major side effects. These are the stringent requirements 
which must be met in order for the drug to be approved by the MHRA and FDA, and therefore be used 
in a clinical setting. 
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5 Analytical Techniques 
 
5.1 Single crystal X-ray Diffraction 
 
The diffraction of X-rays by single crystals and powders is a technique widely used to determine 
unequivocally the arrangements of atoms in space and therefore the inter-molecule interactions which 
contribute to the packing motif formed. Several books and monographs have been published detailing 
the techniques currently in use for data collection and solution.162-164 
 
X-ray diffraction techniques are limited somewhat because hydrogen atoms have 1/50th of the X-ray 
scattering power of carbon atoms, therefore their position is difficult to determine.7 If higher precision of 
the positions of hydrogen atoms is required, neutron diffraction can be performed. The significant 
limitations of this technique include the requirement for much larger crystals (1mm3) than for standard 
X-ray diffraction experiments (therefore limiting the samples which can be run), neutron sources are 
limited and data collection times are much longer, which may contribute to decomposition of the sample 
before analysis is complete.165 
 
X-rays generated by a synchrotron source allow data to be collected from crystals which would be 
unsuitable for analysis by standard lab based instruments. Data collection using a standard in-laboratory 
molybdenum or copper source can fail for several reasons, but most commonly small crystal size and 
weak diffraction are to blame.  Crystals with a shortest dimension <0.01 mm or which show only low 
angle diffraction are often referred to national synchrotron sources for data collection. Successful 
analysis of smaller and flawed crystals is possible due to the shorter wavelength and increased intensity 
of the synchrotron radiation.162-164 
 
 
  
56 
 
5.2 Diffusion NMR spectroscopy 
 
Diffusion NMR uses a conventional NMR instrument to perform non-destructive investigation into the 
shape and size of a species in solution. This technique is becoming widely used in medical sciences and 
more recently is becoming important in drug discovery, allowing probing of interactions between a 
larger host molecule and a smaller guest molecule.108 
 
The work of Cohen et al. (discussed above in section 4.1.3.4) shows that formation of a supramolecular 
species can be monitored by diffusion NMR. It is possible to monitor the encapsulation of guest 
molecules because as the supramolecular assembly moves as a single entity the diffusion coefficient of 
an encapsulated molecule will be the same as the larger host molecule.78, 80, 103, 105-108, 111, 166 
 
The diffusion coefficient of a spherical species through a solution can be determined using the Stokes-
Einstein equation:29 
h
b
r
Tk
D
piη6
=
 
Where D is the diffusion coefficient, kb is the Boltzmann constant, T the absolute temperature η is the 
viscosity of the solution and rh is the hydrodynamic radius of the species. For non-spherical species the 
Einstein-Smoluchowski equation can be used: 
Nf
RTD =
 
Where N is Avogadro’s number and f is the frictional coefficient which is dependent on the shape of the 
molecule. The diffusion coefficient of a species is proportional to the signal intensity which is 
proportional to the magnetic field gradient across the length of the NMR coil. 
 
The diffusion NMR experiment is limited to systems which are at equilibrium with no concentration 
gradients across the sample as diffusion and convection will adversely affect any results. Most diffusion 
experiments are conducted using the PGSE pulse sequence. From the PGSE pulse sequence using an 
extra degree of data analysis a DOSY analysis can be performed. The DOSY experiment allows the 
separation of mixtures by their diffusion coefficients.108 
  
 
 
 
 
 
 
 
 
Chapter 2 - Synthesis and molecular structures 
of C-alkyl-calix[4]arenes 
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1 Synthesis 
 
In order to study the molecular interactions which govern the nanometer scale architectures of C-
alkyl-calix[4]pyrogallolarenes and C-alkyl-calix[4]resorcinarenes, a library of these compounds was 
synthesised and crystals grown from a variety of solvents. The crystals were then analysed by single 
crystal X-ray diffraction crystallography (SCXRD) and mass spectroscopy (MS). 
  
 
Figure 26 - General calixarene synthesis 
 
The library of compounds was synthesised by optimisation of the procedure detailed by Gibb et al. for 
the maximum yield of the cone conformation.167 In the article, Gibb details conditions for the 
synthesis of C-(butanol)-calix[4]resorcinarene by the slow addition of 2,3-dihydropyran to a solution 
of resorcinol in methanol hydrochloric acid, and subsequent heating for 5 days at 60°C. In the 
literature, other authors do not advocate slow addition of aldehydes or long reaction times for alkyl / 
aryl calix[4](resorcin/pyrogallol)arenes and favour rapid addition followed by reflux for up to 8 
hours.42, 43, 115  
Both ‘green’ and ‘conventional’ approaches were investigated and were found to give the desired 
product in moderate to high yields. It was found that longer reaction times gave materials which were 
easier to purify and therefore isolated yields were increased. 
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The reaction products which were produced were routinely analysed by 1H and 13C NMR with 
resonances diagnostic of formation of a macrocyclic product detected.  These characteristic 
resonances can be attributed to the hydrogen bonded to the bridging carbon atom of the macrocycle in 
the 1H spectra. There is also only a single aryl proton detectable by 1H NMR which indicates an 
identical environment for the constituent protons therefore this excludes higher homologues of the 
calixarenes because the larger macrocycle size allows conformational flexibility which would result in 
a disruption of the NMR signals attributable to the proton of the aromatic rings. In the 13C{1H} NMR 
spectrum, there is a characteristic decrease in the intensity of the signal of the carbon atoms of the aryl 
ring (carbon atoms 4 and 6 of 1,2,3-trihydroxybenzene) which become bound to the macrocycle and 
therefore have their protons substituted. 
 
It has been shown in the literature that during the calixarene synthesis the macrocyclisation reaction is 
reversible under the conditions. It has been determined that the cone conformation is the 
thermodynamic product, the intramolecular hydrogen bonds between phenolic hydroxyl groups give 
this conformation greater thermodynamic stability. This conformation also has lower solubility in the 
reaction mixtures than the other conformational isomers.59, 63 Therefore a long, low temperature 
reaction was chosen for the synthesis of calix[4]pyrogallolarenes over the relatively short reaction at 
reflux favoured in the synthesis of t-butyl derived calix[4]arenes.43 Figure 2 shows the conformations 
which a calix[4]arene can adopt, A – cone, B – partial cone, C – pinched cone, D – chair. The cone 
isomer is the only conformation to possess a structure suitable for nano-sphere formation, therefore it 
is the desired isomer in the work of this thesis. 
 
 
Figure 27 - Conformations of calix[4]resorcinarenes and calix[4]pyrogallolarenes 
 
The solubility of the desired cone conformation is sufficiently low in the reaction mixture to allow its 
precipitation under the conditions, performance of the reaction under thermodynamic control therefore 
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allows the cone conformation to be the sole product of the reaction. The product was isolated by 
filtration of the precipitate which formed on cooling of the reaction mixture. The product was purified 
further by recrystallisation from a variety of solvents, with acetonitrile being used in preference for the 
initial isolation of product due to its rapid precipitation of the desired product when cooled. 
 
During the synthesis of the library of compounds, it was found that the rate of addition of the aldehyde 
to the acidic solution of pyrogallol was critical to the yield of calixarene isolated. This was 
particularly evident when performing ring opening of 2,3-dihydrofuran and 2,3-dihydropyran. Rapid 
addition of an aldehyde to an acidic pyrogallol mixture gave low yields. The addition of acid to a 
mixture of pyrogallol and aldehyde was found to yield low amounts of the desired calixarenes.  
 
This finding can be rationalised if the condensation reaction with pyrogallol or resorcinol was less 
rapid than the self condensation reaction which generates aldol products. This self condensation of 
enolisable aldehydes under the reaction conditions would be uncontrolled and therefore give a wide 
variety of products. This is exemplified in Figure 3 below. 
 
 
Figure 28 - Aldol condensation R1 = alkyl / aryl R2 = alkyl / aryl / hydrogen 
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In the past, pyrogallol was used in the laboratory as an indicator of the presence of oxygen, because it 
is easily oxidised, forming a black solution when exposed to oxygen. This high colouration is due to 
the formation of purpurogallin and related oligomers.168 Therefore, in order to improve the yield of 
product, the calixarene syntheses were heated under a nitrogen atmosphere to prevent oxidation. 
 
 
Figure 29 - Oxidation of pyrogallol to Purpurogallin 
 
For clarity and ease of reading, the calixarene molecules have been given their own shortened 
nomenclature system; for example C-methyl-calix[4]pyrogallolarene will be noted as C1Pg. The 
number represents the number of carbon atoms in the pendant chain and the Pg or Rs suffix denotes 
the pyrogallolarenes and resorcinarenes respectively. This nomenclature system is demonstrated in 
Figure 5 below. 
 
 
Figure 30 - Cartoon demonstrating calix[4]arene nomenclature system 
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Crystals were grown by slow evaporation of the pure product from the desired solvent. Where this 
method failed, diffusion methods of growing crystals were attempted. The calixarene was dissolved in 
a solvent and the solution was placed in a vial within a sealed container which contained a second, 
more volatile solvent in which the calixarene had low solubility. As the counter-solvent slowly 
diffuses into the calixarene solution, this causes crystallisation to occur, producing materials which 
were suitable for single crystal X-ray diffraction analysis. 
 
The single crystal X-ray structures reported in this thesis were collected at three sources, Daresbury 
synchrotron, the EPSRC crystallography service at Southampton University and Heriot Watt 
University. At the non-synchrotron sources MoKα radiation was used and in order to minimise the 
inter-atomic movement the crystals were cooled to 120 K. Structures were solved by direct methods 
using SHELX-97 via the X-SEED interface.169-171 Molecular geometries and inter-atomic distances 
were calculated using X-SEED or Mercury programmes, X-ray coordinates have been deposited with 
the CCDC.172 Volumes of cavities or solvent filled voids were calculated using the MCAVITY 
programme.173 Where a hydrogen atom is geometrically generated using the AFIX command, 
hydrogen bond distances are quoted as the inter-heteroatom distance in addition to the hydrogen – 
heteroatom distance. 
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2 Molecular structures of C-alkyl-calix[4]arenes 
 
2.1 C-Methyl-calix[4]pyrogallolarene 
 
C-Methyl-calix[4]pyrogallolarene was successfully synthesised in the cone conformation using 
methods which required solvent and the solvent free technique. Crystals of the material were grown 
by slow evaporation of a saturated solution of calixarene in diethyl ether and acetonitrile. 
 
The acetonitrile solvate (C32H32O12·3(CH3CN)) crystallises in the space group P2/n and shows a head-
to-tail arrangement of the calixarene molecules. A single acetonitrile molecule resides within the 
cavity which is formed between the pendant chains of one calixarene and the upper rim of the 
calixarene below. The acetonitrile is aligned vertically with respect to the cavity of the calixarene, 
with its methyl group pointing towards the cavity and a hydrogen bonding interaction between the 
nitrogen of the cyano group and the hydrogen atoms of the lower rim of the calixarene above. These 
hydrogen bonds interactions are N(1) ··· H(9) = 2.601 Å and N(1) ··· H(1A) = 2.60 Å in length are 
within the expected limits for this type of interaction (2.2 – 3.2 Å) as reported by Jeffrey (N(1) ··· C(1) 
= 3.53 Å and N(1) ··· C(9) = 3.53(6) Å).7 
 
 
Figure 31 - C-Methyl-calix[4]pyrogallolarene acetonitrile clathrate 
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The volume of the cavity formed between the upper rim of one calixarene and including the pendant 
methyl groups and the lower rim of the calixarene molecule above was calculated using MCAVITY.  
The cavity was found to be approximately 85 Å3 in volume and the volume of the guest acetonitrile 
(shown in a space filling representation in Figure 8 above) was calculated with X-SEED to be 47.3 Å3. 
This represents 56% occupancy of the total volume of the cavity comparing favourably with 
Mecozzi’s 55±9% solution for synthetic receptors.101 
 
The very small difference in distances of the hydrogen bonds between the protons and the guest 
acetonitrile molecule show that the acetonitrile is centrally arranged and that there is very little 
distortion of the macrocycle in the solid state. This lack of distortion can be quantitatively assessed by 
generating centroids ((1)(2)(3)(4)) in the constituent aromatic rings of the calixarene and measuring 
the distance between opposite rings and comparing the difference between the two possible distances 
as shown in Figure 32 below. 
 
 
Figure 32 - Distortion factor calculation 
 
This gives the distortion factor, which in this case is 0.99 indicating near perfect symmetrical 
arrangement of the aryl rings. 
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A second acetonitrile molecule is found in the crystal lattice forming a hydrogen bond to the upper 
rim of the calixarene molecule (N(2) … H(2A) = 1.86 Å (N(2) … O(2) = 2.71 (6) Å)); however, this 
causes no perturbation of the macrocycle or packing arrangement because the calixarene above is 
perfectly superimposed onto the original. This means that an infinite 2D chain of calixarene molecules 
are formed because the neighbours in the other plane are arranged in the same way so there are chains 
of oppositely arranged calixarene molecules this is shown in Figure 33 below.  
 
 
Figure 33 - Packing diagram of C-methyl-calix[4]pyrogallolarene acetonitrile clathrate (solvent 
molecules and hydrogen atoms removed for clarity) 
 
A solid state molecular structure of the diethyl ether clathrate (C32H32O12·3(CH3CH2OCH2CH3)) was 
solved from data collected on crystals formed by slow evaporation of a solution of C1Pg in ether 
which had been sonicated for 20 minutes. The structure which forms is markedly different to that of 
the acetonitrile solvate. It is in space group C2/c with molecules arranged in a head-to-head packing 
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motif. The calculated density of the diethyl ether solvate is significantly lower (1.21 g cm-3) than that 
of the acetonitrile solvate (1.35 g cm-3). This may be due to the greater volume occupied by the three 
solvent molecules present in the lattice in the diethyl ether clathrate over the two acetonitrile 
molecules present in the previous structure. 
 
 
Figure 34 - C-Methyl-calix[4]arene diethyl ether solvate (exo solvent molecules removed for clarity) 
 
Three solvent molecules are included in the asymmetric unit, the first of which partially resides within 
the cavity of the calixarene. One of the guest’s ethyl groups resides in the cavity forming CH – pi 
interactions (H(34B) … (1) = 2.91 Å and C(34) … (1) = 3.56 Å). The ethereal oxygen forms a hydrogen 
bond (O(13) ··· H(10A)  = 1.86 Å and O(13) ··· O(10) = 2.61(6) Å) to the upper rim of the calixarene 
which is arranged in a head-to-head fashion with the first calixarene. This interaction causes a 
misalignment in the head-to-head arrangement and only approximately one third of the cavity’s 
opening is covered by a single calixarene molecule above. 
 
The remaining two solvent molecules reside outside the calixarene’s cavity but form hydrogen bonds 
to the upper rim of the first calixarene molecule (O(15) ··· H(2A) = 1.98 Å and O(14) ··· H(5A) = 1.63 
Å (O(15) ··· O(2) = 2.754 Å and O(14) ··· O(5) = 2.746(6) Å). One of these exo solvent molecules has 
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its alkyl chains disordered over two positions (shown as blue and red chains in the Figure below).  
Disorder is not seen in the endo solvent molecule, which indicates there is a greater freedom of 
movement in the exterior solvent molecules.  
 
 
Figure 35 - C-Methyl-calix[4]arene diethyl ether solvate 
 
 
Figure 36 - Misalignment of head-to-head arrangement (solvent molecules and hydrogen atoms 
removed for clarity) 
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2.2 C-Ethyl-calix[4]pyrogallolarene 
 
C-Ethyl-calix[4]pyrogallolarene was synthesised in the cone conformation by both the method 
requiring use of solvent and the grinding method. It was found that a significant proportion of the 
material generated by the grinding process was in the chair conformation which can be separated from 
the cone conformation by recrystallisation from acetonitrile. As the cone isomer is less soluble in 
organic solvents it is easily isolated by filtration. 
 
Crystals were grown by the slow evaporation of an acetonitrile solution. This gave a structure which 
was dramatically different to that shown by the C1Pg acetonitrile clathrate (C36H40O12·5(CH3CN)). 
The molecule crystallises with one calixarene and five acetonitrile in its asymmetric unit and the unit 
cell is filled by symmetry operations of the space group P21/c, and as a result of the 21 screw axis a 
mixture of both head-to-head interactions and also head-to-tail interactions is found. 
 
Figure 37 - Packing motif in C-ethyl-calix[4]pyrogallolarene acetonitrile clathrate (solvent molecules 
removed for clarity) 
 
There are two crystallographically unique hydrogen bonds between the upper rims of calixarenes 
which have been rotated and translated: H(2A) ··· O(3) = 1.89 Å (O(2) ··· O(3) = 2.70 Å) and H(5A) ··· 
O(8) = 2.07(7) Å (O(5) ··· O(8) = 2.73(5) Å). 
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The head-to-tail interaction covers approximately one quarter of the surface area of the upper rim of 
each calixarene. Approximately half this area again is taken up by a head-to-tail interaction, with the 
remaining area being filled by three well defined solvent molecules. 
 
One of the crystallographically unique acetonitrile molecules resides within the cavity of the 
calixarene but in contrast to the C1Pg case is tilted at an angle of 54° from the central plane of the 
calixarene, and does not interact with a lower rim of the above calixarene. This molecule instead 
interacts with the upper rim of a calixarene which has been inverted N(1) ··· H(7B) = 2.13 Å (N(1) ··· 
O(7) = 2.86 Å). A crystallographically unique acetonitrile coordinates to the lower rim of each 
calixarene molecule and is well aligned with the plane of the ring (shown as the red line in Figure 39) 
and is tilted 37.5° from the calixarene normal (shown as blue line in Figure 39) and forms a hydrogen 
bond to the lower rim of the annulus 2.69 Å long. 
 
 
Figure 38 - C-Ethyl-calix[4]pyrogallolarene acetonitrile solvate 
 
The hydrogen bonding interaction between an acetonitrile molecule and the lower rim of a calixarene 
is shown to be important to the formation of different packing architectures. This effect can be clearly 
observed in the packing motif of calixarenes which have pendant chains functionalised with nitrile 
groups, which will be discussed in later sections. 
 
37.5° 
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2.3 C-Ethyl-calix[4]resorcinarene 
 
C-Ethyl-calix[4]resorcinarene was synthesised by a slow drop-wise addition of propanal to an acidic 
solution of resorcinol. The reaction was heated to 70°C for 4 days and upon cooling the desired 
product precipitated from solution. Recrystallisation of the material from ethanol gave the product in 
moderate yield. Crystals were grown by the slow evaporation of solvent from an acetonitrile solution. 
 
 
Figure 39 - C-Ethyl-calix[4]resorcinarene acetonitrile water clathrate (exo solvent molecules removed 
for clarity) 
 
The packing motif and molecular structure (C36H40O8·(CH3CN)(H2O)) which is revealed on solution 
of the data is strikingly different to that of C-ethyl-calix[4]pyrogallolarene acetonitrile water clathrate 
and bears a closer resemblance to the molecular structure of C-methyl-calix[4]pyrogallolarene 
acetonitrile clathrate. Firstly, the calixarene molecules are arranged in a head-to-tail packing motif 
which P2/n symmetry converts into an alternating infinite vertical sheet architecture, which is seen in 
C1Pg acetonitrile clathrate.  
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Secondly the position of the acetonitrile is remarkably different to that seen in the C-ethyl-
calix[4]pyrogallolarene analogue, with the acetonitrile molecule being in parallel alignment with the 
calixarene and forming a hydrogen bond to the annulus of the calixarene above (N(1) ··· H(6) = 2.82 Å 
(N(1) ··· C(6) = 3.77(6) Å) and N(1) ··· H(15) = 2.85 Å (N(1) ··· C(15) = 3.72(6) Å)). 
 
A water molecule resides exo to the cavity, and forms an intra-sheet bridge between calixarene 
molecules, This bridge runs from H(1A) of the upper rim to the oxygen of the water O(5) and is 1.85 
Å long (O(1) ··· O(5) = 2.68(6) Å). The water molecule then forms a hydrogen bonds from one of its 
hydrogen atoms (H(5C)) to the upper rim of the adjacent calixarene (O(2)) which is 2.12 Å long (O(5) 
– O(2) = 2.79(6) Å). 
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2.4 C-Propyl-calix[4]pyrogallolarene 
 
C-Propyl-calix[4]pyrogallolarene was produced by conventional and ‘green’ methods in high yield. 
This molecule was amenable to crystallisation and crystals were grown from saturated solutions of 
acetone, acetonitrile, diethyl ether, and ethanol to give four distinct phases. 
 
In the ethanol clathrate the expected bilayer structure is formed (C40H48O12·3C2H5OH·2H2O). This 
bilayer is formed by the interdigitation of the pendant chains of calixarenes which are arranged in a 
head-to-head packing motif. The closest approach of the pendant chains to the annulus is 
H(20A,B&C) – plane generated from H(1,11,21,31) = 2.905 Å (C(20) – Plane (C(1,11,21,31)) = 4.045 
Å) The asymmetric unit (ASU) contains one complete calixarene, three ethanol and two water 
molecules. The structure is in space group P which converts the ASU into a bilayer as shown in the 
Figure below.  
 
 
Figure 40 - Interdigitation of pendant chains in C-propyl-calix[4]pyrogallolarene ethanol water 
clathrate 
 
Each face of the bilayer is formed by the square packing of calixarene molecules with alternating 
absences. These absences are filled with solvent molecules (two ethanol and two water molecules). 
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The solvent molecules form hydrogen bonds to the upper rims of the adjacent calixarenes (O(16) ··· 
H(4) = 1.83 Å (O(16) ··· O(2) = 2.65(5) Å), H(50) ··· O(11) = 2.19 Å (O(16) ··· O(11) = 2.83(5) Å),  
H(34) ··· O(17) = 1.84 Å (O(11) ··· O(17) = 2.71(6) Å)) which hold the layer in place. All four phenyl 
rings of each calixarene are involved in the hydrogen bonding to the solvent pool. The solvent filled 
void does not penetrate the full length of the bilayer and is capped by the pendant chains of a 
calixarene from the interdigitating layer. Above the plane of the bilayer the voids are capped by the 
presence of the cavity of a calixarene. This inclusion of ethanol into the bilayer is reminiscent of the 
disruption by ethanol to lipid bilayers in biological systems which is proposed by Pabst et al.24 
 
An ethanol molecule resides within the cavity which forms a hydrogen bond to the upper rim of a 
calixarene of the next bilayer (O(13) ··· H(25) = 1.91 Å (O(13) ··· O(9) = 2.72(5) Å)). 
 
 
Figure 41 - Plan view of surface of bilayer formed by C-propyl-calix[4]pyrogallolarene ethanol water 
clathrate 
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The acetone clathrate (C40H48O12·3(CH3C(O)CH3)) includes four molecules in its asymmetric unit 
(one calixarene and three acetone molecules). With P2/c symmetry a bilayer is formed. The first 
acetone resides outside the cavity of the calixarene and in a similar manner to C3OHPg (see Chapter 5 
section 3.1) a hydrogen bond is formed from the oxygen of the acetone to the lower rim of the 
calixarene (O(9) ··· H(20) = 2.82 Å (O(9) ··· C(1) = 3.82(6) Å), O(9) ··· H(21) = 2.87 Å (O(9) ··· C(16) 
3.79(6) Å)). 
 
 
Figure 42 - Packing in C-propyl-calix[4]pyrogallolarene acetone clathrate 
 
The second acetone forms a hydrogen bond to the upper rim of the calixarene (O(8) ··· H(17) = 1.83 Å 
(O(5) ··· O(8) = 2.76(5) Å)). The third acetone molecule resides within the cavity and coordinates to 
the upper rim of the next layer with one crystallographically unique hydrogen bond (O(7) ··· H(16) = 
1.91 Å (O(7) ··· O(1) = 2.75(4) Å)).  
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Crystals rapidly formed when a solution of C3Pg in diethyl ether was left to slowly evaporate 
(C40H48O12·(CH3CH2OCH2CH3) (H2O)) . The molecular structure which is revealed shows a bilayer 
arrangement of the calixarene molecules formed of two crystallographically unique calixarene 
molecules, two diethyl ether and one water molecule.  
 
The architecture which is formed is interesting because there is no interdigitation of the pendant 
chains which is a formation commonly observed in the calixarenes bilayer. This is shown in Figure 43 
below with each unique type of calixarene highlighted in a different colour. 
 
 
Figure 43 - Bilayer arrangement of C-propyl-calix[4]pyrogallolarene diethyl ether water clathrate 
(solvent molecules and hydrogen atoms removed for clarity) 
 
Each crystallographically unique calixarene is tilted at an angle of 20.7° to each of other. Due to the 
tilting of each sheet of calixarenes, direct calixarene – calixarene inter layer hydrogen bonding is 
possible. H(25) ··· O(17) = 1.97 Å (O(25) ··· O(17) = 2.78(15) Å), H(15) ··· O(9) = 2.18 Å (O(15) ··· 
O(9) = 2.96(7) Å), H(14) ··· O(8) = 1.94 Å (O(14) ··· O(8) = 2.77(10) Å), H(10) ··· O(17) = 2.10 Å 
(O(10) ··· O(17) = 2.91(8) Å), H(25) ··· O(17) = 1.97 Å (O(11) ··· O(17) = 2.80(10) Å). 
77 
 
In addition to the bilayer packing, there is an additional symmetry in the packing of the calixarene, 
which is expressed by P21/c symmetry. This can be seen in the formation of two sheet-like planes 
composed of one crystallographically unique calixarene molecule per sheet. These sheets are arranged 
perpendicular to the plane of the bilayer and extend in two dimensions throughout the structure. This 
can also be seen in Figure 43 above. There are intra-layer, inter-sheet hydrogen bonds formed between 
the upper rims of the calixarenes: H(22) ··· O(7) = 2.03 Å (O(22) ··· O(7) = 2.73(6) Å), H(3) ··· O(18) 
= 2.02 Å (O(3) ··· O(18) = 2.70(6) Å). The ether molecules which reside within the cavity forms an 
inter layer, intra-sheet hydrogen bond: O(25) ··· H(13) = 1.88 Å (O(25) ··· O(13) = 2.67(15) Å) and 
O(26) ··· H(12) = 1.86 Å (O(26) ··· O(12) = 2.64(23) Å). The shape and positioning of the diethyl ether 
molecules determines the architecture which is formed. Both ether molecule reside centrally within 
the respective cavities which gives the opportunity to form hydrogen bonds to the ethereal oxygen 
atoms by the next layer. This causes an offsetting of the packing of the calixarene molecules from 
central alignment as seen in earlier examples.  
 
Both unique calixarenes within the structure have one of their pendant chains disordered over two 
positions from the α position to the macrocycle (disordered positions C(39), C(40) and C(49), C(50)). 
One of the calixarenes has one of its pendant chains projecting perpendicularly to the cavity (so that it 
is parallel to the plane of the bilayer). This is the first example of this projection of the pendant chains 
in the homologous series of C-alkyl-calix[4]pyrogallolarenes. The projection is intra sheet and 
therefore the projection of the pendant chain runs parallel to the plane of the bilayer in one plane but 
within the sheet. The calixarenes are tilted with respect to the plane of the bilayer and therefore in 
order to fill the space which is created between the calixarenes the projection fills any void which 
would otherwise form due to the tilted arrangement. 
 
The molecular structure of the acetonitrile clathrate (4(C40H48O12)·6(CH3CN)·3(H2O)) revealed a large 
unit cell (volume 4034 Å3) with an unusually large number of molecules within the unit cell (4 
calixarenes, 6 acetonitrile and 3 water molecules). The crystal is packed according to P symmetry; no 
higher symmetry could be determined using PLATON’s ADDSYM programme. The calixarene 
molecules once packed form a bilayer motif in a similar manner to that formed by the ethyl acetate, 
with each calixarene holding a single acetonitrile molecule within its cavity 
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Figure 44 - Packing in C-propyl-calix[4]pyrogallolarene acetonitrile water clathrate 
 
In a significant departure from the ethyl acetate derivative and the acetonitrile clathrates reported in 
shorter alkyl chain derivatives, the two crystallographically unique acetonitrile which are not bound 
by the cavity of the calixarenes are entrapped between the pendant chains of two calixarenes. The 
position of the solvent inclusion alternates over the a axis (1,0,0), This packing motif extends 
perpendicularly to the plane of the bilayer, therefore forming sheets of solvent including and 
excluding calixarenes which is reminiscent of C3Pg diethyl ether clathrate. This packing architecture 
can be seen in Figure 44 above and the individual detail of a solvent molecule including and excluding 
dimer can be seen below in Figures 45 and 46 respectively. 
 
Unlike the C2Pg MeCN clathrate, the exo acetonitrile molecules are not aligned along the plane of the 
phenyl rings of the pyrogallolarene. Therefore the distance between the annulus and the nitrogen of 
the acetonitrile (N(6) – H(1A) = 2.93 Å (N(6) – C(1) = 3.872(6) Å and N) is greater than previously 
seen. The anti-parallel arrangement of the acetonitrile molecules is similar to that shown by C5Pg 
MeCN clathrate. 
79 
 
 
Figure 45 - Detail of structural repeating unit in solvent including sheet of C-propyl-
calix[4]pyrogallolarene 
 
Unusually the water molecule which is present within the lattice resides close to the lower rim of the 
pendant chain and does not form a hydrogen bond to the upper rim of the any calixarenes. The 
calixarenes in the non-solvent including show strong interdigitation of the pendant chains in order to 
prevent void formation. 
 
Figure 46 - Detail of non- solvent including sheet motif of C-propyl-calix[4]pyrogallolarene 
acetonitrile clathrate (hydrogen atoms removed for clarity) 
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2.5 C-Butyl-calix[4]pyrogallolarene 
 
C-Butyl-calix[4]pyrogallolarene solvates were grown from ether and acetonitrile. Both structures 
show dramatically different packing architectures whose origin can be attributed to the structure of the 
guest molecule which is present within the crystal lattice. 
 
The diethyl ether clathrate (C44H56O12·(CH3CH2OCH2CH3)·3(H2O)) contains five molecules in its 
asymmetric unit (three water, one diethyl ether and one calixarene molecule) which fills its unit cell 
with P21/c symmetry.  
 
 
Figure 47 - Asymmetric unit of C-butyl-calix[4]pyrogallolarene diethyl ether water clathrate 
 
As with previously reported examples of the diethyl ether clathrates of C-alkyl-
calix[4]pyrogallolarenes, a bilayer architecture results. What separates this structure from the C1Pg 
and C3Pg clathrates is the interdigitation of the pendant chains, within the lipophilic region of the 
bilayer. Like the previously reported examples there is close proximity of the upper rims in opposite 
faces of the bilayers because there is a hydrogen bond between the solvent molecule and the upper rim 
of the facing calixarene. Therefore the bilayer does not form a contiguous solvent filled void across 
the lattice. Three water molecules are entrapped between the layers and form a hydrogen bonded 
network which links the polar upper rims of two facing bilayers.  
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O(13) ··· H(7) = 2.01 Å (O(13) ··· O(7) = 2.79(6) Å), O(14) ··· H(10) = 1.97 Å (O(14) ··· O(10) = 
2.77(7) Å), O(14) ··· H(15B) = 1.75 Å (O(14) ··· O(15) = 2.76(8) Å), H(14B) ··· O(11) = 1.64 Å (O(14) 
··· O(11) = 2.76(7) Å), H(14A) ··· O(13) = 1.82 Å (O(14) ··· O(13) = 2.82(7) Å), O(15) ··· H(5) = 1.84 
Å (O(15) ··· O(5) = 2.65(7) Å), O(15) ··· H(16B) = 1.51 Å (O(15) ··· O(16) = 2.65(8) Å), H(15A) ··· 
O(6) = 1.95 Å (O(15) ··· O(6) = 2.80(6) Å), O(16) ··· H(2) = 2.10 Å (O(16) ··· O(2) = 2.72(7) Å), 
O(16) ··· H(1) = 1.91 Å (O(16) ··· O(1) = 2.62(7) Å), H(16A) ··· O(9) = 1.59 Å (O(16) ··· O(9) = 
2.73(7) Å) 
 
When crystallised from acetonitrile C44H56O12·5(CH3CN)(H2O), molecules within the crystal were 
found to pack into a hexameric nano-sphere formation. When the volume was calculated using 
MCAVITY the six C-butyl-calix[4]pyrogallolarene molecules enclose 1274 Å3 of space.  
 
The asymmetric unit consists of four acetonitrile molecules, one water and one calixarene molecule, 
as shown in Figure 48 below. Two of the acetonitrile and one water molecule reside exo to the capsule 
while the remaining two unique acetonitrile molecules are encapsulated within the nano-sphere. 
 
 
Figure 48 - Asymmetric unit of C-butyl-calix[4]pyrogallolarene acetonitrile water clathrate 
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The identity and position of twelve acetonitrile guest molecules encapsulated within the sphere can be 
conclusively determined. Location of the guest molecules within calixarene spheres is highly unusual; 
previously reported spheres have been formed from relatively non polar solvents (chloroform and 
ethyl acetate), which do not form strong interactions with the walls or seam of the capsule. The 
movement of these solvent molecules which do not interact with the walls of a sphere is unrestricted, 
therefore the guests may act as a liquid within the sphere and diffraction of X-rays is not possible. In 
the acetonitrile clathrate there has been sufficient ordering of the solvent molecules within the capsule 
to allow their determination (the specific interactions will be discussed later). There is however 
remaining unassigned electron density within the capsule, from which the structure of a guest 
molecule could not conclusively be determined and was therefore modelled as diffuse electron 
density. There is sufficient space within the capsule to accommodate a further six acetonitrile 
molecules (one extra MeCN per ASU1). This would be acceptable under the 55 ± 9% rule proposed by 
Mecozzi et al. as 62% of the available volume would be occupied by the eighteen acetonitrile 
molecules, rather than 41% with twelve acetonitrile molecules encapsulated.101 
 
There are four crystallographically unique faces which the sphere forms are highlighted with different 
colours in Figure 49 below. Each face demonstrates a different set of Inter- and intra-molecular 
interactions and architectures. The nano-sphere is formed by R symmetry operation on the 
crystallographically unique calixarene molecule, therefore any perturbation of the walls of the sphere 
must originate from the individual macrocycle. This highlights the importance of understanding how 
the inclusion of guest molecules affects the structure of the macrocycle. 
                                                          
1
 (The average volume of an acetonitrile molecule is calculated (using XSEED) to be 43.85 Å3) 
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Figure 49 - Image showing unique faces of the nano-sphere formed by C-butyl-
calix[4]pyrogallolarene acetonitrile clathrate (pendant chains, hydrogen atoms and solvent molecules 
removed for clarity) 
 
Face 1 (shown in blue) and Face 4 (shown in pink) are enantiomers, as are Faces 2 and 3. The 
capsules are stacked along the c axis (0,0,1) with Face 4 being stacked against Face 1, the separation 
of the faces is 6.224 Å. Within a capsule Face 4 has its phenyl rings rotated through 60° relative to 
Face 1; therefore because the capsule is not rotated when stacked, the phenyl rings of Faces 1 and 4 
are not directly aligned directly above each other. 
 
 
Figure 50 - Stack of nano-capsules C-butyl-calix[4]pyrogallolarene acetonitrile clathrate (endo solvent 
molecules removed for clarity) 
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The faces are separated by a channel of solvent molecules which are entrapped between Faces 1 and 4 
and enclosed on all sides by the pendant chains of adjacent stacks of nano-spheres. The six acetonitrile 
molecules and six water molecules which reside within the channel are arranged into a torus shape 
with the acetonitrile molecules forming the exterior of the torus by a head-to-tail interaction and the 
six water molecules residing within the centre of the ring formed by the acetonitrile molecules. This is 
shown in Figure 51 below. 
 
 
Figure 51 - Plan view of stack of nano-capsules showing exo solvent molecules in space-filling 
representation (hydrogen atoms removed for clarity) 
 
The pendant chains of adjacent stacks of nano-spheres interpenetrates the gap between Faces 1 and 4 
this allows the stacks of nano-capsules are offset along the c axis, therefore the nano-spheres form a 
hexagonal close packing arrangement. 
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2.6 C-Pentyl-calix[4]pyrogallolarene 
 
C-Pentyl-calix[4]pyrogallolarene was synthesised by the solvent and solvent free methods in the cone 
conformation. A molecular structure was obtained by growing crystals from a solution of acetonitrile. 
  
The first structure to be solved was that of C-pentyl-calix[4]pyrogallolarene acetonitrile water 
clathrate C48H64O12·(CH3CN)(H2O). This structure has three molecules in its asymmetric unit (1 
calixarene, 1 water molecule and one acetonitrile. On packing the unit cell a capsular arrangement 
arises from the P21/c symmetry operations applied to the asymmetric unit. Two acetonitrile molecules 
are completely encapsulated by the head-to-head arrangement of the calixarene molecules. Two water 
molecules (both symmetrically identical) fringe the capsule. The distance between upper rims (2.26 
Å) (planes generated from average O2, O5, O8, O11) combined with the offset of the capsules from 
perfect alignment (by 1.71 Å when viewed along crystallographic axis b and 1.54 Å when viewed 
along crystallographic axis c (0,0,1)) mean that direct calixarene – calixarene hydrogen bonding 
between layers is impossible. 
 
 
Figure 52 – C-Pentyl-calix[4]pyrogallolarene acetonitrile water clathrate 
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The acetonitrile guest is held in place by a hydrogen bond from the central hydroxyl group of a phenyl 
ring (H(13) ··· N(43) = 2.04 Å and N(43) ··· O(2) = 2.76 Å). The water molecule which is included in 
the crystal lattice forms four hydrogen bonds linking the calixarene capsule to three other capsules via 
bonds within layers and between layers.  H(16) ··· O(8) = 1.88 Å (O(13) ··· O(8) = 2.73(6) Å), H(2) ··· 
O(12) = 1.91 Å (O(13) ··· O(12) = 2.77(6) Å), H(9) ··· O(13) = 1.84 Å (O(7) ··· O(13) = 2.75(6) Å), 
O(13) ··· H(12) = 1.88 Å (O(3) ··· O(13) = 2.63(6) Å). Dimeric capsules have been reported in the 
literature but with shorter chain lengths and the guests were simple alkylammonium salts.110 On 
calculating the molecular volume of each acetonitrile guest species in X-SEED (44 Å3) and comparing 
it to the volume of the cavity as calculated by MCAVITY (Test sphere radius = 1.56 Å, Resolution = 
0.5 Å, limiting sphere radius = 0.5 Å) (155 Å3), 56% of the available volume of the cavity is occupied 
by the two acetonitrile guests. This is a favourable when compared to the optimal 55% occupancy of 
synthetic receptors proposed by Mecozzi et al.101 
 
 
Figure 53 - Interdigitation of pendant chains in C-pentyl-calix[4]pyrogallolarene acetonitrile water 
clathrate 
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2.7 C-Hexyl-calix[4]pyrogallolarene 
 
C-Hexyl-calix[4]pyrogallolarene hydrochloride acetonitrile clathrate (C52H72O12·(CH3CN)(H3OCl)) 
was synthesised by dissolving the crude material isolated from the calixarene synthesis reaction in 
acetonitrile. The solution was allowed to slowly evaporate and after 1 week crystals suitable for 
SCXRD studies were formed. On solution of the data, a structure is revealed which contains three 
species in its ASU; a calixarene, one chloride ion (the source is the hydrochloric acid used in the 
synthesis), one acetonitrile and one water molecule. 
 
In a manner similar to enzymes, the cavity of the calixarene modifies its shape to accommodate its 
acetonitrile guest. The guest is tilted and the inter phenyl centroid distance is shortest along the 
longest edge of the acetonitrile molecule (centroid C(40)-C(45) to centroid C(14)-C(19) is shorter than 
the other inter phenyl distance.). This causes distortion of the macrocycle and the Df for this species is 
0.87. 
 
Figure 54 - C-Hexyl-calix[4]pyrogallolarene hydrochloride acetonitrile clathrate 
 
The P symmetry generates a head-to-head packing motif with the pendant chains formed into two 
groups, the first containing three chains and the second only one. This grouping of the pendant chains 
allows their interdigitation. The closest approach to the calixarene below is by H(26D) whose closest 
contact is 2.620 Å but the average separation from the hydrogen atoms of the annulus is 3.18 Å. 
88 
 
The lipophilic layer created by the pendant chains allows a separation of cavities of 8.58 Å (inter 
plane distance where the plane is calculated from the mean positions of H(1), H(14), H(27) and 
H(40)). The average through space distance from methine carbon to the terminal hydrogen atom e.g. 
C(7) – H(13C) is 7.94 Å and the average along bond distance is 10.09 Å. This is accounted for by 
twisting of the chain but if either of these figures is added to the mean separation between the terminal 
hydrogen and the annulus this gives a distance which is larger than that seen between layers. This 
means that the layers are tilted at 42° from the plane which is calculated from the average positions of 
C(1), C(4), C(27) and C(30) (shown by the red lines in Figure 55). 
 
 
Figure 55 - Tilting of pendant chains in C-hexyl-calix[4]pyrogallolarene hydrochloride acetonitrile 
clathrate (solvent molecules and hydrogen atoms removed for clarity) 
 
The strong inter-phenyl hydrogen bonding observed around the upper rim of each calixarene in this 
structure demonstrates why the cone isomer is thermodynamically favoured (H(1A) ··· O12 = 1.87 Å 
(O(1) ··· O(12) = 2.82(5) Å),  H(4A) ··· O(3) = 1.87 Å (O(4) ··· O(3) = 2.71(5) Å),  H(6A) ··· O(7) = 
1.89 Å (O(6) ··· O(7) = 2.72(5) Å), H(9A) ··· O(10) = 1.82 Å (O(9) ··· O(10) = 2.66(5) Å)). The central 
hydroxyl in each pyrogallol group forms intra-molecular hydrogen bonds, H(8A) forms a hydrogen 
bond to the chloride in the lattice (H(8A) ··· Cl(1) = 2.19(7) Å) and the oxygen bearing this hydroxyl 
group is hydrogen bonded to the water in the lattice (O(8) ··· H(13A) = 1.77 Å (O(8) ··· O(13) = 
2.88(7)  Å)). 
θ = 42° 
θ = 42° 
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Figure 56 - C-Hexyl-calix[4]pyrogallolarene hydrochloride acetonitrile clathrate 
 
There is an unusual arrangement of hydrogen bonding in the crystal structure; Firstly no inter-layer 
calixarene hydrogen bonds are observed, the bilayer is held together by hydrophobic interactions of 
the pendant chains and the bridge which is formed by the chloride ion. Secondly only a single 
hydrogen bond holds the acetonitrile within the cavity (H(12A) – N(1) = 1.92 Å) this causes the guest 
molecule to become ‘twisted’ within the cavity (i.e. directed towards H(3A) rather than H(2A)). This 
twisting of the guest molecule can be attributed to the presence of the chloride ion which bridges two 
calixarene molecules. Hydrogen bonds are formed between H(2A) and the Cl(1) and H(8A) and Cl(1) 
(H(2A) ··· Cl(1) = 2.33 Å (O(2) ··· Cl(1) = 3.06(6) Å)) rather than directed inwards towards N(1) 
(compare with C-pentane-calix[4]pyrogallolarene acetonitrile clathrate). The water molecule only 
bridges intra-layer calixarene molecules forming hydrogen bond from H(13E) to O(1) = 2.08 Å in 
addition to the H(13A) ··· O(8) bond described earlier. 
 
This structure is very similar to the molecular structure of C-pentyl-calix[4]pyrogallolarene 
acetonitrile water clathrate reported earlier, but differs significantly because while it forms a highly 
overlapped head-to-head arrangement, the two acetonitrile guest molecules are not completely isolated 
from the exterior medium. This is due to the offset of the two calixarenes, which is a result of the 
coordination to the upper rims of the chloride ion.  
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2.8 C-Heptyl-calix[4]pyrogallolarene 
 
Crystals of C-heptyl-calix[4]pyrogallolarene were grown from acetonitrile, diethyl ether, ethyl acetate 
and ethanol. In line with previous findings, different molecular architectures were formed according to 
which guests were present within the crystal lattice. 
 
C-Heptyl-calix[4]pyrogallolarene ethyl acetate clathrate C56H80O12·2(CH3CH2OC(O)CH3) is arranged 
by R symmetry into a capsular architecture. The sphere which is formed shows both similarities and 
differences to the C-butyl-calix[4]pyrogallolarene acetonitrile clathrate sphere previously presented 
(See Chapter 1, Section 2.5).  
 
 
Figure 57 - Nano-capsule formed by C-heptyl-calix[4]pyrogallolarene ethyl acetate clathrate 
 
The volume of the ethyl acetate sphere (calculated by MCAVITY) is smaller (~1249.5 Å3) than that of 
the acetonitrile sphere which has two of its faces (1 & 4) bulging outwards (~1274 Å3). This change in 
the distortion of the sphere parallels the change in the shape of the monomeric macrocycle when 
different guests are present within the cavity. 
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There is extensive disorder of guests within the capsule, due to their lack of permanent interactions 
with the capsule interior surface or its seam. Therefore the molecules within the capsule had to be 
modelled as diffuse electron density. Taking into consideration Mecozzi’s 55±9% packing rule and 
the molecular volume of the exo ethyl acetate molecule calculated using XSEED (87.4 Å3), there is 
potential for between seven and nine ethyl acetate molecules to be encapsulated within the sphere. 
Cave et al. performed a TGA-gas phase IR study on ethyl acetate containing nano-capsules which 
revealed that six ethyl acetate and one water molecule can reside within a calix[4]pyrogallolarene 
derived nano-sphere.67 
 
In a major difference between the capsules, the ethyl acetate capsule has its pendant chains radiating 
out around the full sphere in three dimensions, whereas the acetonitrile sphere has its pendant chains 
directed only in two directions (perpendicularly to the stack of nano-capsules). This difference in 
packing architecture is due to the larger molecular volume of the exo guest molecule which 
coordinates to the lower rim via its carbonyl oxygen (O(14) ··· H(15A) = 3.05 Å (O(14 ··· C(15) = 
3.98(19) Å) and O(14) ··· H(43A) = 3.10 Å (O(14) ··· C(43) = 4.05(18) Å)). 
 
 
Figure 58 - Asymmetric unit of C-heptyl-calix[4]pyrogallolarene ethyl acetate clathrate 
 
The sphere has four crystallographically unique faces consisting of two pairs of enantiomers (Face 1 is 
a mirror image of 4 and likewise for Faces 2 and 3) therefore rendering the sphere racemic (like the 
acetonitrile sphere). This can easily be determined by viewing each face along the plane of its phenyl 
rings and noting the arrangement of the pendant chains (as seen in Figure 57). Face 1 and 4 are each 
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comprised of three identical phenyl rings (C(1)-C(6)) whereas each of the other two faces (2 & 3) are 
comprised of a three non-identical phenyl rings. 
 
The positioning (and increased length) of the pendant chains causes a difference in the packing 
arrangement of the nano-spheres. Unlike the acetonitrile sphere which forms stacks of nano spheres 
with Faces 1 & 4 arranged parallel to each other, interdigitation of the pendant chains dominates the 
packing and prevents nano spheres coming into close contact, and a hexagonal close packed 
arrangement of the spheres results. 
 
Although the diethyl ether clathrate (C56H80O12·2(CH3CH2OCH2CH3))  of C-heptyl-
calix[4]pyrogallolarene forms a bilayer in a similar manner to previously described examples, the 
structure shows a significant departure from the previously described ether clathrates. This difference 
is due to a combination of the increased length of the pendant chains and the positioning of a diethyl 
ether molecule exo to the cavity of the calixarene.  
 
 
Figure 59 - Asymmetric unit of C-heptyl-calix[4]pyrogallolarene diethyl ether water clathrate 
 
There is a three to one split in the alignment of the pendant chains of the calixarene. This allows 
interpenetration of the pendant chains by the lower layer. There is a close approach of the pendant 
chain of the acetonitrile methyl group of one calixarene to the annulus of the calixarene on the 
opposite face of a bilayer. Interestingly it is not the methyl group of the pendant chain which makes 
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the closest approach to the annulus, it is the penultimate methylene (CH2) group which comes into 
closest contact with the lower rim. (H(9A) ··· H(23) = 2.90 Å (C(9) ··· C(23) = 4.77(8) Å)) 
 
The exo solvent molecule causes a disruption of the bilayer packing arrangement with an alternate 
solvent filled channel which is highlighted in the figure below. The alignment of the endo cavity 
solvent molecules (shown in blue in Figure 60 above) shows that there is a 90° rotation between the 
faces of each subsequent bilayer, is allowed to come into close contact with the subsequent bilayer 
because the endo solvent molecule’s ethyl group which resides above the plane of the upper rim, 
penetrates the solvent filled channel. The solvent filled channel has a defined base which is formed by 
the extension of one of the pendant chains of the calixarene molecule 
 
 
Figure 60 – Packing diagram highlighting the solvent filled channel in C-heptyl-
calix[4]pyrogallolarene diethyl ether water clathrate 
 
This crystal structure shows an excellent mimic of the postulated disruption seen in biological 
membranes when polar anaesthetic molecules interact with the bilayer. This causes a contraction of 
the bilayer to less than twice the molecular length of the individual molecules. In the calixarene 
system, interdigitation is present in the majority of the bilayer architectures, however it is usually the 
terminal methyl group which makes the closest approach to the lower rim of the calixarene on the 
opposite face of the bilayer. 
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The separation between the upper rim of the bilayers from planes generated (using Mercury) from 
oxygen atoms (3), (5), (9) and (13) = 16.88 Å. The molecular length of an individual calixarene 
molecule from the upper rim oxygen atoms to the terminal carbon atoms of the trimer of pendant 
chains (C(11), C(41), C(46), C(55) = 9.25 Å).  This shows a significant contraction of the thickness of 
the bilayer. It has been postulated in the biological model that the contraction has allows an increased 
number of van der Waals interactions between the pendant chains to form. This compensates for the 
decrease in the number of hydrogen bonds which are formed between the upper rims of the calixarene 
molecules. 
 
The ethanol clathrate (2(C56H80O12)·5(CH3CH2OH)3(H2O))  has ten molecules in its asymmetric unit. 
In a similar fashion to the diethyl ether clathrate, there is a single solvent molecule included within the 
bilayer, disrupting the packing of the calixarene molecules into a face of the bilayer. Contraction of 
the bilayer is observed but not to the same extent as the diethyl ether clathrate as the distance between 
upper rims is 17.654 Å. One of the asymmetric calixarene molecules has two of its pendant chains 
directed parallel to the plane of the bilayer. In a similar manner to the ether clathrate, the pendant 
chains form the base to the solvent filled pocket in the face of the bilayer. 
 
The exo solvent molecules (one ethanol and one water molecule) of one layer coordinates to the endo 
molecule of the next face of the structure, this means that the solvent filled pocket contains three 
solvent molecules. This is shown in the figure below which shows the calixarene which forms the 
base of the void in blue and the unperturbed calixarene in red. 
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Figure 61 - Plan view of bilayer face showing exo solvent molecules creating voids within the bilayer 
structure 
 
The material obtained directly from the ‘boil’ reaction was recrystallised from acetonitrile, the crystals 
which grew were suitable for single crystal X-ray diffraction studies (C56H80O12·CH3CN·H2O). While 
the interdigitated bilayer which is formed is similar to the bilayers of the ethanol and diethyl ether 
clathrates there is a significant difference because there are only endo solvent molecules present 
within the crystal lattice. This means that the calixarenes are formed into a hexagonal arrangement 
within the faces of the bilayer. 
 
As with the previous structures of the C7Pg discussed, there is a 3:1 split of the pendant chains with 
one of the pendant chains being directed parallel to the plane of the bilayer. This can be justified for 
two reasons; firstly, the pendant chain fills a void which forms due to the upper rim of the calixarene 
being wider than that of the lower rim (diameter of the upper rim C(8) – C(46) = 9.24(14) Å diameter 
of lower rim C(31) – C(26) = 5.23(11) Å) This is illustrated in the figure below which shows the chain 
filling the void in red and the two calixarenes which surround the chain in blue. 
 
96 
 
 
Figure 62 - Packing of pendant chains in C-heptyl-calix[4]pyrogallolarene hydrochloride acetonitrile 
clathrate 
 
Secondly there is insufficient space between the calixarenes to have a completely interdigitated 
bilayer when all four pendant chains are directed vertically away from the annulus. Therefore the 
structure which results is a compromise between the formation of van der Waals interactions between 
the pendant chains on interdigitation and the packing efficiency gained by the horizontal projection of 
the pendant chain. This projection allows maximum interdigitation, and fills a void that would 
otherwise form. This also allows coordination of an appropriate guest molecule to the upper rim of the 
calixarene while residing in a non polar region (typical of guests which contain polar and non polar 
elements such as ethanol or diethyl ether). 
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2.9 C-Octyl-calix[4]pyrogallolarene 
 
C-Octyl-calix[4]pyrogallolarene was synthesised by solvent and solvent-less methods. The crude 
filtrate from the reaction was taken up into acetonitrile, heated to boiling and then allowed to cool and 
slowly evaporate at room temperature. Crystals were produced which were suitable for single crystal 
X-ray diffraction studies (C60H88O12·CH3CN·H2O·HCl). The acetonitrile clathrate includes chloride 
ions which remain from the hydrochloric acid catalyst. 
 
 
Figure 63 - Molecular structure of C-octyl-calix[4]pyrogallolarene hydrochloride acetonitrile clathrate 
 
The molecular structure which is revealed shows the formation of an architecture closely related to C-
hexyl-calix[4]pyrogallolarene hydrochloride acetonitrile clathrate; that is a bilayer which has 
calixarene molecules in facing layers are offset from perfect head-to-head alignment to allow 
hydrogen bonding from the upper rim of the calixarene to the chloride ion which is present in the 
lattice. (H(2) ··· Cl(1) = 2.21 Å (O(2) ··· Cl(1) = 3.02(6) Å) and H(8) ··· Cl(1) = 2.31 Å (O(8) ··· Cl(1) = 
3.06(6) Å)). The angle at which the pendant chains are tilted relative to the cavity of the calixarene is 
reduced over the hexyl homologue to 34.5° (rather than 42°). 
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A similarity in the two hydrochloride analogues presented is the shape of the cavity. The cavity of the 
calixarenes are distorted in two ways; firstly by compression of one of the phenyl rings towards the 
centre of the macrocycle. In the octyl derivative the phenyl ring of C(16-21) is closer to the centre  of 
the macrocycle (centroid 1) than the opposite ring (C(46-51)) ((1) ··· (2) = 3.13 Å and (1) – (3) = 3.27 
Å). 
 
 
Figure 64 - Distortion of macrocycle in C-octyl-calix[4]pyrogallolarene hydrochloride acetonitrile 
clathrate 
 
The second form which the distortion takes is the splaying outwards of one of the phenyl rings (C(31)-
(36)). This is at its most extreme at C(33) which is furthest from the centre of the macrocycle (C(33) 
··· (1) = 4.34 Å and C(35) ··· (1) = 4.29 Å). Both cases of distortion may be attributed to the presence 
of the acetonitrile guest molecule which is orientated diagonally across the cavity. The phenyl ring 
bent inwards is furthest from the methyl group and therefore its distortion will minimise the void 
which is formed. The phenyl ring which is distorted outwards is due to the electrostatic repulsion 
between the nitrogen of the acetonitrile group and the upper rim (N(1) and O(7)). 
  
 
 
 
 
 
 
 
 
Chapter 3 - Host-guest chemistry of C-alkyl-
calix[4]pyrogallolarenes 
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1 Introduction 
 
Co-crystallisations of pyrogallol and other molecules were attempted to study the possible 
supramolecular interactions which calix[4]pyrogallolarenes form. Crystallisations were attempted 
using ortho-carborane and buckminsterfullerenes (C60) under a variety of conditions (solvent 
calixarene pendant chain length, concentration and crystallisation technique) but none of the 
attempted combinations gave crystals which showed co-crystallised material. 
 
It can be speculated that the systems are too electron rich to enter the cavity which has a hydroxyl 
fringed upper rim. Also the fullerene may be too large to be accommodated. In the literature several 
covalently bound calix[4]arene-fullerene species have been reported but it is only in the higher 
calix[n]arenes (n = 6, 8) that non-covalent coordination is observed.48, 51 A notable exception is the 
coordination of C60 by cyclotriveratrylene (CTV) whose cavity walls are at a sufficiently large angle 
to accommodate the large spherical guest.53 
 
Following the work of Cave et al. co-crystallisation of calixarene derivatives with terpyridines was 
carried out.54, 56 A variety of terpyridines were synthesised using the green synthetic method 
developed by Cave et al.174 
 
 
Figure 65 - Terpyridine synthesis 
It was attempted to synthesise a phenanthrene substituted pyridine in order to probe the nature of the 
cavity formed by calix[4]arenes,  
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Figure 66 - 2,6-(2'-phenanthrene)-4-phenyl-pyridine 
 
It was desired that the phenanthrene moiety could interact with the hydrophobic cavity while the 
pyridine could hydrogen bond with the upper rim of the cavitand. Unfortunately, the synthesis failed 
and material which had undergone the aldol reaction and subsequently dehydrated could be the only 
product isolated from the reaction mixture. This may be due to steric constraints at the 3 position of 
the 2,3-unsaturated carbonyl compound (C(35) and C(39)) (labelled in Figure 68), meaning that 
extended reaction times are required for 1,6-dicarbonyl compound formation.  
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2 Single crystal X-ray diffraction studies 
 
Crystals of sufficient quality to undergo SCXRD investigations were obtained by recrystallising the 
solid from glacial acetic acid. 
 
 
Figure 67 – SCXRD image of Phenanthren-2-yl-3-phenyl-propenone 
 
The herringbone type packing of aromatic groups is observed for this species; however, the packing of 
this is somewhat unusual when compared to simple aromatic species such as benzene.8 The structure 
shows very little overlap of the aromatic groups and also no CH – pi interactions, due to a significant 
offset between the layers. 
 
A variety of solvent / terpyridines / calix[4]arene combinations were mixed and allowed to slowly 
evaporate after sonication. Only a single combination of 2,6-(2-pyridyl)-4-phenylpyridine and C-
heptane-calix[4]pyrogallolarene in methanol gave crystals suitable for single crystal X-ray diffractions 
studies. 
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The synthesis of this supramolecular species was achieved by addition of the terpyridine to a solution 
of calixarene, sonication for 10 minutes and then leaving the resulting solution to slowly evaporate. 
The product (C56H80O12·C21H15N3·2(CH3OH)(HCl)) crystallised from solution and the crystals were 
found to be suitable for single crystal X-ray diffraction studies, with a synchrotron source as the 
crystals were weakly diffracting.  
 
 
Figure 68 - C-Heptyl-calix[4]pyrogallolarene terpyridine complex 
 
A hydrogen bond is formed between an aromatic hydrogen in the 3-position of the peripheral pyridine 
ring (H(65)) and the pi-system of the interior face of the cavity (centroid 1). The closest contact is 2.85 
Å (C(65) ··· (1) = 3.90 Å). This is reminiscent of the herringbone architecture formed by a large 
number of planar aromatic systems when crystallised.8 
 
The closest contact is between the terpyridine and the calixarene is between the centre of the 
terpyridine nucleus and the upper rim of the calixarene H(80) ··· O(11) = 3.08 Å. The presence of 
chloride ion close by indicates protonation of the terpyridine and therefore this suggests a hydrogen 
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bond between the protonated terpyridine and the upper rim of the pyrogallolarene. This is in contrast 
to Cave et al. who show coordination of unprotonated terpyridines which bridge the gap between two 
resorcinarenes.97 
 
 
Figure 69 - C-Heptyl-calix[4]pyrogallolarene terpyridine complex showing pi-pi interactions 
 
The structure shows a fascinating variety of intermolecular interactions. There are pi stacking 
interactions between the external face of the calixarene with the terpyridine. The closest contact 
between the two species is centroid (2) – C(57) = 3.157 Å. This is significantly shorter distance than 
the only other reported instance of exo-coordination by a calixarene discovered by Messina et al. who 
discovered that per-halobenzenes can interact with bis-pyridylmethyl-tetra-tert-butylcalix[4]arene.175 
105 
 
These interactions were in the range 3.4 – 3.8 Å. Other pi stacking interactions discovered involving 
endo coordination of phenanthroline ligated metals to calixarenes are in the range of 3.50 – 3.59 Å.176 
 
The distortion factor of the macrocyle is 0.79 compared to crystal structures of C7Pg with small 
molecules as guests datas is: 0.86 - Et2O, 0.98 - EtOAc, 0.92 - EtOH, 0.87 - MeCN. This shows that if 
the guest are in the cavity then the cup can distort to a certain extent to accommodate the guest 
molecule. This has been shown in the case of strong cation – pi interactions to distort the macrocycle 
into a pinched cone conformation.47 Taking the evidence from this structure it is possible to maipulate 
the structure of the macrocycle with significantly weaker interactions. Similar structure 
interconversions have been modelled by Mattay et al. in the conformation changes which take blace 
between C-methyl-resorcin[4]arene in its solvated and desolvated form.177, 178  
  
 
 
 
 
 
 
 
 
 
Chapter 4 - Green chemistry  
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In order to rapidly generate the materials required for the structural studies of calix[4]pyrogallolarenes 
green chemistry methods were employed.73, 84 When pyrogallol, para-toluene sulphonic acid and an 
appropriate aldehyde were ground together in a mortar and pestle, it was found that the 
macrocyclisation reaction was rapid, but the chair conformation was a significant by-product.  
 
Calixarene Green chemistry 
(Total Yield by NMR) 
% 
Chair Conformation 
(By NMR) % 
Standard Method 
(isolated  yield) % 
C1Pg 82 0 99 
C2Pg 86 0 50 
C3Pg 72 0 77 
C4Pg 80 0 51 
C5Pg 61 53 49 
C6Pg 91 55 72 
C7Pg 60 3 71 
C8Pg 83 15 85 
C9Pg 92 2 95 
C10Pg 80 4 99 
Table 2 - Green Chemistry Results 
 
This conclusion was arrived at by inspection of the 1H NMR spectra. The data shows a splitting of the 
aromatic proton resonance from a single signal at 7.2ppm to two individual signals at 7.3 and 7.1ppm. 
This is indicative to the chair isomer as it possesses two aromatic environments which would cause 
the splitting. (for a detailed discussion of conformational analysis of calix[4]arenes by NMR see C-(4-
nitrophenyl)-calix[4]pyrogallolarene in Chapter 5 Section 4). 
 
Separation of the conformational isomers was achieved by repeated recrystallisation from either 
diethyl ether or acetonitrile depending on the length of the pendant chain (as this has a significant 
effect on the solubility of the calixarene in organic solvents). This technique exploits the difference in 
solubility of the chair and cone conformers in organic solvents, the chair conformation is considerably 
more soluble in polar organic solvents than the cone conformation, and therefore can be separated by 
filtration and recrystallisation. 
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The use of automated grinding techniques was attempted to speed the synthesis of 
calix[4]pyrogallolarenes. Firstly a Fritsche Pulverisette # 6 ball mill was used. This instrument grinds 
the sample in a stainless steel bowl containing ball bearings which rapidly spin round the bowl when it 
is subjected to eccentric rotation within the instrument. The second piece of apparatus to be used was 
the Pulverisette # 2, which is an automatic pestle and mortar. The sample is placed in a ceramic bowl 
which rotates and the sample is ground by a pestle that can be positioned to affect the intensity of the 
grinding. Both pieces of apparatus are shown in Figure 70 below. 
 
 
Figure 70 - Fritsche Pulverisette # 6 ball mill (left) and Fritsche Pulverisette # 2 automatic pestle and 
mortar (right) 
 
When the calix[4]pyrogallolarenes were ground using the ball mill the reaction did not progress 
further than the eutectic melt stage and un-cyclised intermediates were isolated. It was speculated that 
due to the sealed nature of the system the water liberated by the condensation reaction could not 
escape and thereby prevent the reaction from progressing to completion. A series of experiments 
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where activated molecular sieves were added to the grinding bowl to absorb the water liberated during 
the reaction failed to yield the desired product and only oligomers could be isolated.  
 
When the calixarene synthesis was attempted using the automated pestle and mortar, the desired 
product was obtained in yields identical to those gained with the hand held pestle and mortar. 
However, the temperature of the bowl had to be carefully monitored; if the bowl became too hot, and 
prolonged grinding took place (>1 hour) decomposition of the product was observed. 
 
It can therefore be concluded that a ball mill is unsuitable for the synthesis of 
calix[4]pyrogallolarenes. This can be speculated that the failure of the reaction to progress to 
completion  is due to the grinding being too energetic rather than the sealed nature of the system 
failing to allow water to be liberated. The automated pestle and mortar can be used to synthesise 
calix[4]pyrogallolarenes in a solvent free manner, but the conditions must be carefully monitored in 
order to maximise the yield of the desired product. 
 
When the approach of functionalising the pendant chains of a calixarene was found to be impractical, 
the synthesis of functionalised aldehyde derivatives became necessary. However in doing this it 
became necessary to protect the aldehyde group during the synthesis of the additional functional 
groups.  
 
Protecting aldehydes as cyclic acetals is a commonly used technique in synthetic organic chemistry.179 
These protecting groups are relatively easy to form yet are resistant to a wide variety of organic, 
organometallic and basic reagents. They are easily cleaved with a dilute solution of aqueous acid, a 
scheme showing their synthesis is shown in Figure 71 below: 
 
 
Figure 71 - Acetal formation 
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Traditionally the acetal group is prepared by reaction of the aldehyde with a 1,3-diol under para-
toluenesulphonic acid catalysis. The reaction is typically performed in a toluene solution using a 
Dean-Stark apparatus to remove the water generated by the condensation reaction. This technique 
involves relatively large solvent volumes and lengthy reaction times.179 It is possible to perform a 
wide variety of organic reactions under microwave irradiation.68 An unmodified domestic microwave 
was used to perform the synthesis of an acetal group without the use of solvents and with minimal 
catalyst present. A typical procedure is as follows: 
 
Acetaldehyde (0.17 ml, 3 mmol), 2,2-dimethyl-1,3-propanediol (0.312 g, 3 mmol) and para-
toluenesulfonic acid (0.02 g, 0.105 mmol) were mixed in a vial. The mixture was heated for 120 
seconds in a domestic microwave (ONN, Model OM010, 800 W). The reaction was allowed to cool, 
an NMR was taken of the resulting colourless solid showing product (>99 % yield). 
 
This procedure has been shown to be successful in producing protected aldehydes with 1,3-propane-
diol, 2-methyl-1,3-propane-diol and 2,2-dimethyl-1,3-propane diol. These findings are summarised in 
the table below which show the yields obtained for reaction of linear aliphatic aldehydes with ,2,2-
dimethyl-1,3-propane diol. 
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Aldehyde Yield by NMR 
% 
CH3CHO 99 
C2H5CHO 97 
C3H7CHO 99 
C4H8CHO 98 
C5H11CHO 99 
C6H13CHO 99 
C7H15CHO 99 
C8H17CHO 98 
C9H19CHO 99 
C10H21CHO 99 
C11H23CHO 99 
Table 3 - Yields of acetals formed by microwave irradiation 
 
This shows that lengthy reaction times, and large solvent volumes are unnecessary for the synthesis of 
acetals. The pTSA can be removed from an ethereal solution of the reaction mixture by liquid –liquid 
extraction using an aqueous base to yield the pure product. 
  
 
 
 
 
 
 
 
 
Chapter 5 - Synthesis of functionalised 
calixarene derivatives 
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1 Introduction 
 
The use of a calix[4]pyrogallolarene nanometer scale spheres as a drug delivery vectors relies on the 
decoration of the exterior of the capsule with functionality to enable targeting of the sphere to a 
specific tissue. This requires understanding of the factors which govern the host-guest interactions 
which guide capsule formation which was in part achieved by the preliminary investigations into the 
alkyl calixarenes and their interactions with solvent molecules. 
 
The nano-capsule has 24 sites for potential functionalisation (these are highlighted in green in Figure 
72 below).  The purpose of the functionalisation is to allow delivery of the nano-capsule to dendritic 
cells. The nano-capsule may be decorated with peptide sequences which have been found exclusively 
on the surface of cancerous cells. This may lead to a novel form of antineoplastic immunotherapy. 
 
 
Figure 72 - Nano-capsule with potential functionalisation points highlighted in green 
 
In cancer, due to mutation of cancerous cell’s genetic code, peptide sequences unique to the cancer are 
presented on the surface of the cell. The genetic mutation may cause disruption of the protein’s 
primary structure, and therefore could be recognised by the immune system as ‘non self’. If 
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recognised as ‘non-self’ an immune response may be produced against the cell which carries the 
mutated peptide, and therefore regression of the tumour.180 In order for the immune response to be 
activated the antigen must first be processed by an antigen presenting cell, which are usually dendritic 
cells. Dendritic cells present the metabolised peptide to T-cells which can then begin the response to 
the antigen in the body.181 It is therefore essential to design a delivery system with high selectivity and 
low toxicity to dendritic cells. 
 
Initial investigations were focused on the functionalisation of calix[4]arene derivatives. This was 
because the calixarene synthesis uses very harsh conditions (concentrated hydrochloric acid / 
methanol) and long reaction times (up to 6 days) which would destroy a large variety of functional 
groups. Secondly, the calixarene synthesis has widely variable yields (from 20 – 100% reported) 
which strategically is potentially very wasteful. Therefore the C-(dec-10-ene)-calix[4]pyrogallolarene 
(C10enePg) was synthesized.  
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Figure 73 – C-(Dec-10-ene)-calix[4]pyrogallolarene 
 
The boiling method which has proven successful for the library of aliphatic calixarenes was shown to 
be unsuccessful, possibly due to the hydro-chlorination of the alkene and subsequent nucleophilic 
substitution reactions with pyrogallol. The molecule was eventually synthesized by following the 
grinding technique developed by Antesberger et al.73 Grinding pyrogallol and a catalytic amount of 
para-toluenesulfonic acid to a fine powder followed by drop-wise addition of undecyleneic aldehyde 
and further grinding and recrystallisation using ethyl acetate gave the desired product in high yield. 
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2 C-(Dec-10-ene)-calix[4]pyrogallolarene 
 
When a solution of C-(dec-10-ene)-calix[4]pyrogallolarene in ethyl acetate is a allowed to slowly 
evaporate, crystals grow which are suitable for single crystal X-ray diffraction studies 
((C68H96O12·(CH3CH2OC(O)CH3)). The data shows a capsular arrangement of molecules in the solid 
state. There is a single calixarene and a disordered ethyl acetate molecule in the asymmetric unit of the 
structure, which is transposed into a large unit cell (a = 37.22 Å, b = 37.22 Å, c = 26.03 Å) and 
spherical architecture by R symmetry. The figure below shows the nano-capsule which has been 
formed with the pendant chains and encapsulated solvent molecules removed for clarity. 
 
 
Figure 74 - Nano-capsule formed by C-(dec-10-ene)-calix[4]pyrogallolarene (pendant chains removed 
for clarity) 
 
The exact location of the encapsulated guests could not be determined due to extensive disorder 
within the capsule. Therefore the contents of the nano-capsule were modelled as diffuse electron 
density. This disorder is due to a lack of interaction between the guest and the walls of the cavity 
making the contents fluid. Earlier gas-phase-infra-red-thermogravimetric analysis by Cave et al. 
showed that six ethyl acetate molecules are encapsulated within the sphere.67 In the shorter chain 
capsules reported to date, 67 there are solvent molecules included in the lattice exo to the capsule, and 
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the extension of the chain length by 4 carbon atoms means that the lipophilic domain created by the 
pendant chains is sufficient to stabilise the nano-spheres without the inclusion of extra solvent 
molecules. 
 
Each calixarene interacts with its pendant chains two faces of an adjacent sphere in a CH – pi 
interaction (C(15) ··· centroid (11) = 2.97 Å and C(64) ··· centroid (10) = 2.86 Å). These interactions 
lead to a short inter-sphere distance. This inter-sphere distance is calculated by generating a centroid 
at centre of each macrocycle. A final centroid is generated from the position of the six monomers’ 
centroid which gives the location of the centre of the capsule. This also gives the internal diameter of 
the nano-sphere to be 17.83 Å. The inter-capsule between centres of the capsule is 23.17 Å.  
 
 
Figure 75 - Interactions between capsules (pendant chains and hydrogen atoms removed for clarity) 
 
The lack of permanent interactions between the capsule and its contents and low distortion of the 
pendant chains means that the macrocycle is not perturbed significantly in conformation (Df = 0.97). 
The capsule is a result of R symmetry and this lack of distortion of the macrocycle leads to the 
capsule that is formed showing little perturbation of the walls and a good alignment of the phenyl 
rings which make up the walls. This is in contrast to the “nano-rods” formed by C6Pg ethyl acetate 
capsules forming inter-capsule hydrogen bonds.67 
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The molecular structure of the capsule also demonstrates clearly why three individual signals in the 1H 
NMR spectra are observed when in the capsule formation and only two are seen while in the 
monomer. There are three possible environments (square planar, trigonal or uncoordinated) for the 
hydrogen atoms, which is identical to the arrangement of hydrogen atoms in the metal fringed 
capsules reported in the literature.93  
 
2.1 Synthetic manipulations of C-(dec-10-ene)-calix[4]pyrogallolarene (C10enePg) 
 
With the C10enePg in hand, efforts to functionalise the pendant chains were pursued with a view to 
forming an attachment point on the terminus of the pendant chains for a peptide sequence. 
 
It has been reported in the literature that the pendant chains of an alkene substituted resorcinarene can 
be thiolated by a photolytic mechanism. The thiol group was targeted because the group would give 
some degree of water solubility by increasing the polarity of the pendant chains, and secondly if a 
disulfide link to a cysteine amino acid this would form an ideal biodegradable link to a peptide chain 
which could be metabolised within a dendritic cell. Despite several attempts using different reaction 
conditions including; varying intensity and wavelength of ultraviolet light, different batches of starting 
material and reagents, solvent and reaction time, this reaction could not be repeated on the 
pyrogallolarene system and only starting materials were recovered. 
 
 
Figure 76 - Thioloation of C-(dec-10-ene)-calix[4]pyrogallolarene 
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In addition to thiolation, efforts to brominate the macrocycle were undertaken. Under a variety of 
conditions (NBS & AIBN, HBr, Br2 Et3N/pyridine, 9-BBN) the eventual result of the reaction was a 
black intractable solid. For the strongly acidic hydrobromic acid it would be reasonable to suggest that 
the macrocycle was destroyed during this reaction by protodealkylative ring opening and subsequent 
oxidation of the pyrogallol residues. If the bromination was partially complete it was speculated that 
oligomers of the calixarene have formed by nucleophilic substitution of the bromine by a phenolic 
hydroxyl group. When solids isolated from the reaction were analysed by 1H NMR, residual alkene 
peaks were visible, indicating the reaction was incomplete. This lends further support to the 
suggestion that the calixarene has formed a cross linked ether polymer. 
 
 
Figure 77 - Bromination of C-(dec-10-ene)-calix[4]pyrogallolarene 
  
In order to attach peptide sequences to the nano-sphere amino or carboxyl substituted pendant chains 
were targeted. With the experience gained in the efforts to functionalise and protect the alkene 
substituted calixarene of bases turning the calixarene solution black and eventually forming an 
intractable resinous mixture, it was decided that the carboxyl group rather than the basic amino groups 
would prove simpler for further development as a synthetic target. 
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3 Hydroxyl footed calix[4]arenes 
 
Hydroxyl footed calix[4]arenes were synthesised by following the method of Gibb et al..167 This 
involves the acid catalysed ring opening of unsaturated pyran or furans to yield an enol intermediate 
which tautomerises to a hydroxyl substituted aldehyde as shown in the Figure below. On cooling the 
acidic mixture, the desired product (cone conformation) precipitates from solution. This solid is 
filtered and suspended in water which is sonicated to remove any acidic residues. Crystals are grown 
by the slow evaporation of a solution of calixarene in the relevant solvent. 
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Figure 78 - Synthetic route to hydroxyl substituted calix[4]pyrogallolarenes 
 
3.1 C-(3-Propanol)-calix[4]pyrogallolarene acetone clathrate 
 
Two unique crystal structures have been obtained for C-(3-propanol)-calix[4]pyrogallolarene acetone 
clathrate (C40H44O16·5(CH3C(O)CH3)·4(H2O)) and (C40H44O16·(CH3C(O)CH3)·3H2O). These 
molecular structures show significant differences in the packing motif. The first structure to be 
presented is the higher molecular symmetry polymorph. This crystal structure has nine molecules (two 
calixarene, four acetone and three water molecules) in the asymmetric unit which fill a unit cell by 
P21/c symmetry operation. On inspection of the packing arrangement of the molecules, the calixarenes 
form a head-to-tail arrangement with the hydroxyl groups of the pendant chains forming hydrogen 
bonds to the upper rim of the calixarene below (H(9) ··· O(14) = 1.91 Å (O(11) ··· O(14) = 2.70(5) Å) 
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and H(23) ··· O(13) = 2.14 Å (O(10) ··· O(13) = 2.90(5) Å)). In the cavity which is formed between the 
cavity of one calixarene molecule and the pendant chains of the calixarene above one acetone 
molecule is hosted (shown in space-filling representation). The three remaining acetone molecules are 
exo to the cavity of the calixarene as shown in Figure 79. 
 
 
Figure 79 - C-(3-Propanol)-calix[4]pyrogallolarene acetonitrile water clathrate 
 
The acetone guest molecule coordinates to the annulus of the calixarene forming hydrogen bonds the 
mean separation between the hydroxyl oxygen and the lower rim hydrogen atoms (O(17) ··· (H(21), 
H(30), H(31), H(32)) is 2.86 Å (mean separation between O17 and carbon atoms (11) (21) (31) (41)= 
3.83 Å). Despite the void which is present below the encapsulated acetone molecule the macrocycle 
remains undistorted with a distortion factor of 0.98. This forms an alternating sheeting like 
arrangement with calixarenes aligned in opposite directions. Below the acetone molecule there is a 
significant void which has formed.  
 
In the second crystal structure there is significantly lower lattice symmetry with five molecules 
comprising the asymmetric unit (one calixarene, one acetone molecule and three water molecules). 
This is transposed into a significantly smaller unit cell by P symmetry. 
 
121 
 
Like the higher symmetry polymorph, there is an infinite alternating sheet architecture formed due to 
the inversion centre which is present. However, the solvent molecules which lie between the sheets of 
the higher symmetry sheet is not present in the lower symmetry polymorph. The closer proximity of 
the sheets allows inter-sheet hydrogen bonding (H(10) ··· O(14) = 1.84 Å, O(10) ··· O(14) = 2.68(4) 
Å). This inter sheet bonding forms two sheets which are linked by mutual pendant chain to upper rim 
hydrogen bonding. This double sheet is bonded by upper rim to upper rim bonding to another sheet – 
dimer. 
 
 
Figure 80 - C-(3-Propanol)-calix[4]pyrogallolarene acetonitrile water clathrate 
 
There is also a significant tilting of the acetone molecule (23.8°) relative to the plane of the calixarene 
(shown in Figure 82 above) whereas the first example is tilted only 1.1° from the plane of the 
calixarene.  The tilted acetonitrile is also twisted by 13.2°. This tilt and twist of the hosted acetone 
molecule allows formation of a hydrogen bond between to one of the hydroxyl groups (H(13) ··· O(20) 
= 2.03 Å, O(13) ··· O(20) = 2.81(12) Å) instead of bonding to the annulus of the calixarene above. 
This non central alignment of the guest molecule affects the geometry of the macrocycle and causes a 
decrease in the symmetry of the calixarene and the distortion factor is 0.88.  
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A tetrahydrofuran clathrate (C40H44O16·C4H8O·2H2O) was formed by slow evaporation of a solution of 
C3OHPg in THF. Like the acetone clathrates described earlier, the molecule is arranged in a head-to-
tail stacking pattern but a higher degree of molecular symmetry is present, with a mirror plane passing 
through the centre of the calixarene. Three molecular fragments are present in the asymmetric unit; 
half a calixarene molecule, half a THF, and a water molecule which are subjected to P2/n symmetry 
operation which fills the unit cell. Tetrahydrofuran is present within the void created between the 
lower rim and pendant chains of one calixarene and the upper rim and cavity of one below (shown 
with transparent van der Waals radii in Figure 81 below). 
 
Figure 81 - C-(3-Propanol)-calix[4]pyrogallolarene tetrahydrofuran water clathrate 
 
The space between calixarene molecules is gated by two water molecules (O(10)) which form two 
hydrogen bonds; one to the pendant chain (O10 ··· H7 = 1.97 Å (O10 ··· O7 = 2.80(6) Å)) and the 
second to the upper rim of the calixarene (O(10) ··· H(4) = 1.87 Å (O(10) ··· O(4) = 2.67(5) Å)) below.  
 
A relatively large distance separates the ethereal oxygen of the tetrahydrofuran and the lower rim of 
the calixarene above (O(9) ··· H(11) = 3.69 Å (O(9) ··· C(11) = 4.58(18) Å) and O(9) ··· H(1) = 3.68 Å 
(O(9) ··· C(1) = 4.75(18) Å)). Therefore, there is no coordination of the guest’s oxygen atom to the 
annulus of the calixarene above unlike the acetone clathrates. This separation may be due in part to the 
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steric requirement of the two methylene groups which form the ether linkage of THF preventing 
closer approach of the oxygen, also it may be due to the different electronic structure of the oxygen 
with the carbonyl oxygen being more polar than the ether which is present in the THF and is therefore 
less attracted to the slightly positive lower rim. The guest molecule is located centrally in the cavity 
between two calixarenes. The accommodation of the guest is compensated for by the distortion of one 
of the pendant chains in the asymmetric unit (and therefore two chains in the complete calixarene 
molecule) and also distortion of the macrocycle. The Df is 0.91 which is significantly lower than the 
distortion observed in the acetone clathrate. This distortion can be found to be prevalent in the 
macrocycle at the methine bridging point (C(17)) bearing the pendant chain which is not distorted 
outwards (C(18-20)) the angle formed between C(2)-C(17)-C(16) is 111.34° compared to C(6)-C(7)-
C(12) = 109.78°. 
 
The water molecule which bridges the gap between calixarene molecules also forms a hydrogen bond 
to the upper rim of a calixarene chain which is arranged anti-parallel to the original chain (H(10C) ··· 
O(1) = 2.11 Å (O10 ··· O1 = 3.14(5) Å)) shown in Figure 82  below. 
 
 
Figure 82 - Anti-parallel arrangement of calixarene chains in C-(3-Propanol)-calix[4]pyrogallolarene 
tetrahydrofuran clathrate (solvent molecules removed for clarity) 
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A second unique chain is arranged in an anti-parallel alignment to the original chain and shows a 
mutual hydrogen bond between the same faces upper rim and pendant chain (H(8) ··· O(1) = 1.85 Å, 
(O8 ··· O1 = 2.73(6) Å)) this interaction is highlighted below in Figure 83. 
 
Figure 83 - Hydrogen bonding between anti-parallel calixarene chains in C-(3-Propanol)-
calix[4]pyrogallolarene tetrahydrofuran water clathrate (solvent molecules removed for clarity) 
 
As the yield of the calixarene synthesis was only 45% of the desired product, the filtrate from initial 
separation of the precipitate from the reaction mixture was concentrated. This caused small crystals to 
form; this solution was left to slowly evaporate further to promote growth of crystals which were of 
suitable quality for single crystal X-ray diffraction studies. On solution the molecular structure reveals 
the chair conformation. In the asymmetric unit there is a single calixarene molecule and five water 
molecules.   
 
Figure 84 - C-(3-Propanol)-calix[4]pyrogallolarene tetra-hydrate chair conformation 
125 
 
The unit cell is in space group P but possesses high molecular symmetry as the molecule has the 
inversion centre. This crystal structure clearly reveals why two signals for the hydrogen atoms are 
observed because H(11) and H(3) are clearly in inequivalent molecular environments and the up-field 
shift of one of the signals may be due to the proximity of the quadrupolar electron cloud of the phenyl 
rings arranged in the axial positions. This effect is shown in the enlargement of the aromatic region of 
the 1H NMR spectrum. The peaks at 5.86 and 5.74 ppm are derived from the proton resonance which 
has split due to the different arrangement of atoms in space. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 85 - Enlargement of aromatic region in 1H NMR showing chair conformation of C-(4-
nitrobenzene)-calix[4]pyrogallolarene 
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3.2 C-(3-Propanol)-calix[4]resorcinarene 
 
C-(3-Propanol)-calix[4]resorcinarene was synthesised solely by traditional methods requiring the use 
of solvents, as the solvent free method failed to give the desired product. The failure of the green 
chemistry reaction may be due to the anhydrous reaction conditions because water is required to 
catalyse the hydrolysis of the alkylated enol equivalent (2,3-dihydropyran). Crystals were grown by 
dissolution of the product from the reaction in the relevant solvent and allowing the solvent to slowly 
evaporate.  
 
Two polymorphic structures have been obtained for the acetonitrile clathrate which show similar 
differences in the arrangement of the guest molecules to that of C-(3-propanol)-
calix[4]pyrogallolarene acetone clathrate. Like the structures previously discussed, the calixarene 
molecule is arranged in a head-to-tail packing motif with the alternating alignment of the calixarenes 
forming a sheet-like architecture (C40H42O12·CH3CN·2H2O) . This is in contrast to the bilayers 
observed in the C-alkyl-calix[4]arenes. 
 
 
Figure 86 - Sheet of alternating calixarenes in C3OHRs acetonitrile clathrate 
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Hydrogen bonds are formed within the sheet between the upper rim of the calixarene to the hydroxyl 
groups of the pendant chain of the calixarene adjacent as shown in Figure 87 below. (H(3) ··· O(12) = 
1.89 Å (O(3) ··· O(12) = 2.72(7) Å), H(4) ··· O(11) = 1.80 Å (O(4) ··· O(11) = 2.63(9) Å), H(7) ··· 
O(10) = 1.77 Å (O(7) ··· O(10) = 2.61(7) Å), H(8) ··· O(9) = 1.81 Å (O(8) ··· O(9) = 2.64(9) Å)).  
 
 
Figure 87 - C-(3-Propanol)-calix[4]resorcinarene acetonitrile water clathrate (solvent molecules 
removed for clarity) 
 
Between each sheet of calixarenes there are three crystallographically unique solvent molecules (one 
acetonitrile and two water molecules). Unusually one of the water molecules is located on the interior 
surface of the cavitand and forms a hydrogen bond to one of the pendant chains (H(9) ··· O(14) = 2.12 
Å (O(9) ··· O(14) = 2.86(14) Å)) of a calixarene in the upper sheet. This hydrogen bond causes a 
misalignment of the calixarene producing a cubic packing arrangement with the calixarene molecules 
of each sheet arranged directly above each other. This disruption of the packing of the calixarene 
molecules affects the orientation of the acetonitrile molecule located within the void formed between 
the cavity of a calixarene and the pendant chains of a calixarene above. The misalignment of the 
acetonitrile causes the distance between the annulus and the nitrogen to be too great to form hydrogen 
bonding interactions. At closest contact (N(1) ··· H(21) = 3.15 Å (N(1) ··· C(21) = 4.35(10) Å)). 
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The second structure is a polymorph of the acetonitrile clathrate which has the same ratio of water to 
the acetonitrile (2:1) shown in the previous structure. A different architecture has been produced 
which possesses significantly higher molecular and packing symmetry; Only one quarter of the 
calixarene is crystallographically unique because the structure is in space group  P42/ncm with the 
mirror planes passing through the centre of the calixarene. 
 
The higher symmetry polymorph (C40H44O12·(CH3CN)·3(H2O)) forms a similar packing motif to the 
lower symmetry polymorph with a layer arrangement with alternating up-down intra-layer 
arrangement of the calixarene molecules being shown (as seen in Figure 88). The difference between 
the structures sheet motifs is the uneven surface of each sheet in the higher symmetry polymorph, the 
intra-sheet interactions cause an alternating height difference between the constituent calixarene 
molecules within the sheet. The water molecules which are present in the crystal lattice are exo to the 
cavity of the calixarene, therefore there is no disruption of vertical parallel arrangement of the 
calixarenes. Hydrogen bonds are formed between the upper rim of the calixarene and the pendant 
chains of the calixarene above (H(3B) ··· O(2) = 1.99 Å (O(3) ··· O(2) = 2.80(4) Å)).  
 
 
Figure 88 - C-(3-Propanol)-calix[4]pyrogallolarene acetonitrile water clathrate (exo water molecules 
removed for clarity) 
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The phenolic groups which are involved in hydrogen bonding to the pendant chains form a pi-pi 
stacking motif and the closest approach is between a centroid generated between C(9) and C(12) and a 
symmetry generated C(9) (3.70 Å). This distance is within the accepted limits for this type of 
interaction.8 
 
The acetonitrile molecule is completely enclosed in the cavity which is formed between the pendant 
chains of one calixarene and the cavity of a second calixarene. This is a similar binding motif to that 
seen in C1Pg and C3OHPg acetonitrile clathrate. However the distance between the nitrogen of the 
guest molecule and the lower rim of the calixarene is greater than seen in other examples of 
coordination to the annulus (N(1) ··· H(12A) = 3.28 Å (N(1) ··· C(12) = 4.19(6) Å), N(1) ··· H(4A) = 
3.18 Å (N(1) ··· C(4) = 4.09(6) Å)). The distance is at the upper limit of a weak hydrogen bond 
proposed by Jeffrey. 7 
 
The phenolic hydroxyl groups which are not involved in hydrogen bonding to the calixarene directly 
above form intra-sheet hydrogen bonds to the adjacent calixarene which is orientated in the opposite 
direction (H(1B) ··· O(3) = 1.85 Å (O(1) ··· O(3) = 2.66(4) Å)) as shown in Figure 89 below. 
 
 
Figure 89 - C-(3-Propanol)-calix[4]resorcinarene acetonitrile water clathrate 
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4 C-(4-nitrophenyl)-calix[4]pyrogallolarene 
 
In order to access amino-substituted calixarenes, C-(4-nitrophenyl)-calix[4]pyrogallolarene was 
synthesised  from its corresponding aldehyde with the plan in mind to hydrogenate the resulting 
product. The synthesis gave the desired product in good yield and purity under standard calixarene 
synthesis conditions of heating in acidic methanol for 6 days at 60°C.  
 
 
Figure 90 - Synthetic Route to C-(4-nitrophenyl)-calix[4]pyrogallolarene 
 
The hydrogenation was unsuccessful in a variety of solvents under atmospheric pressure of hydrogen, 
however the conditions of the hydrogenation allowed the recrystallisation of the product into crystals 
suitable for single crystal X-ray diffraction studies. This shows that the prediction of the alpha carbon 
to the aldehyde was a phenyl group then the chair conformation would dominate, the NMR data also 
supported this because of the presence of two aryl hydrogen resonances which shows the two 
conformations. 
 
131 
 
 
Figure 91 - C-(para-nitrophenyl)-calix[4]pyrogallolarene 
 
This also shows that aromatic nitro groups could successfully withstand the calixarene synthesis 
conditions and would be a suitable handle from which to build an amino group. The difficulty in 
hydrogenation could be due to solubility problems as when the hydrogenation took place in non polar 
solvents such as toluene significant clumping of the carbon catalyst was observed. When non polar 
solvents were used then the clumping was not observed. This was speculated to be because the amino 
groups when formed made the molecule very insoluble in the non-polar solvents and so stuck to the 
surface of the catalyst making the reaction cease. However when the product was analysed from the 
polar solvent (methanol) there appeared to be no change. 
 
This success in introducing the nitro functional group into the calixarene system prompted pursuit of 
an aliphatic nitro-aldehyde, attempts to synthesise this key intermediate however were unsuccessful.   
 
 
 
 
  
 
 
 
 
 
 
 
 
Chapter 6 - Synthesis of halogenated 
calix[4]pyrogallolarenes 
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1 Synthesis 
 
Accessing a calixarene with a brominated pendant chain is highly desirable because it allows the 
further functionalisation of the molecule. This is because bromide is an excellent leaving group and is 
therefore readily substituted by a variety of nucleophiles.  
 
Taking earlier work on the bromination of the alkene substituted pyrogallolarene into consideration it 
was found that the approach of functionalising calixarenes was impractical (see section 1.5.1). 
Therefore this tactic was abandoned in favour of producing an aldehyde precursor bearing a functional 
group which would both survive the calixarene synthesis conditions and not disrupt the 
macrocyclisation by hydrogen bonding to the phenolic hydroxyl groups. Halogen functionalised 
aldehydes were therefore synthesised. 
 
To minimise the number of steps in the synthetic sequence the direct conversion of a bromo-acid to 
the corresponding aldehyde using 9-BBN was attempted. This failed to give the desired product and 
intractable mixtures were formed. Therefore the commonly used two step procedure of reducing the 
acid to the alcohol and then using a mild oxidising agent to produce the corresponding aldehyde was 
used. 
 
 
Figure 92 - Synthetic route to 11-Bromoundecanal 
 
The bromo-acids were reacted with borane dimethyl sulphide in freshly distilled tetrahydrofuran. Thin 
layer chromatography revealed that the starting materials had been consumed after an hour at reflux, 
after which any residual borane complex was quenched with methanol. The removal of the solvent 
and the trimethyl borate on a rotary evaporator gave the corresponding bromo alcohol in high yield 
and purity. These halo-alcohols were oxidised using Corey’s reagent (pyridinium chlorochromate) in a 
dichloromethane solution.182 The product was separated from the spent oxidising agent by passing the 
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reaction mixture through a silica plug and eluting it with dichloromethane. The desired bromo-
aldehydes was shown to be isolated in high purity by GCMS and NMR analysis. 
 
The bromo aldehyde was reacted with pyrogallol to form the corresponding calixarenes. The solvent 
free grinding technique was attempted but failed to give the desired product, the NMR of the reactions 
suggest the reaction produced a mixture of oligomers which were inseparable. When the synthesis was 
attempted in solution, only 5-bromopentanal, 6-bromohexanal and 11-bromoundecanal gave products 
which could be isolated from the reaction mixture. When the reaction mixture was cooled in an ice-
bath the product was precipitated from the reaction with crystals of sufficient quality to be submitted 
for X-ray crystallography analysis. Unfortunately the remaining bromo calixarene syntheses failed to 
yield product. 
 
 
Figure 93 - Synthetic route to C-(bromo-alkyl)-calix[4]pyrogallolarenes 
 
Aldehyde Yield of calixarene % 
3-Bromopropanal 0 
4-Bromobutanal 0 
5-Bromopentanal 49 
6-Bromohexanal 43 
8-Bromooctanal 0 
11-Bromoundecanal 56 
 
Table 4 - Yields of brominated calixarenes 
 
Upon analysis of X-ray data collected on crystals of C4BrPg and C5BrPg the thermal parameters of 
the terminal atom did not match with those expected for bromine. On close inspection of the mass 
spectra it showed that there had been a substitution of the bromine atom on the pendant chains for a 
chlorine atom.  As the GCMS and NMR results for the aldehyde synthesis show conclusively that 
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bromo-aldehydes had been produced, halogen exchange must be taking place during the calixarene 
synthesis. 
 
As the sole source of chloride in the calixarene synthesis was the hydrochloric acid catalyst, a reaction 
was performed to see if the presence of pyrogallol was essential for bromine substitution. This was 
achieved by submitting the aldehyde to the calixarene synthesis reaction conditions in the absence of 
pyrogallol. The reaction was monitored by gas chromatography-mass spectroscopy (GCMS) analysis 
which shows halogen exchange taking place via an enol-derived cyclic intermediate which is 
subsequently ring opened to the chloro-aldehyde. 
 
 
Figure 94 - Halogen exchange in aldehydes 
 
Attempts to repeat the calixarene synthesis with hydrobromic acid as the catalyst failed to yield the 
desired bromo-calixarene. Three possible reasons for the failure of the reaction under hydrobromic 
acid catalysis have been considered: The increased strength of the acid catalyst may destroy either the 
aldehyde or open the calixarene macrocycle and allow oxidation of the pyrogallol rings. Thirdly under 
the reaction conditions there may have been nucleophilic substitution of the bromide by the phenolic 
hydroxyl group, producing cross linked polymers in a similar manner to that which is suspected in the 
bromination of the alkene substituted calixarene. 
 
Crystals of the C4ClPg have been grown from diethyl ether, methanol, ethanol, isopropanol and 
acetonitrile. 
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2 C-(4-Chlorobutane)-calix[4]pyrogallolarene diethyl ether clathrate 
 
Crystals were grown from a saturated solution of C-(4-chlorobutane)-calix[4]pyrogallolarene in 
diethyl ether which had been sonicated for 30 minutes and left to slowly evaporate. On solution of the 
diffraction data, the structure which is formed is in space group P with one calixarene and two 
solvent molecules comprising the asymmetric unit (C44H52O12Cl4·2(CH3CH2OCH2CH3)). The P 
symmetry operation imparts a head-to-head bilayer packing motif on the calixarenes.  There is 
extensive disorder of the terminal atoms in three of the four pendant chains, in one of the pendant 
chains (C(41) – C(44)) there is a complete split of the pendant chains at C(41) with the chain being 
disordered over two positions. In all of the pendant chains there is an extremely close contact with the 
interdigitating calixarene towards its annulus. 
 
 
Figure 95 - C-(4-Chlorobutane)-calix[4]pyrogallolarene diethyl ether clathrate 
 
One of the ether molecules resides within the cavity of the calixarene in a similar arrangement to that 
of C1Pg diethyl ether clathrate. However, unlike the former structure, the ethyl group of the guest 
molecule which is above the upper rim of the calixarene (C(47) & C(48)) does not reside in the cavity 
of a symmetry generated calixarene. The second ethyl group is therefore exo to the calixarene. The 
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guest molecule is held within the cavity by van der Waals interactions between the ethyl group of the 
chains and the aromatic rings of the cavity wall. It also held by hydrogen bonding to the next bilayer 
forming a bond to the upper rim of a calixarene between O(13) and H(1) (O(13) ··· H(1) = 1.93 Å 
(O(13) ··· O(1) = 2.71(5) Å)). The second solvent molecule resides exclusively exo to any calixarene 
cavity, but forms a strong hydrogen bond to the upper rim of the calixarene (O(14) ··· H(4) = 1.86 Å, 
(O(14) ··· O(4) = 2.69(6) Å)). 
 
 
Figure 96 - Bilayer packing motif for C4ClPg diethyl ether clathrate 
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3 C-(4-Chlorobutane)-calix[4]pyrogallolarene propan-2-ol clathrate 
 
Crystals of C-(4-chlorobutane)-calix[4]pyrogallolarene 2-propanol clathrate (C44H52O12Cl-
4·(CH3CH(OH)CH3)·5H2O) were grown by slow evaporation of a saturated solution of  C-(4-
chlorobutane)-calix[4]pyrogallolarene in propan-2-ol. The molecular structure generated from the data 
shows a higher degree of symmetry than the diethyl ether clathrate being in space group P21/c. The 
asymmetric unit contains 7 molecules; one calixarene, one propan-2-ol and five water molecules. In 
addition to the higher symmetry which is present, the molecule has significantly less disorder 
affecting its pendant chains, with only a single terminal chloride atom (Cl4) being disordered over two 
positions. 
 
 
Figure 97 - C-(4-chlorobutane)-calix[4]pyrogallolarene 2-propanol water clathrate 
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Due to its bulky methyl groups and ability to form hydrogen bonds with the upper rim, the 2-propanol 
guest molecule is tilted to an angle of 85° and forms a hydrogen bond between O(17) and H(8) is 1.76 
Å long with the inter-oxygen distance 3.05 Å.  
 
Due to the tilting of the molecule there is a considerable distance between the atom which is furthest 
within the cavity and a plane created from the average positions of C(1), C(12), C(23), C(34) (H(45A) 
– plane C(1),C(12),C(23),C(34) = 2.20 Å and C(45) – plane C(1),C(12),C(23),C(34) = 2.98 Å) . This 
creates a void at the base of the cavity which is larger than observed in other examples reported in this 
thesis: for example – C-methyl-calix[4]pyrogallolarene acetonitrile clathrate has a separation between 
the plane of the annulus and the closest atom of the guest molecule to be 2.02 Å (H(17B) – C(1)/C(9) 
plane and C(17) – C(1)/C(9) plane = 2.35 Å). 
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4 C-(4-Chlorobutane)-calix[4]pyrogallolarene ethanol water clathrate 
 
As expected a bilayer packing arrangement is found in the ethanol clathrate with three ethanol, two 
water and one calixarene molecule comprising the asymmetric unit (C44H52O12·2(CH3CH2OH)·2H2O) 
. 
 
 
Figure 98 - Packing motif for C-(4-chlorobutane)-calix[4]pyrogallolarene ethanol water clathrate 
 
Two of the ethanol molecules are exo to the cavity and fill a void created by the U shaped 
arrangement of the pendant chains this is highlighted in the cartoon below. 
 
 
Cavity of calixarenes 
Pendant chains 
Solvent filled void 
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Figure 99 - Packing cartoon of C-(4-chlorobutane)-calix[4]pyrogallolarene ethanol water clathrate 
The solvent filled void forms a three-molecule (two ethanol and one water molecule) hydrogen 
bonded linker between the calixarenes: H(1A) ··· O(13) = 1.84 Å (O(1) ··· O(13) = 2.66(7) Å), H(13) 
··· O(14) = 1.85 Å (O(13) ··· O(14) = 2.68(12) Å), H(14) ··· O(16) = 1.94 Å (O(16) ··· O(14) = 2.76(13) 
Å), H(8A) ··· O(16) = 1.99 Å (O(8) ··· O(16) = 2.76(8) Å). 
 
In previously reported examples of calixarene bilayers where the pendant chains are strongly 
interdigitated there is distortion of one of the pendant chains in a direction which is parallel to the 
plane of the bilayer. This allows the voids between calixarene walls to be filled and interdigitation to 
take place. In C7Pg diethyl ether and ethanol clathrates, this distorted pendant chain forms the base of 
a solvent filled void. In the molecular structure of C4ClPg the pendant chains are strongly 
interdigitated but are too short to allow distortion to take place and are therefore all aligned in the 
same direction. The interdigitation is made possible by the increased polarity of the chloride group 
allowing interactions with the annulus of the calixarene on the opposite face of the bilayer and also 
creating a sufficiently polar environment in which the ethanol molecules can reside between the 
calixarenes. 
 
 
Figure 100 - Interdigitation of pendant chains in C-(4-chlorobutane)-calix[4]pyrogallolarene ethanol 
water clathrate 
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The mean separation between the calixarene’s annulus and the chloride atom is 3.39 Å (Cl(1) ··· H(1), 
H(2), H(10), H(31) and Cl(1) – C(1), C(12), C(23), C(34) = 4.30 Å) this is a larger value than the 
interactions between the annulus of a calixarene and acetonitrile previously reported, however the 
significantly larger ionic radius of the chloride is not taken into account. Therefore no void is formed 
below the annulus. 
 
Only a single inter layer hydrogen bond exists between the hydroxyl group of the endo ethanol 
molecule and the upper rim of the calixarene in the next layer. (H(10A) ··· O(17) = 1.96 Å (O(10) ··· 
O(17) = 2.76(8) Å)). 
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5 C-(5-Chloropentane)-calix[4]pyrogallolarene ethanol clathrate 
 
Crystals of C5ClPg were grown from a saturated solution of ethanol. As expected from data gathered 
in C-alkyl-calix[4]pyrogallolarenes a bilayer packing motif is formed by the three molecules of the 
asymmetric unit undergoing the inversion operation of the P space group C48H60O12·2(CH3CH2OH) . 
 
In a manner like the previously reported long-chain pyrogallolarene – ethanol clathrates there are two 
solvent molecules in the asymmetric unit, one of which is bound by the cavity, and the second of 
which resides externally of the cavity of the calixarene. The exo solvent molecule resides within the 
interstices created by the cubic packing of the calixarene molecules and forms hydrogen bonds to the 
upper rim of the calixarenes which surround it. H(14) ··· O(6) = 2.68 Å (O(14) ··· O(6) = 3.23(4) Å), 
H(9) ··· O(14) = 2.17 Å (O(9) ··· O(14) = 2.77(3) Å). 
 
 
Figure 101 - Location of exo ethanol molecule in C-(5-Chloropentane)-calix[4]pyrogallolarene 
ethanol clathrate (endo solvent molecules removed for clarity) 
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Unusually the terminal chloride atoms do not form hydrogen bonds to the annulus of the calixarene 
forming the opposite face of the same bilayer, and are directed parallel to the plane of the bilayer. This 
enables very close packing of the bilayer, and the distance between upper rims of opposite faces of the 
same bilayer is 16.29 Å. (for the unfunctionalised C5Pg MeCN clathrate the inter-upper rim distance 
is 16.00 Å). Cl(1) forms a van der Waals interaction with its symmetry generated counterpart, Cl(2) 
and Cl(3) both form hydrogen bonds to the terminal methylene groups of opposite calixarene 
molecules (Cl(3) ··· H(24A) = 2.95 Å (Cl(3) ··· C(24) = 3.76(8) Å), Cl(2) ··· H(12A) = 3.31 Å (Cl(2) ··· 
C(12) = 3.97(9) Å)). Finally Cl(4) is attached to the pendant chain which is parallel to the plane of the 
bilayer. This can be seen in Figure 102 below. 
 
 
Figure 102 - Detail of interdigitation of pendant chains in C-(5-chloropentane)-calix[4]pyrogallolarene 
ethanol clathrate (hydrogen atoms and solvent molecules removed for clarity) 
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6 Solid state structures of C-(10-bromodecane)-calix[4]pyrogallolarene 
methanol and ethanol clathrates 
 
C-(10-Bromodecane)-calix[4]pyrogallolarene was successfully synthesised using traditional solvent 
methods. There was no halogen exchange observed between the calixarenes which may be a result of 
the increased chain length preventing formation of a cyclic intermediate in the halogen exchange 
reaction. Two crystal structures were obtained by the slow evaporation from saturated solutions of 
methanol and ethanol (C68H100O12Br4·4(CH3OH)) and (C68H100O12·xCH3CH2OH). 
 
Unusually the calixarene system, C10BrPg formed capsular architectures in the solid state when 
crystals were grown from ethanol and methanol. This is highly unusual because in addition the 
examples discussed in the previous section showing methanol and ethanol clathrates of C-alkyl-
calix[4]arenes in bilayer packing motifs there is also wide literature precedent for polar protic solvents 
to break up the capsular architecture.106, 115 
 
 
Figure 103 - Nano-capsule formed by C-(10-bromodecane)-calix[4]pyrogallolarene ethanol clathrate 
 
In the ethanol clathrate the contents of the capsule could not be conclusively assigned due to extensive 
disorder, therefore the interior of the capsule was modelled as diffuse electron density. This loss of 
order in the ethanol sphere may be a result of the slightly more lipophilic and conformationally 
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flexible nature of the guest than the acetonitrile derived capsule whose guests’ location could be 
determined. 
 
The packing of the nano-spheres is very similar to that of the acetonitrile spheres, with a face to face 
hexagonal packing arrangement. The external solvent molecules which were observed to form a 
torroidal arrangement between the stacking faces of the nano-capsules are absent in this structure., 
This lack of solvent molecules is compensated for by the longer pendant chains which form a 
lipophilic layer between the capsule, with a high degree of molecular symmetry and a helical 
arrangement of pendant chains. Each gap between the capsules is filled by six calixarenes donating 
three out of their four chains to the inter-capsule gap. 
 
 
Figure 104 - Inter capsule packing of pendant chains in C-(10-bromodecane)-calix[4]pyrogallolarene 
ethanol clathrate 
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The methanol nano-spheres have the same arrangement of the pendant chains and therefore show 
exactly the same packing arrangement as the ethanol clathrate discussed above. In a significant 
difference between the structures, the methanol guest molecules’ position can be determined as shown 
in Figure 108. This structure shows 24 guest molecules which occupy 65% of the available space. 
This is just out of range of the ideal packing coefficient of 55%±9. 
 
Nano-spheres Pendant chains 
Figure 105 - Cartoon showing packing arrangement of nano-spheres generated by C-(10-
bromodecane)-calix[4]pyrogallolarene ethanol clathrate 
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Figure 106 - Nano-capsule formed by C-(10-bromodecane)-calix[4]pyrogallolarene methanol clathrate 
 
When compared to the alkene substituted calixarene, the spheres formed from the halogenated 
derivatives show significant distortion of the macrocycle and therefore capsule due to the more polar 
guests which have been included into the nano-sphere. This distortion results in a decrease in 
molecular volume encapsulated (1213 Å3 for ethanol clathrate and 1209 Å3 for methanol clathrate) 
compared to the previously reported nano-spheres (C4Pg MeCN – 1274 Å3 and C7Pg EtOAc – 1249 
Å3) this is a significant decrease in molecular volume which is encapsulated. 
 
The pendant chains of the brominated calixarene are aligned in bi-directionally, with a trimer of 
pendant chains with potential hydrogen bonding interactions between the bromine and the methylene 
hydrogen atoms of the terminal carbon in the chain. The trimers in the methanol sphere interact with 
another trimer from an adjacent sphere whose chain is perpendicular to the line of the original chain. 
The remaining pendant chain is aligned in the opposite direction to the trimer and interacts with the 
annulus of an adjacent sphere, so each sphere interacts with another six spheres via the individual 
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pendant chain. This is perhaps why the shorter alkyl chained halogenated calixarenes cannot form the 
nano-sphere in very polar solvents because trimer formation is prevented. 
 
 
Figure 107 - ASU of C-(10-bromodecane)-calix[4]pyrogallolarene ethanol clathrate 
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7 Behaviour of C-(10-bromodecane)-calix[4]pyrogallolarene in solution 
 
Investigation of the behaviour of C-(10-bromodecane)-calix[4]pyrogallolarene in solution by DOSY 
NMR shows that the capsular arrangement is formed in chloroform but is broken down to its 
constituent monomers in methanol solution.  
 
 
Figure 108 - DOSY NMR data of C-(10-bromodecane)-calix[4]pyrogallolarene in CDCl3 
 
 
Figure 109 - DOSY NMR data of C-(10-bromodecane)-calix[4]pyrogallolarene in CD3OD 
 
In CDCl3, the diffusion coefficient is 2.23x10-10 m2s-1 therefore the hydrated radius is 17 Å. In CD3OD 
solution, the diffusion coefficient is 3.66x10-10 m2s-1 therefore the hydrated radius is 10 Å.  In CD3OD 
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the diffusion coefficient corresponds to that of a monomeric calixarene. This shows that in alcoholic 
solution the material is in its monomer form but when crystals are grown of the material, the 
calixarene self assembles into a sphere conformation. 
 
The imperfect correlation between the calculated molecular size of the monomer and the hydrated 
radius which is derived from the Stokes-Einstein equation is due to the shape of the calixarene. The 
Stokes Einstein equation is designed for spherical species, while the long alkyl chain of the calixarene 
gives it a more cylindrical shape. The difference in molecular size is sufficiently large to differentiate 
between the monomer and the sphere conformation. 
 
The formation of nano-spheres in the solid state by halogenated calixarene derivatives could be due 
the weak bonds between the trimer of pendant chains which is strong enough to overcome the 
destructive force of the polar protic solvents. This could be tested by the synthesis of fluorinated 
derivatives which would show a stronger bond as the electronegativity of the fluoride is significantly 
higher.  
  
 
 
 
 
 
 
 
Chapter 7 - Synthesis of cyano substituted 
calix[4]pyrogallolarenes 
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1 Introduction 
 
To overcome the problem of denaturation of calixarenes during their functionalisation with basic 
reagents, the aldehyde used for the calixarene synthesis was substituted with a functional group. This 
culminated in the synthesis of cyano functionalised calixarenes. It was envisioned that the cyano 
group would be hydrolysed to the corresponding carboxylic acid during the calixarene synthesis, 
therefore providing a scaffold from which to bind peptide sequences to the calixarene scaffold. 
 
 
Figure 110 – Cyano-calixarene to carboxyl calixarene 
 
2 Synthesis 
 
The commercially available bromo-carboxylic acid was reduced using borane methyl sulphide 
complex in THF to yield the corresponding 11-bromoundecanol (step A). A simple nucleophilic 
substitution of the bromide using sodium cyanide in DMF, gave the cyano alcohol in quantitative 
yield (Step B). 11-cyanoundecanol was smoothly oxidised to the corresponding aldehyde (step C) 
using Corey’s reagent (pyridinium chlorochromate) in 72% yield over the three steps.  
 
 
Figure 111 - Synthetic route to 11-cyanoundecanal 
 
The calixarene synthesis was attempted both under conditions developed during the synthesis of the 
calixarene library (6 days heating at 60°C in acidic ethanol solution) and by green techniques of 
grinding the aldehyde and pyrogallol together with a pestle and mortar and an automatic pestle and 
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mortar. The green techniques failed to produce the desired product and only produced a resinous 
orange material which failed to be recrystallised from any solvent and the NMR failed to show 
product formation, therefore the reactions were abandoned. 
 
 
Figure 112 - Synthetic route to C-(10-cyanodecane)-calix[4]pyrogallolarene 
 
The standard conditions using a strongly acidic solution of ethanol proved successful but only gave 
the desired calixarene in 15 % yield. A low yielding step so far down a synthetic sequence is 
obviously undesirable but investigations have shown it to be unavoidable. There is, however, potential 
for further refinement of the method which is used in order to improve the yield. The product was 
isolated by crystallisation from the reaction mixture during cooling in an ice bath after 6 days heating 
at 60°C, the crystals which grew were suitable for single crystal X-ray diffraction studies. 
 
As there was strong literature precedent for the hydrolysis of nitrile groups in strongly acidic alcohol 
solutions, it was expected that the nitrile would hydrolyse to the corresponding acid substituted 
calixarene.183 The crystalline precipitate which formed on cooling the reaction mixture was analysed 
by NMR and SC-XRD. Both techniques show hydrolysis had not taken place and the cyano group was 
preserved during the reaction in both the bulk material and the crystals which formed. 
 
 
Figure 113 - Proposed route to C-carboxyl-calix[4]pyrogallolarene 
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3 Single crystal X-ray diffraction studies 
 
Because the crystals which were analysed were grown from polar protic solvents it was expected that 
a bilayer packing motif would be formed, however it was found that an unusual capsule packing 
arrangement was formed. 
 
 
Figure 114 - SCXRD image of C-(10-cyanodecane)-calix[4]pyrogallolarene 
 
The cyano-calixarene forms a chloride gated, dimeric capsule, enclosing a single benzene molecule 
(2(C72H100N4O12)·(C6H6)(2HCl)) . The benzene was an impurity in the reaction solvent. The benzene 
molecule (molecular volume 77.4 Å3) occupies 60% of the available volume within the cavity 
(130 Å3). 
 
The cone of the calixarene is slightly distorted, with a distortion factor (Df) = 0.83. The Df for 
unfunctionalised C-decyl-calix[4]pyrogallolarene ethanol clathrate = 0.97. This distortion may be 
attributed to either the presence of a non-spherical guest molecule (benzene) causing contraction of 
the cavity to maximise host-guest interactions or the presence of the chloride ions which interact with 
the upper rim. 
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Figure 115 - Dimeric capsule formed by C-(10-cyanodecane)-calix[4]pyrogallolarene (Image 
generated from SCXRD data) 
 
The dimeric capsule is tilted 13.55° from parallel alignment of upper rims, allowing the chloride ions 
to form an electrostatic interaction with the upper rim (Cl(1) – H(2) = 2.386 Å (Cl(1) – O(2) = 
3.168(15) Å)). A monolayer is formed with calixarene molecules alternately rotated through 180°. 
Uniquely the pendant chains show no interdigitation even though all solid state structures of 
calixarenes with pendant chains longer than 5 carbons show this type of packing in order to maximise 
the van der Waals forces between the chains. 
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Figure 116 - Alternating monolayer formation of C-(10-cyanodecane)-calix[4]pyrogallolarene 
hydrochloride benzene clathrate (solvent molecules and hydrogen atoms removed for clarity). 
 
The cyano-calixarene shows a 3:1 split of pendant chains with no interdigitation of the triad of chains 
but in the isolated chain there is coordination to the annulus of an adjacent calixarene via N(2) as 
shown in Figure 119. The average distance from cyano nitrogen to hydrogen ions of lower rim is 
3.214 Å. 
 
 
Figure 117 - Coordination of C-(10-cyano-decane)-calix[4]pyrogallolarene 
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Efforts to hydrolyse the cyano group have failed. Subjecting the cyano-calixarene to more vigorous 
conditions; suspending the solid product in concentrated acid (HCl, HBr, aqueous TFA) and heating, 
forms a black intractable mixture. This decomposition of the calixarene may be due to hydrolysis of 
the macrocycle and subsequent oxidation of the phenyl rings.63 
 
 
Figure 118 - Hydrolysis of nitrile group 
 
The cyano group also offers the potential to be reduced to the corresponding amine. In the literature it 
was shown to be very troublesome to hydrogenate a cyano group.183 This is because the intermediate 
imine formed, reacts with amines previously produced and results in the production of a mixture of 
secondary and tertiary amines. 
 
 
Figure 119 - Reduction of nitrile group 
 
Therefore to avoid this alkylation of the amine groups the reaction can be performed in acetic 
anhydride or in strongly acidic methanol solution.183 Both these solutions immediately render the 
amine un-reactive by acetylation or protonation, under the reaction conditions. 
 
 
Figure 120 - Protection of amino groups generated from nitrile hydrolysis 
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Both techniques were attempted using atmospheric hydrogenation apparatus using a palladium on 
charcoal catalyst (10% metal loading). When the reaction was performed in the strongly acidic 
conditions did not produce any reduction and starting material was recovered. When the reaction was 
performed using acetic anhydride as the reaction solvent a new product was found to have formed, 
which was on further investigation was proved to be a fully acetylated cyano-calixarene. Therefore it 
can be concluded that under atmospheric pressure which the apparatus available can exert was 
insufficient for reduction to occur. Reduction of the nitrile group was attempted using LiAlH4, SnCl2 
and BH3·SMe2 both proving to be unsuccessful with starting materials being isolated after the 
reaction. This is perhaps due to reagent complexation with the upper rim of the macrocycle in 
solution, but this theory has not been verified. 
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4 NMR Studies 
 
The NMR spectrum of the unprotected cyano calixarene is as expected. However when NMR analysis 
was performed on the acetylated calixarene, the 1H shows no aromatic hydrogen peak and the 13C 
spectrum showed only a broad peak in the region where the phenyl carbons were expected (100 – 140 
ppm) with no resolved peaks which correlate to the phenyl rings. When cooled to –50°C, the solution 
the  broad peak in the 13C  spectrum coalesced to well resolved peaks which correspond to the carbon 
atoms of the phenyl rings. 
 
 
 
 
 
 
 
 
 
Figure 121 - Resolution of broad peaks in 13C NMR spectra of acetylated cyano-calixarene 
 
This indicates some molecular movement or interconversion was taking place rapidly on an NMR 
timescale but when it was cooled, the motion was slowed and peaks could be resolved. Taking the 
work of Höegberg 62 as inspiration this would indicate a conversion between pinched cone 
conformations. 
 
Figure 122 - Interchange between pinched cone conformations in acetylated-cyano-
calix[4]pyrogallolarene 
161 
 
In order to test the capsule forming ability of the pyrogallolarene system, diffusion NMR experiments 
where carried out on the cyano-calixarene in both chloroform which is known to promote the 
formation of capsule and methanol where no capsular arrangement of the molecules has been 
observed. 
 
 
 
 
 
When the Stokes-Einstein equation is applied to this data it shows that even in chloroform, the cyano-
calixarene exists as a monomer with a hydrated radius of 12 Å which is not significantly different to 
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that calculated from the data gathered while in methanol solution (12.4 Å). This shows that in solution 
the nitrile groups on the pendant chain are sufficiently polar to break up the capsular arrangement of 
the calixarene nano-sphere. 
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5 X-ray diffraction studies of acetylated cyano-calixarene 
 
The structure of (undecyl-acetyl)C-(10-cyanodecane)-calix[4]pyrogallolarene shows significant 
differences to the un-protected molecule in both the arrangement of the monomer and the packing 
motif which it therefore forms. The acetylated molecules are, like their unprotected counterparts 
arranged in a head-to-head packing motif, however, this is the sole similarity. 
 
The difference in structure is due to the complete acetylation of the upper rim hydroxyl groups and its 
stereo-electronic effect on the macrocycle. The macrocycle is severely deformed into the pinched cone 
conformation (distortion factor = 0.674). The strain on the macrocycle also causes deformation of the 
aromatic rings away from the ideal hexagonal form. The conformation which the macrocycle adopts 
means that the cavity is no longer available for binding guest molecules and unusually for calixarene 
molecules there are no solvent molecules entrapped in the crystal lattice. The Figure below is aligned 
to highlight the pinched cone conformation. 
 
 
Figure 123 – SC-XRD image of acetylated C-(10-cyanodecane)-calix[4]pyrogallolarene 
 
The average distance from cyanide nitrogen to annulus is 2.992 Å which is much closer than 
unprotected analogue.  The acetylation of the hydroxyl groups means that the phenyl rings are slightly 
more electron deficient than the unprotected cyano as shown in the up-field shift of the peaks. This 
164 
 
electron deficiency allows four hydrogen bonds to form between phenyl hydrogen and nitrile group. 
This interaction draws adjacent molecules closer, allowing interdigitation of the calixarene’s pendant 
chains.  
 
Even though the ring is more electron deficient when acetylated compared to the acetonitrile solvates 
(C1Pg MeCN – 2.6 Å) this is a longer hydrogen bond but this could be accounted for by the greater 
steric encumbrance of the pendant chains which have to become organised. This suggests that it is not 
only the presence of groups at the terminus of a pendant chain which determine the packing motif but 
the electron density around the phenyl rings. 
 
In concordance with the structures published by Han et al.58 there are interpenetration of the acetyl 
groups of the adjacent calixarenes so the acts as a guest to prevent formation of a large unoccupied 
cavity forming because “nature abhors a vacuum”.184 The dimer is held together with 4 hydrogen 
bonds between a methyl group of an acetal group and the carbonyl oxygens. In the figure below one 
monomer is shown in red the other in blue. 
 
 
Figure 124 - Dimerisation of acetylated C-(10-cyanodecane)-calix[4]pyrogallolarene (pendant chains 
removed for clarity)
  
 
 
 
 
 
 
 
Chapter 8 - Calixarenes as drug delivery 
vectors 
 
  
 1 Toxicity of C-alkyl
 
The following section will discuss the investigations undertaken to assess the viability of using 
calix[4]pyrogallolarene derived systems as drug delivery vectors.
 
In order to complete preliminary toxicity data the toxicity of a variety of 
calix[4]pyrogallolarenes was tested. This was to assess the
chain lengths. The tests were performed by addition of a 10 
immature dendritic cells and incubating them together for 168 hours
mature. After a week the cell count was assessed and the number of surviving cells was counted. The 
data as shown in the Figure 
own towards immature dendritic cells.
 
 
 
 
 
 
-calix[4]pyrogallolarene derivatives
 
 effect on the toxicity of a variety of alkyl 
µg/ml DMSO solution of the calixarene to 
 in order to allow the cells to 
below shows that the calixarenes do not show significant toxicity on their 
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C-alkyl-
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Dendritic cells were used because immature DC cells will uptake a wide variety of materials by 
phagocytosis. Also more significantly when exposed to a peptide the DC cells mature and present the 
peptide on the surface of the cell. This peptide sequence is now in an acceptable form to enable the 
activation of T-cells which will induce an immune response against cells bearing this surface peptide. 
This will allow the targeting of specific cell types for immunotherapy. Currently no adjuvant for the 
delivery of short peptide sequences is approved for human use, therefore if the peptide can be 
immobilised on the surface of a calix[4]pyrogallolarene supramolecular scaffold (in addition to 
aqueous solubilising groups) a therapy can be developed based on the principles detailed above. 
 
A second round of testing of cytotoxicity was performed once C-(10-cyanodecane)-
calix[4]pyrogallolarene was synthesised in order to assess the effect of including a highly polar 
functional group on the pendant chain on the cellular toxicity which the calixarenes present. The assay 
was shorter in duration due to the peripheral blood mononuclear cells (PBMC) used. While there is 
significant cell mortality during this assay, when compared to the media-only controls this cannot be 
attributed to the presence of C10CNPg. Any toxic effect due to the calixarene is rapidly shown (with a 
significant decrease in cell viability after 5 minutes). 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
Chapter 9 - Conclusions 
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Construction of a calix[4]pyrogallolarene containing polar functional groups on its pendant chain is 
possible by pre-forming the desired functionality onto the aldehyde which is reacted with pyrogallol. 
Efforts to functionalise the calixarene once formed were complicated by difficulties in protecting the 
upper rim of the macrocycle and its decomposition.  
 
If the pendant alkyl chains of calix[4]pyrogallolarenes are unconstrained by functionalisation, it is the 
guest which appears to determine the geometry of the macrocycle. If the chains are functionalised it is 
the interactions originating from the groups on the chain which takes precedence for the packing motif 
and any distortion of the macrocycle. Therefore, it may be possible to have sphere-promoting and 
sphere-dissociating functionality on the pendant chains. The capsule is surprisingly robust when the 
additional functional groups which promote the formation of a nano-sphere (in the case of the halogen 
functionalised spheres) are present. 
 
If the pendant chains of the calixarene are sufficiently long (>6 carbon atoms long) the chain can 
distort and allow solvent molecules to be included within the face of a bilayer, this causes a 
contraction of the bilayer to allow greater van der Waals interactions to form between the pendant 
chains. 
 
In a manner similar to that of the induced fit model of enzymes, the macrocycle can distort to 
accommodate the presence of guest molecules within the cavity. The capsule is generally formed by 
R symmetry, therefore any change in the conformation of the macrocycle is duplicated around the 
sphere. This distortion can lead to changes in the supramolecular architecture which is formed. 
Distortion of the conformation of the calixarene is seen in the nano-spheres which contain highly 
polar guest molecules (e.g. chloro spheres containing methanol and ethanol and the acetonitrile 
sphere). Therefore there are guest molecules which are sphere promoting and sphere dissociating.  
 
When the upper rim is unfunctionalised, the hydrogen atoms of the lower rim bear a slight positive 
charge and therefore electron donors may form hydrogen bonds to the calixarene. These interactions 
dramatically affect the behaviour of the molecule both in solution and in the solid phase. This is seen 
in the acetylated cyano calixarene derivatives, where disruption of the hydrogen bonding which keeps 
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the macrocycle in its cone conformation is eliminated, causing the molecule to become much more 
conformationally flexible. 
 
The calixarene scaffold shows great potential with initial toxicity data indicating a lack of significant 
toxicity to the dendritic cells which are the target of the therapy. The obvious target is the synthesis of 
an amino or carboxyl substituted calixarene which will allow therapeutic peptide sequences to be 
tagged onto the exterior of the capsule. Further toxicity testing on all derivatives synthesised will aid 
the understanding of the toxicological profile of this class of molecules. 
 
  
 
 
 
 
 
 
 
Chapter 10 - Experimental 
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1 Instrumentation  
 
Nuclear magnetic resonance (NMR) spectra were recorded on a JEOL ECX 400 (1H: 400 MHz and 
13C: 100 MHz) spectrometer in the deuterated solvent stated. All chemical shifts (δ) are quoted in ppm 
and coupling constants (J) in Hz. Residual signals from the solvents were used as an internal 
reference. Infrared spectra were recorded on a Perkin-Elmer Spectrum 100 Fourier Transform 
spectrophotometer with an attenuated total reflectance (ATR) sampling accessory, allowing direct 
analysis of the sample. Only the characteristic peaks are quoted in cm-1. All reactions involving 
moisture sensitive reagents were performed under an atmosphere of nitrogen via standard vacuum line 
techniques. Tetrahydrofuran was distilled under an atmosphere of dry nitrogen from potassium. All 
other solvents were used as supplied (Laboratory, Analytical or HPLC grade), without prior 
purification. Thin layer chromatography was performed on aluminium sheets coated with 60 F254 
silica. Sheets were visualised using 1% potassium permanganate. Mass spectra were obtained upon an 
APCI Platform spectrometer with only molecular ions, fragments from molecular ions and major 
peaks being reported. Elemental analyses were performed by the microanalysis service of the 
Inorganic Chemistry Laboratory, London Metropolitan University. Single crystal analysis was 
performed at Daresbury synchrotron laboratories, Heriot Watt University and by the EPSRC X-ray 
crystallography service at The University of Southampton. The instruments used respectively were: 
Bruker-Nonius KappaCCD diffractometers with a rotating anode X-ray generator. One of the 
instruments has a Bruker Apex II detector. Both diffractometers are fitted with a Cobra cryogenic 
system. 
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2 Method for cytotoxicity assay on calixarenes 
 
Cytotoxicity studies were performed using a Trypan blue assay in sterile fume hoods. C-(10-
cyanodecane)-calix[4]pyrogallolarene was diluted using DMSO to final concentration of 10 mgml-1. 
500 ml of RPMI® media was modified by addition of 1% glutamine and 10% Foetal Calf Serum 
(FCS). The PBM cells were given an initial wash using the modified media. This was performed by 
adding the defrosted PBM cells to the modified media. This suspension was centrifuged for 3 minutes 
at 3Gs. The supernatant was then removed and the pellet re-suspended in modified RPMI media. 
 
The initial cell count was performed by creating a 1 in 10 cell dilution using 450 µl of Trypan blue 
and 50 µl of the cells. A haemocytometer was cleaned in 70% ethanol, and the cell solution was plated 
and the cells counted in the four 0.25 mm x 0.25 mm grids. There were 17.5 x104 ml-1 cells present in 
the initial sample. As the original volume of the sample was 4 ml, the original sample contained 7x106 
cells. For the cytotoxicity studies, it was necessary to have 0.5 million cells per well. Each well can 
contain 1 ml, so 286µl of PBMC cell suspension was added to 14 wells. This was topped up to 1ml 
using the modified RPMI media, and incubated overnight at 37°C.  
 
Dilutions of C-(10-cyanodecane)-calix[4]pyrogallolarene were created using modified RPMI media to 
give final concentrations of 10, 1, and 0.1 mg ml-1. Serial 1 in 10 dilutions of DMSO were prepared in 
a similar manner to give 1 in 10, 1 in 100 and 1 in 1000 dilutions for testing. After 24 hours, 100 µl of 
the supernatant was removed from 12 of the 14 wells. 100 µl of 10 mlml-1 C10CNPg was added to 
two wells, 100 µl of 1 mgml-1 of C10CNPg was added to two wells and 100µl of C10CNPg was added 
to two wells. The DMSO was added to 6 wells in a similar fashion. Two wells were left alone in order 
to provide a control. The cells were then incubated at 37°C. At 5 minutes, 30 minutes, 1 hour and 2 
hours the well was removed from the incubator and 100 µl of each removed into a 1 ml aliquot. The 
plate was then placed back in the incubator. To each aliquot, 100 µl of Trypan blue was added to 
provide a 1 in 2 dilution of the cells. Samples were placed on a haemocytometer and the live and dead 
cells counted in each sample.  
  
174 
 
3 Synthesis of C-methyl-calix[4]pyrogallolarene (C1Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37 % 25 ml) was 
added and the solution was stirred for 5 minutes. Acetaldehyde (4.40 ml, 79 mmol) in ethanol (20 ml) 
was added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred 
for 24 hours at room temperature then was heated to 60°C for a further 120 hours. The reaction 
mixture was cooled in an ice bath and a pale yellow precipitate was observed to form from the brown 
solution. The solid was filtered under vacuum and washed with ice cold ethanol (3 x 10 ml) to yield a 
buff coloured solid (11.961 g) shown to be product (99% yield). 
 
1H ((CD3)2SO δppm 400 MHz) 6.67 (1 H, s), 4.43 (1 H, t, 3J = 6.9 Hz), 1.44 (3 H, d, 3J  = 7.32 Hz) 
13C {1H}707070707069 ((CD3)2SO δppm 400 MHz) 140.2, 132.4, 114.4, 28.9, 21.0 IR νmax ATR cm-1 
3309, 3158, 2967, 2931, 1609, 1488, 1446, 1316, 1275, 1198, 1094, 1076, 1030.5, 1002, 961, 875, 
772, 725, 646. MS m/z (ESI+) 609 ([M+H]+·, 100%), 626 ([M+H2O]+·15), 631 ([M+Na]+·20), 646 
([M+K]+· 20), 1217 ([2M+H]+·, 25), 1234 ([2M+H2O]+· 15), 1240 ([2M+Na]+· 15), 1255 ([2M+K]+· 
15) 
 
Crystal data for C-methyl-calix[4]pyrogallolarene diethyl ether clathrate: 
(C32H32O12·3(CH3CH2OCH2CH3)), M = 830.75, colourless block, 0.10 x 0.08 x 0.04 mm3, monoclinic, 
space group C2/c (No. 15), a = 27.3835(9), b = 21.9504(7), c = 17.4697(5) Å, β = 120.1140(10)°, V = 
9083.4(5) Å3, Z = 8, Dc = 1.215 g/cm3, F000 = 3568, Bruker-Nonius APEX II CCD camera on 
goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.3º, 53344 reflections collected, 
10426 unique (Rint = 0.0807).  Final GooF = 1.125, R1 = 0.0869, wR2 = 0.1590, R indices based on 
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6989 reflections with I >2σ (I) (refinement on F2), 608 parameters, 0 restraints.  Lp and absorption 
corrections applied, µ  = 0.091 mm-1. 
 
Crystal data for C-methyl-calix[4]pyrogallolarene acetonitrile clathrate: (C32H32O12·3(CH3CN)), M = 
731.74, colourless slab, 0.58 x 0.22 x 0.10 mm3, monoclinic, space group P2/n (No. 13), a = 
12.3862(3), b = 7.2689(2), c = 19.9868(6) Å, β = 94.4630(10)°, V = 1794.04(9) Å3, Z = 2, Dc = 1.355 
g/cm3, F000 = 772, Bruker-Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  
T = 120(2)K, 2θmax = 55.2º, 19932 reflections collected, 4122 unique (Rint = 0.0525).  Final GooF = 
1.077, R1 = 0.0887, wR2 = 0.2441, R indices based on 2866 reflections with I >2σ (I) (refinement on 
F2), 111 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.102 mm-1. 
 
4 Synthesis of C-ethyl-calix[4]pyrogallolarene (C2Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes. Propionaldehyde (5.72 ml, 79 mmol) in ethanol (20 
ml) was added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was 
stirred for 24 hours at room temperature then was heated to 60°C for a further 120 hours. The reaction 
mixture was cooled in an ice bath, and the pale purple precipitate which formed was filtered. The solid 
was washed with ice cold chloroform which decolourised the powder to pale grey. NMR confirms 
solid as product (4.906 g, 50% yield) 
 
1H ((CD3)2SO δppm 400 MHz) 6.88 (1 H, s), 4.03 (1 H, t, 3J = 8.48 Hz), 2.15 (2 H, qn, 3J = 7.32), 
0.79 (3 H, t, 3J = 6.88 Hz). 13C {1H} ((CD3)2SO δppm 100 MHz) 139.6, 132.9, 124.4, 113.6, 36.1, 
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26.0, 12.8. IR νmax ATR cm-1 3220, 2962, 2872, 1607.5, 1500, 1477, 1384, 1322, 1246, 1228, 1209, 
1114, 1087, 1057, 1033, 988, 948, 934, 906, 873, 776, 721, 601. MS m/z (ESI) 664 ([M+H]+·, 30%), 
682 ([M+H2O]+· 40), 687 ([M+Na]+· 35), 703 ([M+K]+· 100), 1329 ([2M+H]+·, 5), 1352 ([M+Na]+· 40), 
1368 ([M+K]+· 90) 
 
Crystal data for C-ethyl-calix[4]pyrogallolarene acetonitrile clathrate: C36H40O12·5(CH3CN), M = 
869.97, Colourless Block, 0.28 x 0.24 x 0.18 mm3, monoclinic, space group P21/c (No. 14), a = 
11.2014(3), b = 21.3303(4), c = 19.3327(4) Å,β = 92.1080(10)°, V = 4616.02(18) Å3, Z = 4, Dc = 
1.252 g/cm3, F000 = 1848, Bruker-Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 
0.71073 Å,  T = 120(2)K, 2θmax = 55.1º, 54117 reflections collected, 10598 unique (Rint = 0.0791).  
Final GooF = 1.036, R1 = 0.0617, wR2 = 0.1418, R indices based on 6599 reflections with I >2σ (I) 
(refinement on F2), 605 parameters, 0 restraints.  Lp and absorption corrections applied, µ  = 0.091 
mm-1. 
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5 Synthesis of C-ethyl-calix[4]resorcinarene (C2Rs) 
 
HO OH HO OH
4
O
H
HCl
EtOH
 
 
Resorcinarene (10 g, 91 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) 
was added and the solution was stirred for 5 minutes. Propionaldehyde (6.55 ml, 79 mmol) in ethanol 
(20 ml) was added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was 
stirred for 24 hours at room temperature then was heated to 70°C for a further 144 hours. The reaction 
mixture was cooled in an ice bath, and the pale purple precipitate which formed was filtered. The solid 
was washed with ice cold chloroform and dried in a vacuum oven overnight. NMR confirms solid as 
product (23.08 g, 88% yield) 
 
1H ((CD3)2SO δppm 400 MHz) 7.21 (s, 1H), 6.14 (s, 1H), 4.07 (t, 1H, 3J = 7.88 Hz), 2.08 (p, 2H, 3J = 
6.64, 7.32 Hz), 0.77 (q, 3H, 3J = 6.96 Hz) 13C{1H} ((CD3)2SO δppm 100 MHz) 151.9, 125.1, 123.3, 
100.2, 35.3, 27.9, 12.8 
 
Crystal data for C-ethyl-calix[4]resorcinarene: C36H40O8·(CH3CN)(H2O), M = 659.81, colourless slab, 
0.44 × 0.33 × 0.10 mm3, monoclinic, space group P2/n (No. 13), a = 13.8457(3), b = 7.8652(2), c = 
18.3617(5) Å, β = 103.156(2)°, V = 1947.09(8) Å3, Z = 2, Dc = 1.238 g/cm3, F000 = 772, Bruker-
Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 
55.0º, 20276 reflections collected, 4477 unique (Rint = 0.0457).  Final GooF = 1.083, R1 = 0.0931, 
wR2 = 0.2454, R indices based on 3538 reflections with I >2σ (I) (refinement on F2), 244 parameters, 
0 restraints.  Lp and absorption corrections applied, µ = 0.088 mm-1. 
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6 Synthesis of C-propyl-calix[4]pyrogallolarene (C3Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes. Butyraldehyde (7.15 ml, 79 mmol) in ethanol (20 
ml) was added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was 
stirred for 24 hours at room temperature then was heated to 60°C for a further 120 hours. After 24 
hours at 60°C the solution darkened to dark brown. The mixture was cooled in an ice bath and the 
purple precipitate was filtered. The solid was washed with ice cold toluene which caused 
decolourisation. Analysis shows the solid to be the desired product (10.389 g, 77% yield). 
 
1H ((CD3)2SO δppm 400 MHz) 6.90 (1 H, s), 4.19 (1H, t, 3J = 7.76 Hz), 2.14 (2 H, q, 3J = 7.8 Hz), 
1.18, (2 H, m), 0.88 (3 H, t, 3J = 6.88). 13C{1H} ((CD3)2SO δppm 100 MHz)  139.6, 132.8, 124.5, 
113.6, 34.9, 33.4, 20.8, 13.9. IR νmax ATR cm-1 3357, 2953, 2927.5, 2867, 1615, 1474, 1465, 1299, 
1237, 1196, 1110, 1076.5, 1040, 976, 949, 877, 855, 839, 782, 748, 730, 682, 609, 589. MS m/z (ESI) 
721 ([M+H]+·, 100%), 736 ([M+H2O]+· 70) 
 
Crystal data for C-propyl-calix[4]pyrogallolarene ethanol water clathrate: C40H48O12·3C2H5OH·2H2O, 
M = 895.02, colourless plate, 0.46 × 0.20 × 0.03 mm3, triclinic, space group P-1 (No. 2), a = 
11.5628(5), b = 12.2343(5), c = 17.2991(9) Å, α = 72.332(2), β = 82.829(2), γ = 86.732(3)°, V = 
2313.04(18) Å3, Z = 2, Dc = 1.285 g/cm3, F000 = 964, Bruker-Nonius Roper CCD camera on goniostat, 
MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.2º, 45995 reflections collected, 10590 
unique (Rint = 0.0644).  Final GooF = 1.014, R1 = 0.0613, wR2 = 0.1301, R indices based on 7213 
179 
 
reflections with I >2σ (I) (refinement on F2), 829 parameters, 0 restraints.  Lp and absorption 
corrections applied, µ = 0.097 mm-1. 
 
Crystal data for C-propyl-calix[4]pyrogallolarene acetone clathrate: C40H48O12·3(CH3C(O)CH3), M = 
894.40, colourless cut block, 0.56 × 0.44 × 0.28 mm3, monoclinic, space group P2/c (No. 13), a = 
12.0951(3), b = 14.3546(5), c = 15.3913(5) Å, β = 109.098(2)°, V = 2525.16(14) Å3, Z = 3, Dc = 1.254 
g/cm3, F000 = 1024, Bruker-Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  
T = 120(2)K, 2θmax = 55.1º, 28932 reflections collected, 5805 unique (Rint = 0.0460).  Final GooF = 
1.067, R1 = 0.0545, wR2 = 0.1448, R indices based on 4555 reflections with I >2σ (I) (refinement on 
F2), 428 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.092 mm-1. 
 
Crystal data for C-propyl-calix[4]pyrogallolarene diethyl ether water clathrate: C88H116O29, M = 
1637.81, colourless plate, 0.25 × 0.22 × 0.04 mm3, monoclinic, space group P21/c (No. 14), a = 
20.6338(8), b = 11.2266(4), c = 36.0871(15) Å, β = 92.6060(10)°, V = 8350.8(6) Å3, Z = 4, Dc = 1.303 
g/cm3, F000 = 3504, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.0º, 81565 reflections 
collected, 18806 unique (Rint = 0.1095).  Final GooF = 1.038, R1 = 0.1180, wR2 = 0.3195, R indices 
based on 8934 reflections with I >2σ (I) (refinement on F2), 1082 parameters, 0 restraints.  Lp and 
absorption corrections applied, µ = 0.097 mm-1. 
 
Crystal data for C-propyl-calix[4]pyrogallolarene acetonitrile water clathrate: C40H48O12·C2H3N1 H2O, 
M = 794.11, colourless lath, 0.26 × 0.12 × 0.02 mm3, triclinic, space group P1 (No. 1), a = 12.3620(5), 
b = 18.9976(10), c = 20.0390(11) Å, α = 62.434(2), β = 76.306(3), γ = 88.490(3)°, V = 4034.3(3) Å3, 
Z = 4, Dc = 1.307 g/cm3, F000 = 1691, Bruker-Nonius APEX II CCD camera on goniostat, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.7º, 59550 reflections collected, 32632 unique (Rint 
= 0.1164).  Final GooF = 1.031, R1 = 0.1443, wR2 = 0.2400, R indices based on 13301 reflections 
with I >2σ (I) (refinement on F2), 2145 parameters, 3 restraints.  Lp and absorption corrections 
applied, µ = 0.096 mm-1.  Absolute structure parameter = 3(3) (Flack, H. D. Acta Cryst. 1983, A39, 
876-881). 
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7 Synthesis of C-butyl-calix[4]pyrogallolarene (C4Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes. Pentanal (8.43 ml, 79 mmol) in ethanol (20 ml) was 
added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred for 24 
hours at room temperature then was heated to 60°C for a further 120 hours. The reaction mixture was 
cooled in an ice bath and the resulting grey precipitate was filtered, and washed with ice cold 
methanol. NMR shows precipitate to be product (7.890 g 51% Yield). 
 
1H ((CD3)2SO δppm 400 MHz)  6.86 (1 H, s), 4.16 (1 H, t, 3J = 7.8 Hz), 2.13 (2 H, m), 1.32 (2 H, m), 
1.17 (2 H, m), 0.85 (3 H, t, 3J = 7.76 Hz) 13C{1H} ((CD3)2SO δppm 100 MHz) 139.6, 132.8, 124.5, 
113.5, 33.9, 33.1, 22.2. 14.3 IR νmax ATR cm-1 3451, 2953, 2926, 2857, 1619, 1495, 1466, 1374, 1276, 
1179, 1114, 1067, 1044, 1011, 969, 935, 873, 851, 779, 718, 676, 610, 584. MS m/z (ESI) 776 
([M+H]+·, 95%), 792 ([M+H2O]+· 100) 
 
Crystal data for C-butyl-calix[4]pyrogallolarene diethyl ether water clathrate: C48H72O16, M = 905.06, 
colourless plate, 0.20 × 0.16 × 0.02 mm3, monoclinic, space group P21/c (No. 14), a = 20.6564(9), b = 
13.1221(6), c = 18.2667(7) Å, β = 108.700(2)°, V = 4689.9(3) Å3, Z = 4, Dc = 1.282 g/cm3, F000 = 
1952, Bruker-Nonius APEX II CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 
120(2)K, 2θmax = 55.3º, 38021 reflections collected, 10627 unique (Rint = 0.0702).  Final GooF = 
1.092, R1 = 0.0999, wR2 = 0.1653, R indices based on 6377 reflections with I >2σ(I) (refinement on 
F2), 623 parameters, 4 restraints.  Lp and absorption corrections applied, µ = 0.095 mm-1. 
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Crystal data for C-butyl-calix[4]pyrogallolarene acetonitrile water clathrate: C48H72O12, C2H3N1 H2O, 
M = 846.11, colourless block, 0.24 × 0.24 × 0.1 mm3, trigonal, space group R (No. 148), a =  b = 
35.7719(4), c = 21.3642(6) Å, V = 23675.6(8) Å3, Z = 21, Dc = 1.246 g/cm3, F000 = 9486, Bruker-
Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 
55.0º, 69106 reflections collected, 12075 unique (Rint = 0.1073).  Final GooF = 1.503, R1 = 0.1611, 
wR2 = 0.4251, R indices based on 6042 reflections with I >2σ (I) (refinement on F2), 664 parameters, 
1 restraint.  Lp and absorption corrections applied, µ = 0.089 mm-1. 
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8 Synthesis of C-pentyl-calix[4]pyrogallolarene (C5Pg) 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes. Hexanal (9.75 ml, 79 mmol) in ethanol (20 ml) was 
added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred for 24 
hours at room temperature then was heated to 60°C for a further 120 hours. The dark purple solution 
was cooled in an ice bath and the purple precipitate which formed was filtered and washed with ice 
cold methanol to give a pale purple solid which was dried in a vacuum oven. NMR shows solid to be 
product (8.13 g 49% Yield) 
 
1H ((CD3)2SO δppm 400 MHz) 6.82 (1 H, s), 4.15 (1 H, t, 3J = 7.7 Hz), 2.11 (2 H, m), 1.30-1.05 (6 H, 
m), 0.84 (3 H, t, 3J = 7.14). 13C{1H} ((CD3)2SO δppm 100 MHz)  139.7, 132.9, 124.5, 113.4, 33.9, 
33.14, 31.6, 27.7, 22.4, 14.1. IR νmax ATR cm-1 3369, 3187, 2953, 2930, 2860, 1625, 1609, 1473, 
1386, 1311, 1274, 1186, 1118, 1085, 1034, 980, 948, 918, 878, 869, 859, 829, 781, 765, 723, 676, 
606.  MS m/z (ESI) 833 ([M + H]+· , 40), 413 ([M + 2H]++·, 100%) 
 
Crystal data for C-pentyl-calix[4]pyrogallolarene acetonitrile water clathrate: C50H69NO13, M = 
892.06, colourless plates, 0.5 × 0.44 × 0.05 mm3, monoclinic, space group P21/c (No. 14), a = 
18.587(4), b = 13.270(3), c = 19.692(4) Å, β = 90.31(3)°, V = 4857.1(17) Å3, Z = 4, Dc = 1.220 g/cm3, 
F000 = 1920, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.0º, 47651 reflections collected, 
11092 unique (Rint = 0.0671).  Final GooF = 1.042, R1 = 0.0968, wR2 = 0.2495, R indices based on 
7618 reflections with I >2σ (I) (refinement on F2), 630 parameters, 12 restraints.  Lp and absorption 
corrections applied, µ = 0.087 mm-1 
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9 Synthesis of C-hexyl-calix[4]pyrogallolarene (C6Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes. Heptanal (11.1 ml, 79 mmol) in ethanol (20 ml) was 
added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred for 24 
hours at room temperature then was heated to 60°C for a further 120 hours. The reaction was then 
cooled, and the pale pink precipitate was filtered and washed with ice cold methanol. NMR shows 
solid (12.598 g) to be product (72% Yield). 
 
1H ((CD3)2SO δppm 400 MHz) 6.78 (1 H, s), 4.20 (1 H, t, 3J = 7.76 Hz), 2.09 (2 H, m), 1.30-1.10 (8 
H, m), 0.85 (3 H, t, 3J = 7.04 Hz), 13C{1H} ((CD3)2SO δppm 100 MHz) 139.7, 132.7, 124.3, 113.3, 
33.7, 33.3, 31.3, 28.7, 27.7, 22.0, 13.7, IR νmax ATR cm-1 3266, 2952, 2926, 2855, 1691, 1611, 1477, 
1467, 1314, 1202, 1115, 1078, 1039, 1004, 973, 943, 877, 779, 721, 591, 497. MS m/z (ESI) 911 ([M 
+ Na]+· , 30), 889 ([M + H]+·, 20%), 685 ([M – 1 C11H18O3 subunit]+·, 100), 445 ([M + 2H]++., 20). 
 
Crystal data for C-hexyl-calix[4]pyrogallolarene hydrochloride acetonitrile clathrate: C54H77ClNO13, 
M = 983.62, colourless block, 0.24 × 0.20 × 0.10 mm3, triclinic, space group P-1 (No. 2), a = 
10.6780(4), b = 12.4618(5), c = 21.1907(10) Å, α = 105.968(2), β = 98.239(2), γ = 95.678(2)°, V = 
2654.49(19) Å3, Z = 2, Dc = 1.231 g/cm3, F000 = 1058, Bruker-Nonius Roper CCD camera on 
goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.2º, 55436 reflections collected, 
12183 unique (Rint = 0.1121).  Final GooF = 1.035, R1 = 0.0758, wR2 = 0.1735, R indices based on 
6663 reflections with I >2σ(I) (refinement on F2), 647 parameters, 0 restraints.  Lp and absorption 
corrections applied, µ = 0.135 mm-1. 
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10 Synthesis of C-heptyl-calix[4]pyrogallolarene (C7Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes. Octanal (12.40 ml, 79 mmol) in ethanol (20 ml) was 
added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred for 24 
hours at room temperature then was heated to 60°C for a further 120 hours. The reaction mixture was 
cooled in an ice bath and after 1 hour a grey crystalline solid had formed in the solution. The solid was 
filtered off, and washed with ice cold methanol, and dried in-vacuo. Analysis shows the solid (13.199 
g) to be the desired product (71% Yield). 
 
1H ((CD3)2SO δppm 400 MHz) 6.72 (1 H, s), 4.13 (1 H, t, 3J = 7.32 Hz), 2.04, (2 H, m), 1.30-1.05 (10 
H, m), 0.82 (3 H, t, 3J = 7.7 Hz). 13C{1H} ((CD3)2SO δppm 100MHz) 139.8, 133.0, 124.4, 113.2, 34, 
33, 31.5, 30, 29.0, 28, 22.2, 14.0. IR ATR cm-1 3269.8, 2922.9, 2853.2, 1612.2, 1479.5, 1465.0, 
1378.1, 1314.9, 1240.3, 1200.2, 1115.8, 1086.3, 1035.1, 978.7, 944.5, 870.3, 781.9, 721.7, 614.8, 
598.4, 574.9, 499.5 MS m/z (ESI) 944 ([M + H]+· , 100%), 961 ([M + H2O]+·, 80). 
 
Crystal data for C-heptyl-calix[4]pyrogallolarene diethyl ether water clathrate: C64H100O12, M = 
1092.63, colourless block, 0.44 × 0.17 × 0.12 mm3, triclinic, space group P-1 (No. 2), a = 10.649(2), b 
= 15.580(3), c = 20.359(4) Å, α = 109.79(3), β = 93.19(3), γ = 98.00(3)°, V = 3128.3(11) Å3, Z = 2, Dc 
= 1.178 g/cm3, F000 = 1208, Bruker-Nonius 95mm CCD camera on goniostat, MoKα radiation, λ = 
0.71073 Å,  T = 120(2)K, 2θmax = 56.1º, 55974 reflections collected, 14352 unique (Rint = 0.0697).  
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Final GooF = 1.401, R1 = 0.1272, wR2 = 0.3665, R indices based on 8252 reflections with I >2σ (I) 
(refinement on F2), 720 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.082 
mm-1. 
 
Crystal data for C-heptyl-calix[4]pyrogallolarene ethanol water clathrate: C112H196O40, M = 2180.00, 
colourless plate, 0.10 × 0.08 × 0.01 mm3, triclinic, space group P-1 (No. 2), a = 16.539(2), b = 
16.629(2), c = 23.088(3) Å, α = 73.037(2), β = 81.318(2), γ = 85.089(2)°, V = 5998.2(13) Å3, Z = 4, 
Dc = 1.197 g/cm3, F000 = 2350, Bruker SMART APEX2 CCD diffractometer, synchrotron radiation, λ 
= 0.6884 Å,  T = 120(2)K, 2θmax = 42.5º, 33635 reflections collected, 14617 unique (Rint = 0.0488).  
Final GooF = 1.040, R1 = 0.0998, wR2 = 0.2717, R indices based on 8324 reflections with I >2σ (I) 
(refinement on F2), 1437 parameters, 21 restraints.  Lp and absorption corrections applied, µ = 0.085 
mm-1. 
 
Crystal data for C-heptyl-calix[4]pyrogallolarene hydrochloride acetonitrile water clathrate: 
C58H83ClNO13, M = 1037.70, colourless slab, 0.20 × 0.18 × 0.07 mm3, triclinic, space group P-1 (No. 
2), a = 10.6185(2), b = 12.5157(4), c = 22.7434(7) Å, α = 105.9370(10), β = 99.380(2), γ = 
95.389(2)°, V = 2836.72(14) Å3, Z = 2, Dc = 1.215 g/cm3, F000 = 1118, Bruker-Nonius Roper CCD 
camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.1º, 52483 reflections 
collected, 12933 unique (Rint = 0.0701).  Final GooF = 1.030, R1 = 0.0646, wR2 = 0.1602, R indices 
based on 8980 reflections with I >2σ (I) (refinement on F2), 663 parameters, 0 restraints.  Lp and 
absorption corrections applied, µ = 0.130 mm-1. 
 
Crystal data for C-heptyl-calix[4]pyrogallolarene ethyl acetate clathrate: C60H88O14, M = 1033.30, 
Colourless Block, 0.58 × 0.54 × 0.50 mm3, trigonal, space group R-3 (No. 148), a =  b = 30.059(4), c 
= 36.910(7) Å, V = 28883(8) Å3, Z = 18, Dc = 1.069 g/cm3, F000 = 10080, Bruker-Nonius 95mm CCD 
camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.3º, 87065 reflections 
collected, 14718 unique (Rint = 0.0900).  Final GooF = 1.866, R1 = 0.2298, wR2 = 0.5702, R indices 
based on 5728 reflections with I >2σ (I) (refinement on F2), 315 parameters, 0 restraints.  Lp and 
absorption corrections applied, µ = 0.075 mm-1. 
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11 Synthesis of C-octyl-calix[4]pyrogallolarene (C8Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37 %, 25 ml) was 
added and the solution was stirred for 5 minutes. Nonanal (13.64 ml, 79 mmol) in ethanol (20 ml) was 
added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred for 24 
hours at room temperature then was heated to 60°C for a further 120 hours. The red solution was 
cooled in an ice bath for 1 hour and the resulting pink precipitate was filtered, and washed with a little 
ice cold methanol and dried to yield cream coloured solid which was shown to be product (16.846 g, 
85 % Yield). 
 
1H ((CD3)2SO δppm 400 MHz) 6.74 (1 H, s), 4.15 (1 H, t, 3J = 7.44 Hz), 2.06 (2 H, m), 1.34 – 1.05 
(12 H, m), 0.85 (3 H, t), 13C{1H} ((CD3)2SO δppm 100 MHz) 139.7, 132.9,  124.3, 113.1, 33.9, 33.3, 
31.4, 29.4, 29.3, 28.9, 28.0, 22.2, 14.0. IR νmax ATR cm-1 3277, 2922, 2853, 1612, 1478.5, 1465, 
1377.5, 1312, 1236, 1209, 1116, 1086, 1036, 979, 947, 869, 775, 720.5, 595, 576.0, 500, MS m/z 
(ESI+) 1119 ([M+H]+·, 15%), 412.08 (100), 250 (20) 
 
Crystal data for C-octyl-calix[4]pyrogallolarene hydrochloride acetonitrile water clathrate: 
C60H88O12·CH3CN·H2O·HCl M = 1106.91, colourless block, 0.58 × 0.24 × 0.12 mm3, triclinic, space 
group P-1 (No. 2), a = 10.6979(6), b = 12.5868(8), c = 23.5520(17) Å, α = 76.818(3), β = 78.637(3), γ 
= 84.395(4)°, V = 3022.6(3) Å3, Z = 2, Dc = 1.216 g/cm3, F000 = 1208, Bruker-Nonius Roper CCD 
camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.4º, 55444 reflections 
collected, 13645 unique (Rint = 0.1319).  Final GooF = 1.005, R1 = 0.0860, wR2 = 0.2020, R indices 
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based on 6082 reflections with I >2σ (I) (refinement on F2), 768 parameters, 66 restraints.  Lp and 
absorption corrections applied, µ = 0.126 mm-1. 
  
12 Synthesis of C-decyl-calix[4]pyrogallolarene (C10Pg) 
 
 
 
Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml). Hydrochloric acid (37 % 25 ml) was 
added and the solution was stirred for 5 minutes. Undecanal (16.37 ml, 79 mmol) in ethanol (20 ml) 
was added drop-wise to the acidic pyrogallol solution over 1 hour. The reaction mixture was stirred 
for 24 hours at room temperature then was heated to 60°C for a further 120 hours. The red / orange 
solution was cooled ad a cream coloured precipitate rapidly formed. The precipitate was filtered and 
dried in a vacuum oven to yield product (21.827 g, 99 % Yield) 
 
1H ((CD3)2SO δppm 400 MHz) 6.71 (1 H, s), 4.22 (1 H, t, 3J = 7.8), 2.04 (2H, m), 1.24 (14 H, m), 
0.84 (5 H, m), 13C{1H} ((CD3)2SO δppm 100 MHz) 139.7, 132.6, 124.0, 112.9, 33.6, 33.3, 31.0, 29.0, 
28.9, 28.8, 28.7, 28.4, 27.6, 21.8, 13.5. IR νmax ATR cm-1 3540, 3505, 3310, 2955, 2919, 2851, 1613, 
1466, 1378, 1307.5, 1237, 1119, 1082.5, 1045, 973, 948, 878, 781, 721, 682, 608, 585, 496, 425, 413, 
MS m/z (ESI+) 1013 ([M+H]+·,20%), 790 (5), 526 (70), 388 (100) 
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13 Synthesis of C-(dec-10-ene)-calix[4]pyrogallolarene (C10enePg) 
 
 
 
Pyrogallol (1 g, 8 mmol) and p-toluene sulfonic acid (2 mg 0.01 mmol) were ground together to a fine 
powder with a mortar and pestle. Undecyleneic aldehyde (1.68 ml, 8 mmol) was added and the 
mixture was ground together. After 10 minutes of grinding the mixture had become viscous and 
thickened. This mixture was left to stand for an hour whereupon it hardened and became brittle. 
Recrystallisation of this solid from acetonitrile gave a white solid which was shown by NMR and MS 
to be the desired product (2.01 g, 1.8 mmol, 88% yield). 
 
1H ((CDCl3 δppm 400 MHz) 6.76 (s, 1H), 5.75 (m, 1H), 4.87 (m, 2H), 4.29 (s, 1H), 2.14 (s, 2H), 1.98 
(m, 2H) 1.30 (m, 12H), 13C{1H} ((CD3)2SO δppm 100 MHz) 139.1, 138.4, 137.3, 131.3, 125.3, 124.0, 
114.1, 33.9, 30.0, 29.8, 29.7, 29.6, 29.3, 29.1, 28.3, IR νmax ATR cm-1 3451, 2923, 2852, 1638, 1505, 
1466, 1276, 907, 720 391, MS m/z (ESI) 1127 ([M+Na]+·, 100%) 
 
Crystal data for C-(dec-10-ene)-calix[4]pyrogallolarene ethyl acetate clathrate: C430H624O84, M = 
7128.63, colourless block, 0.37 × 0.23 × 0.10 mm3, trigonal, space group R-3 (No. 148), a =  b = 
37.216(5), c = 26.038(5) Å, V = 31232(9) Å3, Z = 3, Dc = 1.166 g/cm3, F000 = 11826, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 46.6º, 88333 reflections collected, 10033 unique (Rint 
= 0.0696).  Final GooF = 1.674, R1 = 0.1247, wR2 = 0.3531, R indices based on 5809 reflections with 
I >2σ (I) (refinement on F2), 786 parameters, 11 restraints.  Lp and absorption corrections applied, µ = 
0.081 mm-1. 
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14 Synthesis of C-Propanol-calix[4]pyrogallolarene (C3OH Pg) 
 
 
 
Pyrogallol (10 g, 79mmol) was dissolved in methanol (60ml). Hydrochloric acid (15 ml 37%) was 
added and the mixture stirred for 5 minutes. 2,3-Dihydropyran (6 ml 79 mmol) was added drop-wise 
to the acidic pyrogallol solution and the mixture was stirred for 1 hour at room temperature. The 
reaction mixture was heated to 30°C for 12 hours after which the temperature was increased to 50°C 
and the reaction was stirred for a further 144 hours. The reaction was cooled in an ice bath, the 
colourless precipitate which formed was filtered off. The solid was suspended in water and sonicated 
for 30 minutes. The solid was filtered and dried in a vacuum oven. Analysis shows solid to be product 
(7.649 g  49% Yield). 
 
1H ((CD3)2SO δppm 400 MHz) 6.87 (1 H, s), 4.13 (1 H, t, 3J = 7.8 Hz), 3.42 (2 H, t, 3J = 6.4 Hz), 2.15 
(2 H, m), 1.33 (2 H, m), 13C{1H} ((CD3)2SO δppm 100 MHz) 139.6, 132.9, 124.5, 113.5, 60.7, 33.6, 
31.3, 29.2, MS m/z (ESI) 807 [M+Na]+·, 100%), IR νmax ATR cm-1 3194, 2946, 1637, 1466, 1297, 
1092, 1047, 970, 867, 676, 493 
 
Crystal data for C-(3-hydroxypropane)-calix[4]pyrogallolarene acetone water clathrate: C43H56O20, M 
= 892.94, colourless Blade, 0.50 × 0.20 × 0.05 mm3, triclinic, space group P-1 (No. 2), a = 
10.4216(3), b = 10.8206(4), c = 11.8989(5) Å, α = 91.955(2), β = 104.612(2), γ = 116.399(2)°, V = 
1146.33(7) Å3, Z = 1, Dc = 1.398 g/cm3, F000 = 516, Bruker-Nonius 95mm CCD camera on goniostat, 
MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.5º, 23346 reflections collected, 5293 
unique (Rint = 0.0470).  Final GooF = 1.061, R1 = 0.0536, wR2 = 0.1416, R indices based on 3766 
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reflections with I >2σ (I) (refinement on F2), 435 parameters, 0 restraints.  Lp and absorption 
corrections applied, µ = 0.118 mm-1. 
 
Crystal data for C-(3-hydroxypropane)-calix[4]pyrogallolarene tetrahydrofuran water clathrate: 
C44H60O19, M = 892.92, Colourless Block, 0.14 × 0.07 × 0.03 mm3, monoclinic, space group P2/n (No. 
13), a = 13.9100(4), b = 9.6399(2), c = 16.1474(4) Å, β = 90.4790(10)°, V = 2165.15(9) Å3, Z = 2, Dc 
= 1.370 g/cm3, F000 = 952, Bruker-Nonius 95mm CCD camera on goniostat, MoKα radiation, λ = 
0.71073 Å,  T = 120(2)K, 2θmax = 55.0º, 31057 reflections collected, 4969 unique (Rint = 0.0500).  
Final GooF = 1.066, R1 = 0.0627, wR2 = 0.1699, R indices based on 4149 reflections with I >2σ (I) 
(refinement on F2), 386 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.107 
mm-1. 
 
Crystal data for C-(3-hydroxypropane)-calix[4]pyrogallolarene acetone water clathrate: C55H86O25, M 
= 1147.24, Colourless Needle, 0.168 × 0.014 × 0.015 mm3, monoclinic, space group P21/c (No. 14), a 
= 15.051(2), b = 16.979(2), c = 27.627(3) Å, β = 122.481(5)°, V = 5955.7(12) Å3, Z = 4, Dc = 1.279 
g/cm3, F000 = 2464, Bruker SMART APEX2 CCD diffractometer, synchrotron radiation, λ = 0.6941 
Å,  T = 120(2)K, 2θmax = 54.3º, 51684 reflections collected, 13142 unique (Rint = 0.0364).  Final GooF 
= 1.029, R1 = 0.0413, wR2 = 0.1028, R indices based on 9860 reflections with I >2σ (I) (refinement 
on F2), 919 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.101 mm-1. 
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15 Synthesis of C-Propanol-Calix[4]resorcinarene (C3OH Rs) 
 
OH
OH
HO OH
HCl
EtOH
HO
HO OH
OH
HO OH
O
HO
OH
OH
HO
 
 
Resorcinol (5 g 45 mmol) was dissolved in methanol (200 ml). Hydrochloric acid (37% 50 ml) was 
added and the solution was stirred for 5 minutes at room temperature. 2,3-Dihydropyran (3.18 g, 45 
mmol) in methanol (50 ml) was added drop-wise to the acidic resorcinol solution over 1 hour. The 
reaction mixture was stirred for 1 hour at room temperature under an atmosphere of nitrogen. The 
reaction was then heated to 60°C for 144 hours. The reaction was then cooled in an ice bath and the 
resulting precipitate was filtered. The off-white solid was suspended in water and sonicated for 15 
minutes. The white solid was filtered once more and dried in a vacuum oven overnight. NMR shows 
solid (5.29 g) to be product (65 % Yield). 
 
1H NMR(CD3OD / D2O δppm 400 MHz) 7.23 (s, 1H), 6.23 (s, 1H), 4.25 (t, 1H, 3J = 7.71 Hz), 3.60 (t, 
2H, 3J = 6.75 Hz), 2.23 (m, 2H), 1.48 (m, 2H), 13C{1H} NMR (CD3OD / D2O δppm 100 MHz) 152.6, 
141.4, 125.4, 103.9, 62.8, 35.9, 31.9, 30.7, IR ATR cm-1 3159, 2934, 1616, 1498, 1441, 1366, 1285, 
1223, 1157, 1021, 845, 518, MS m/z (ESI+) 743 [M+Na]+· (100%) 
 
Crystal data for C-(Propan-3-ol)-calix[4]resorcinarene acetonitrile water clathrate: C168H204N4O56, M = 
3175.35, Orange Plate, 0.58 × 0.50 × 0.10 mm3, monoclinic, space group P21/c (No. 14), a = 
13.379(3), b = 19.146(4), c = 18.112(7) Å, β = 119.50(2)°, V = 4038(2) Å3, Z = 1, Dc = 1.306 g/cm3, 
F000 = 1688, Bruker-Nonius 95mm CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 
120(2)K, 2θmax = 55.1º, 50561 reflections collected, 9277 unique (Rint = 0.0465).  Final GooF = 1.075, 
R1 = 0.0954, wR2 = 0.2464, R indices based on 6613 reflections with I >2σ (I) (refinement on F2), 
532 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.098 mm-1. 
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Crystal data for C-(Propan-3-ol)-calix[4]resorcinarene acetonitrile water clathrate: C42H51NO15, M = 
811.88, light yellow slab, 0.40 × 0.32 × 0.14 mm3, tetragonal, space group P42/ncm (No. 138), a =  b = 
15.48520(10), c = 17.4646(3) Å, V = 4187.86(8) Å3, Z = 4, Dc = 1.294 g/cm3, F000 = 1744, Bruker-
Nonius 95mm CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 
55.0º, 34174 reflections collected, 2533 unique (Rint = 0.0442).  Final GooF = 1.210, R1 = 0.0890, 
wR2 = 0.2194, R indices based on 2305 reflections with I >2sigma(I) (refinement on F2), 152 
parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.098 mm-1. 
 
16 Synthesis of C-pNitrobenzene-calix[4]pyrogallolarene (C-pNO2C6H4 
Pg) 
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Pyrogallol (10 g, 79 mmol) was dissolved in ethanol (100 ml), hydrochloric acid (37% 25 ml) was 
added and the solution was stirred for 5 minutes at room temperature. p-Nitrobenzaldehyde (11.9 g 79 
mmol) in ethanol (20 ml) was added drop-wise over 1 hour to the acidic pyrogallol solution. The 
mixture was stirred at room temperature for 1 hour the heated to 60°C for 120 hours. The mixture was 
then cooled and the resulting precipitate was filtered off and the solid (14.29 g) was washed with ice 
cold methanol. Analysis shows solid to be the desired product (70% yield) 
 
1H ((CD3)2SO δppm 400 MHz) 7.76 (d, 2H, J3 = 8.72 Hz), 6.84 (d, 2H, 3J = 8.28 Hz), 5.83 (s, 1H), 
5.77 (s, 1H), 1.22 (s, 1H), 13C{1H} ((CD3)2SO δppm 100 MHz) 152.8, 144.7, 142.8, 142.4, 131.9, 
129.9, 122.2, 121.0, 119.9, 48.6, IR νmax ATR cm-1 3435, 2926, 1624, 1603, 1518, 1462, 1350, 1287, 
1077, 1013, 859, 818, 700, 563 MS m/z (ESI+) 1037 [M+H]+· (25%), 1059 [M+Na]+· (100), 1122 
[M+K]+· 
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Crystal data for C-(4-nitrophenyl)-calix[4]pyrogallolarene ethyl methyl ketone water clathrate: 
C38H42N2O17, M = 798.74, brown-green block, 0.10 × 0.10 × 0.04 mm3, triclinic, space group P-1 (No. 
2), a = 10.909(4), b = 14.075(5), c = 14.615(5) Å, α = 91.686(4), β = 106.942(4), γ = 102.816(4)°, V = 
2082.5(13) Å3, Z = 2, Dc = 1.274 g/cm3, F000 = 840, Bruker SMART APEX2 CCD diffractometer, 
synchrotron radiation, λ = 0.7977 Å,  T = 120(2)K, 2θmax = 47.1º, 15321 reflections collected, 7279 
unique (Rint = 0.0375).  Final GooF = 1.811, R1 = 0.1580, wR2 = 0.4365, R indices based on 4325 
reflections with I >2σ (I) (refinement on F2), 425 parameters, 0 restraints.  Lp and absorption 
corrections applied, µ = 0.101 mm-1. 
17 Synthesis of 3-Bromopropanol 
 
 
 
In a flame-dried, 3 necked round bottomed flask; 3-bromopropionic acid (20 g, 131 mmol) was 
dissolved in freshly distilled THF (250 ml). Borane-methyl sulphide complex (12.6 ml, 131 mmol) in 
THF (200 ml) was added drop-wise. When half the borane solution was added, the reaction was 
heated to reflux. Once at reflux the remaining borane was added drop-wise. The reaction mixture was 
stirred for 2 hours at reflux, then cooled to room temperature. The reaction was slowly poured into ice 
cold methanol (400 ml), once the addition was complete, the solution was allowed to warm to room 
temperature and was then stirred for 1 hour. The solvent was removed by rotary evaporation, and the 
resulting yellow oil (18 g 129 mmol) shown to be product. (99 % Yield) 
 
1H (CDCl3 δppm, 400 MHz) 3.71 (t, 2H, 3J = 6.46 Hz), 3.42 (t, 2H, 3J = 6.36 Hz), 2.021 (q, 2H, 3J = 
6.12 Hz), 13C{1H} (CDCl3, δppm, 100 MHz) 54.9, 38.8, 30.2, IR νmax ATR cm-1 3328, 2949, 2882, 
1726, 1254, 1082, 910, 646, 563, MS m/z (ESI) 137 [M+H]+· (5%), 120 [M – OH + H]+· (100), 58 [M 
– Br + H] +· (90) 
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18 Synthesis of 3-Bromopropanal 
 
 
 
To a rapidly stirring solution of 3-bromopropanol (10 g, 72 mmol) in dichloromethane (300 ml), 
pyridinium chlorochromate was added (18.56 g, 86 mmol). The pale yellow solution immediately 
darkened to a deep brown colour, and the solution was heated to reflux for 3 hours. The reaction was 
monitored by thin layer chromatography (3:7 ethyl acetate / 40 – 60ºC petroleum ether on silica) and 
once the starting materials had been consumed after 3 hours at reflux, the black solution was cooled 
and was passed through a silica plug which was then washed with further portions of dichloromethane 
to ensure complete recovery of product. The solvent was then removed by rotary evaporation to yield 
a yellow oil (7.45 g, 54 mmol), which on analysis was shown to be the desired product. (76 % yield) 
 
1H (CDCl3 δppm, 400 MHz) 9.77 (s, 1H), 3.43 (t, 2H, 3J = 6.5 Hz), 2.64 (t, 2H, 3J = 6.7 Hz), 13C{1H} 
(CDCl3, δppm, 100 MHz) 202.0, 32.91, 42.2, IR νmax ATR cm-1 2925, 2857, 1727, 1421, 1259, 1122, 
1072, 921, MS m/z (ESI) 137 [M+H]+·, (20%), 57 [M – Br] +·(100) 
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19 Synthesis of 4-Bromobutanol 
 
 
 
In a flame dried, 3 necked round bottomed flask; 4-bromobutyric acid (5 g, 30 mmol) was dissolved in 
freshly distilled THF (200 ml). Borane-methyl sulphide complex (2.9 ml, 30 mmol) in THF (200 ml) 
was added drop-wise to the solution. When half the borane solution was added, the reaction was 
heated to reflux. Once at reflux the remaining borane was added drop-wise. The reaction mixture was 
stirred for 1½ hours at reflux and then cooled to room temperature. The reaction was slowly poured 
into ice cold methanol (400 ml), once the addition was complete, the solution was allowed to warm to 
room temperature and was then stirred for a further hour. The solvent was removed by rotary 
evaporation, and the resulting yellow oil (4.362 g) shown to be product. (95 % Yield) 
 
1H (CDCl3 δppm, 400 MHz) 3.55 (t, 2H, 3J = 6.43 Hz), 3.38 (t, 2H, 3J = 6.65 Hz), 1.86 (qn, 2H, 3J = 
7.85, 6.96 Hz), 1.62 (qn, 2H, 3J = 8.10, 6.46), 13C{1H} (CDCl3, δppm, 100 MHz) 60.9, 33.4, 30.6, 
28.9, IR νmax ATR cm-1 3331, 2944, 1630, 1035, 392, MS m/z (ESI) 151 [M+H]+·, (5%), 134 [M - 
OH]+· (25), 55 [M - OH & - Br]+· (100) 
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20 Synthesis of 4-Bromobutanal 
 
 
 
To a rapidly stirring solution of 4-bromobutanol (3 g, 20 mmol) in dichloromethane (100 ml), 
pyridinium chlorochromate was added (5.06 g, 12 mmol). The pale yellow solution immediately 
darkened to a deep brown colour, and the solution was heated to reflux for 3 hours. The reaction was 
monitored by thin layer chromatography (3:7 ethyl acetate / 40 – 60ºC petroleum ether on silica) and 
once the starting materials had been consumed, the black solution was cooled and was passed through 
a silica plug which was then washed with further portions of dichloromethane to ensure complete 
recovery of product. The solvent was then removed by rotary evaporation to yield a yellow oil (2.72 g, 
18 mmol), which on analysis by gas chromatography – mass spectrometry was shown to be the 
desired product. (92 % yield) 
 
1H (CDCl3 δppm, 400 MHz) 9.75 (s,1H), 2.62 (t, 2H, 3J = 7.39 Hz), 2.44 (t, 2H, 3J = 7.17 Hz), 2.12 
(qn, 2H, 3J = 6.74, 6.52 Hz), 13C{1H} (CDCl3, δppm, 100 MHz) 200.8, 53.4, 42.1, 32.7, 24.9, IR νmax 
ATR cm-1 2927, 2860, 1720, 1459, 1440, 1400, 1259, 1174, 735, 635, MS m/z (ESI) 151 [M+H]+·, 
(20%), 71 [M – Br] +·(100) 
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21 Synthesis of 5-Bromopentanol 
 
 
 
In a flame dried, 3 neck round bottomed flask, 5-bromopenanoic acid (20 g, 110 mmol) was dissolved 
in freshly distilled THF (200 ml). Borane-dimethyl sulfide complex (10.6 ml, 110 mmol) in THF (200 
ml) was added drop-wise. When half the borane solution was added, the reaction was heated to reflux. 
Once at reflux the remaining borane was added drop-wise to the refluxing solution. The reaction 
mixture was stirred for 2 hours at reflux, and then cooled to room temperature. The reaction was 
slowly poured into ice cold methanol (400 ml), once the addition was complete, the solution was 
allowed to warm to room temperature and was then stirred for 1 hour. The solvent was removed by 
rotary evaporation, and the resulting yellow oil (18.119 g, 108 mmol) upon analysis was shown to be 
the desired product. (99 % Yield) 
 
1H (CDCl3 δppm, 400 MHz) 3.57 (t, 2H, 3J = 6.22 Hz), 3.36 (t, 2H, 3J = 6.51 Hz), 1.83 (qn, 2H, 3J = 
6.73, 7.65 Hz), 1.56 - 1.42 (m, 4H), 13C{1H} (CDCl3, δppm, 100 MHz) 62.2, 33.7, 32.2, 31.5, 24.3, IR 
νmax ATR cm-1 3333, 2937, 2864, 1732, 1455, 1431, 1246, 1044, 733, 641, 559, MS m/z (ESI) 167 
[M+H]+·, (40%), 87 [M – Br] +·(100) 
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22 Synthesis of 5-Bromopentanal 
 
 
 
To a rapidly stirring solution of 5-bromopentanol (10 g, 60 mmol) in dichloromethane (400 ml), 
pyridinium chlorochromate was added (25.8 g, 120 mmol). The pale yellow solution immediately 
darkened to a deep brown colour, and the solution was heated to reflux for 3 hours. The reaction was 
monitored by thin layer chromatography (3:7 ethyl acetate / 40 – 60ºC petroleum ether on silica) and 
once the starting materials had been consumed, the black solution was cooled and was passed through 
a silica plug which was then washed with further portions of dichloromethane to ensure complete 
recovery of product. The solvent was then removed by rotary evaporation to yield a yellow oil (9.432 
g), which on analysis was shown to be the desired product. (95 % yield) 
 
1H (CDCl3 δppm, 400 MHz) 9.71 (s, 1H), 3.36 (t, 2H, 3J = 6.63 Hz), 2.43 (t, 2H, 3J = 7.29 Hz), 1.87 - 
1.68 (m, 4H), 13C{1H} (CDCl3, δppm, 100 MHz) 201.7, 42.6, 33.0, 31.7, 20.4, IR νmax ATR cm-1 
2940, 2726, 1722, 1433, 1253, 1122, 1061, 751, 560, MS m/z (ESI) 164 [M+H]+·, (20%), 159 [M – 
CHO] +·(100) 
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23 Synthesis of 6-Bromohexanol 
 
 
 
In a flame dried, 3 neck round bottomed flask, 6-bromohexanoic acid (10 g, 51 mmol) was dissolved 
in freshly distilled THF (200 ml). Borane-dimethyl sulfide complex (4.9 ml, 51 mmol) in THF (200 
ml) was added drop-wise. When half the borane solution was added, the reaction was heated to reflux. 
Once at reflux the remaining borane was added drop-wise to the refluxing solution. The reaction 
mixture was stirred for 2 hours at reflux, then cooled to room temperature. The reaction was slowly 
poured into ice cold methanol (200 ml), once the addition was complete, the solution was allowed to 
warm to room temperature and was then stirred for 2 hours. The solvent was removed by rotary 
evaporation, and the resulting yellow oil (9.2 g, 50 mmol) shown to be product. (99 % Yield) 
 
1H (CDCl3 δppm, 400 MHz) 3.52 (t, 2H, 3J = 6.82 Hz), 3.35 (t, 2H, 3J = 6.82 Hz), 1.79 (qn, 2H, 3J = 
6.89, 6.95), 1.52 - 1.25 (m, 6H), 13C{1H} (CDCl3, δppm, 100 MHz) 61.9, 33.6, 32.4, 31.9, 27.6, 24.6, 
IR νmax ATR cm-1 3347, 2933, 2858, 1721, 1459, 1436, 1258, 1051, 1031, 727, 642, 559, 383, MS m/z 
(ESI) 181 [M+H]+·, (20%), 101 [M – Br] +·(100) 
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24 Synthesis of 6-Bromohexanal 
 
 
 
To a rapidly stirring solution of 6-bromohexanol (5 g, 28 mmol) in dichloromethane (150 ml), 
pyridinium chlorochromate was added (11.9 g, 55 mmol). The pale yellow solution immediately 
darkened to a deep brown colour, and the solution was heated to reflux for 3 hours. The reaction was 
monitored by thin layer chromatography (3:7 ethyl acetate / 40 – 60ºC petroleum ether on silica) and 
once the starting materials had been consumed, the black solution was cooled and was passed through 
a silica plug which was then washed with further portions of dichloromethane to ensure complete 
recovery of product. The solvent was then removed by rotary evaporation to yield a colourless oil 
(3.647 g, 20 mmol), which on analysis was shown to be the desired product (74 % yield). 
 
1H (CDCl3 δppm, 400 MHz) 9.72 (s, 1H), 3.37 (t, 2H, 3J = 6.81 Hz), 2.42 (t, 2H, 3J = 7.11 Hz), 1.84 
(qn, 2H, 3J = 6.78, 7.04), 1.61 (qn, 2H, 3J = 7.32, 7.32), 1.47 - 1.39 (m, 2H), 13C{1H} (CDCl3, δppm, 
100 MHz) 202.2, 53.4, 33.4, 32.3, 27.5, 21.0, IR νmax ATR cm-1 2938, 2864, 2723, 1722, 1459, 1437, 
1410, 1265, 1197, 735, 640, 559, MS m/z (ESI) 179 [M+H]+·, (5%), 150 [M – CHO] +·(100) 
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25 Synthesis of 8-Bromooctanol 
 
 
 
In a flame dried, 3 neck round bottomed flask, 8-bromooctanoic acid (5 g, 22 mmol) was dissolved in 
freshly distilled THF (100 ml). Borane-dimethyl sulfide complex (2.15 ml, 22 mmol) in THF (20 ml) 
was added drop-wise. When half the borane solution was added, the reaction was heated to reflux. 
Once at reflux the remaining borane was added drop-wise to the refluxing solution. The reaction 
mixture was stirred for 2 hours at reflux, then cooled to room temperature. The reaction was slowly 
poured into ice cold methanol (200 ml), once the addition was complete, the solution was allowed to 
warm to room temperature and was then stirred for 2 hours. The solvent was removed by rotary 
evaporation, and the resulting yellow oil (4.72 g,  mmol) shown to be product. (99 % Yield) 
 
1H (CDCl3 δppm, 400 MHz) 3.28 (m, 2H), 3.11 (m, 2H), 1.52 (qn, 2H, 3J = 7.18, 7.62 Hz), 1.23 - 0.95 
(m, 10H), 13C{1H} (CDCl3, δppm, 100 MHz) 62.0, 33.5, 32.2, 29.0, 28.5, 27.8, 25.4, IR νmax ATR cm-
1
 3339, 2928, 2855, 1723, 1462, 1272, 1126, 1054, 723, 643, 561, MS m/z (ESI) 209 [M+H]+·, (2%), 
129 [M – Br] +·(100) 
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26 Synthesis of 8-Bromooctanal 
 
 
 
To a rapidly stirring solution of 6-bromohexanol (4 g, 19 mmol) in dichloromethane (150 ml), 
pyridinium chlorochromate was added (8.23 g, 38 mmol). The pale yellow solution immediately 
darkened to a deep brown colour, and the solution was heated to reflux for 3 hours. The reaction was 
monitored by thin layer chromatography (3:7 ethyl acetate / 40 – 60ºC petroleum ether on silica) and 
once the starting materials had been consumed, the black solution was cooled and was passed through 
a silica plug which was then washed with further portions of dichloromethane to ensure complete 
recovery of product. The solvent was then removed by rotary evaporation to yield a colourless oil (1.2 
g, 6 mmol), which on analysis was shown to be the desired product (32 % yield). 
 
1H (CDCl3 δppm 400 MHz) 9.72 (s, 1H), 3.36 (t, 2H, 3J = 6.8 Hz), 2.38 (m, 2H), 1.81 (m, 2H), 1.60 
(m, 2H), 1.41 (m, 2H), 1.29 (m, 4H), 13C{1H} (CDCl3 δppm 100 MHz) 202.6, 43.7, 33.8, 32.6,  28.8, 
28.4, 27.8, 21.8, IR νmax ATR cm-1 2930, 2857, 1707, 1461, 1269, 1122, 1072, 941, 737, 644, 561, MS 
m/z (ESI) 207 [M+H]+·, (25%), 178 [M – CHO] +·(100) 
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27 Synthesis of 11-Bromoundecanol 
 
 
 
In a flame dried, 3 neck round bottomed flask, 11-Bromoundecanoic acid (10 g, 38 mmol) was 
dissolved in freshly distilled THF (150 ml). Borane-dimethyl sulfide complex (3.8 ml, mmol) in THF 
(50 ml) was added drop-wise. When half the borane solution was added, the reaction was heated to 
reflux. Once at reflux the remaining borane was added drop-wise to the refluxing solution. The 
reaction mixture was stirred for 2 hours at reflux, then cooled to room temperature. The reaction was 
slowly poured into ice cold methanol (200 ml), once the addition was complete, the solution was 
allowed to warm to room temperature and was then stirred for 1 hour. The solvent was removed by 
rotary evaporation, and the resulting yellow oil (9.261 g, 36 mmol) crystallised on standing. Shown to 
be product. (98 % Yield) 
 
1H (CDCl3 δppm, 400 MHz) 3.60 (t, 2H, 3J = 6.85 Hz), 3.38 (t, 2H, 3J = 7.01 Hz), 1.82 (qn, 2H, 3J = 
6.85, 6.63 Hz), 1.53 (qn, 2H, 3J = 6.41, 6.85 Hz) 1.39 - 1.17 (m, 14H), 13C{1H} (CDCl3, δppm, 100 
MHz) 63.11, 34.2, 32.9, 32.8, 29.6, 29.6, 29.4 (two concurrent resonances), 28.8, 28.2, 25.8, IR νmax 
ATR cm-1 3427, 2917, 2892, 2850, 1466, 1345, 1302, 1266, 1240, 1209, 1187, 1057, 1050, 1034, 
1001, 982, 972, 723, 644, 594, 519, 492, MS m/z (ESI+) 250 [M + H]+· (100%) 
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28 Synthesis of 11-Cyanoundecanol 
 
HO Br
NaCN
DMF
HO
N
 
 
To a solution of 11-bromoundecanol (20 g, 79 mmol) in N,N’-dimethylformamide (500 ml) sodium 
cyanide (3.9 g, 79 mmol) was added. The mixture was stirred under nitrogen at 60°C for 3 hours after 
which, TLC analysis (3 : 7 ethyl acetate / 40- 60°C petroleum ether) shows the starting material (Rf = 
0.30) has been consumed. The solvent was removed by distillation under reduced pressure. The solid 
residue was suspended in diethyl ether which was then washed three times with water and then once 
with brine. The layers were separated and the organic solvent was dried over anhydrous magnesium 
sulphate then removed on a rotary evaporator to yield a yellow oil (11.18 g, 71 % yield) which 
solidified on cooling. NMR and GCMS analysis shows oil to be pure product. 
 
1H ((CDCl3 δppm 400 MHz) 3.53 (2H, t, 3J = 6.72 Hz), 2.27 (2H, t, 3J = 6.9 Hz), 1.57 (m, 2H), 1.47 
(m, 2H), 1.35 (m, 2H), 1.21 (m, 12H), 13C{1H} (CDCl3 δppm 100 MHz) 162.7, 119.9, 62.8, 32.7, 
29.5,29.4, 29.3, 28.8, 28.7, 25.8, 25.4, 17.1, IR νmax ATR cm-1 3440, 2923, 2853, 2247, 1732, 1466, 
1350, 1052, 722, 581, MS m/z (ESI+) 198 [M+H]+·, (90%), 180 [M – OH + H]+· (100) 
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29 Synthesis of 11-Cyanoundecanal 
 
 
 
To a rapidly stirring solution of 11-cyanoundecanol (5 g, 25 mmol) in dichloromethane (50 ml), 
pyridinium chlorochromate (11.02 g, 50 mmol) was added. The mixture was heated to reflux for 2 
hours after which TLC analysis (3 : 7 ethyl acetate / 40- 60°C petroleum ether) showed complete 
consumption of the starting material (Rf 0.68). The reaction mixture was passed through a plug of 
silica gel which was eluted with dichloromethane. The collected solvent was removed using a rotary 
evaporator to yield a yellow oil (3.48 g, 77 % yield) which was shown by NMR and GCMS analysis 
to be pure product. 
 
1H ((CD3)2SO δppm 400 MHz) 9.69 (s, 1H, Ha), 2.35 (t, 3J = 7.43 Hz, 2H, Hk), 2.27 (t, 3J = 7.20 Hz, 
2H, Hb), 1.56 (m, 4H, Hi,j), 1.37 (m, 2H, Hc), 1.22 (m, 10H, Hd-h), 13C{1H} (CDCl3 δppm 100 MHz) 
202.9 (Ca), 119.9 (Cl), 43.9 (Ck), 29.3, 29.3, 29.2, 29.1, 28.7, 28.6, 25.4, 22.0, 17.1 (Cb-j), IR νmax 
ATR cm-1 2926, 2855, 2720, 2246, 1723, 1465, 1430, 736, 526, MS (ESI+) 194 (M+.), 167 (M – CN) 
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30 Synthesis of C-(4-chlorobutane)-calix[4]pyrogallolarene 
 
 
 
Pyrogallol (2.53 g, 20 mmol) was dissolved in ethanol (100 ml) and hydrochloric acid (25 ml, 283 
mmol) was added. The solution was stirred at room temperature for 10 minutes, after which, 5-
bromopentanal (5 g, 20 mmol) in ethanol (20 ml) was added drop-wise over 20 minutes. The solution 
was stirred for 1 hour at room temperature and then heated to 50ºC for 144 hours. The reaction 
mixture was allowed to cool to room temperature and the crystalline precipitate was filtered (3.525 g, 
49% Yield). NMR shows precipitate to be product. Crystals suitable for single x-ray crystallography 
formed over 24 hours in the mother liquors of the filtration. 
 
1H ((CD3)2SO δppm 400 MHz) 6.86 (s, 1H), 4.16 (t, 1H, 3J = 7.61 Hz), 3.60 (t, 2H, 3J = 6.76 Hz), 
2.16 (m, 2H), 1.76 (m, 2H), 1.29 (m, 2H), 13C{1H} ((CD3)2SO δppm 400 MHz) 39.7, 132.9, 124.3, 
113.4, 56.0, 45.5, 32.2, 25.3, 18.6, IR νmax ATR cm-1 3205, 2934, 2866, 1622, 1475, 1387, 1306, 1094, 
1033, 978, 720, MS m/z (ESI+) 915 ([M+H]+·, 90%), 937 [M + Na]+· (10), 959 [M + C2H5OH + H]+· 
(30) 
 
Crystal data for C-(4-chlorobutane)-calix[4]pyrogallolarene diethylether clathrate: C52H73Cl5O15, M = 
1115.35, colourless plate, 0.48 × 0.36 × 0.08 mm3, triclinic, space group P-1 (No. 2), a = 13.0897(4), 
b = 13.2617(4), c = 18.3750(5) Å, α = 78.5860(10), β = 76.8360(10), γ = 64.842(2)°, V = 2792.75(14) 
Å3, Z = 2, Dc = 1.326 g/cm3, F000 = 1180, Bruker-Nonius Roper CCD camera on goniostat, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.3º, 58121 reflections collected, 12821 unique (Rint 
= 0.0427).  Final GooF = 1.025, R1 = 0.0940, wR2 = 0.2468, R indices based on 10086 reflections 
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with I >2σ (I) (refinement on F2), 719 parameters, 4 restraints.  Lp and absorption corrections 
applied, µ = 0.324 mm-1. 
 
Crystal data for C-(4-chlorobutane)-calix[4]pyrogallolarene 2-propanol clathrate: C188H276Cl16O72, M 
= 4255.29, colourless plate, 0.55 × 0.42 × 0.06 mm3, monoclinic, space group P21/c (No. 14), a = 
18.2796(4), b = 13.2600(5), c = 20.7196(7) Å, β = 94.955(2)°, V = 5003.4(3) Å3, Z = 1, Dc = 1.412 
g/cm3, F000 = 2252, Bruker-Nonius APEX II CCD camera on goniostat, MoKα radiation, λ = 0.71073 
Å,  T = 120(2)K, 2θmax = 62.5º, 45253 reflections collected, 11412 unique (Rint = 0.0931).  Final GooF 
= 1.097, R1 = 0.1113, wR2 = 0.2098, R indices based on 7043 reflections with I >2σ (I) (refinement 
on F2), 697 parameters, 1 restraint.  Lp and absorption corrections applied, µ = 0.310 mm-1. 
 
Crystal data for C-(4-chlorobutane)-calix[4]pyrogallolarene ethanol water clathrate: C48H68Cl4O16, M 
= 900.45, colourless plate, 0.10 × 0.08 × 0.03 mm3, triclinic, space group P-1 (No. 2), a = 11.5783(5), 
b = 12.3650(3), c = 18.5273(7) Å, α = 97.505(2), β = 91.704(2), γ = 94.074(2)°, V = 2621.06(16) Å3, 
Z = 2, Dc = 1.375 g/cm3, F000 = 1148, Bruker-Nonius APEX II CCD camera on goniostat, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.3º, 41446 reflections collected, 11959 unique (Rint 
= 0.0895).  Final GooF = 1.058, R1 = 0.1243, wR2 = 0.2160, R indices based on 6193 reflections with 
I >2σ (I) (refinement on F2), 667 parameters, 6 restraints.  Lp and absorption corrections applied, µ = 
0.296 mm-1. 
 
  
208 
 
31 Synthesis of C-(5-chloropentane)-calix[4]pyrogallolarene 
 
 
 
Pyrogallol (2.53 g, 20 mmol) was dissolved in ethanol (100 ml) and hydrochloric acid (25 ml, 283 
mmol) was added. The solution was stirred at room temperature for 10 minutes, after which, 6-
bromohexanal (5 g, 20 mmol) in ethanol (20 ml) was added drop-wise. The solution was stirred for 1 
hour at room temperature and then heated to 50ºC for 144 hours. The reaction mixture was allowed to 
cool to room temperature and the crystalline precipitate was filtered (43% Yield). NMR shows 
precipitate to be product. Crystals suitable for single X-ray crystallography formed over 24 hours in 
the mother liquors of the filtration. 
 
1H ((CD3)2SO δppm 400 MHz) 6.86 (s, 1H), 4.36 (t, 1H, 3J = 6.74 Hz), 3.55 (t, 2H, 3J = 7.35 Hz), 
2.25 (m, 2H), 1.79 (qn, 2H, 3J = 6.52, 6.52 Hz), 1.58 (m, 2H), 1.36 (m, 2H), 13C{1H} ((CD3)2SO δppm 
400 MHz) 137.4, 131.4, 125.3, 113.6, 58.4, 34.0, 32.6, 27.5, 26.9, 18.4, IR νmax ATR cm-1 3286, 2928, 
2855, 1612, 1474, 1307, 1098, 977, 720, MS m/z (ESI+) 970 [M+H]+·, (90%), 991 [M + Na]+· (15), 
1015 [M + C2H5OH + H]+· (10) 
 
Crystal data for C-(5-chloropentane)-calix[4]pyrogallolarene ethanol clathrate: C52H72Cl4O14, M = 
1062.90, Colourless Slab, 0.2 × 0.18 × 0.06 mm3, triclinic, space group P-1 (No. 2), a = 10.3726(2), b 
= 13.2310(2), c = 19.4494(4) Å, α = 87.0790(10), β = 80.4320(10), γ = 88.1340(10)°, V = 2627.90(8) 
Å3, Z = 2, Dc = 1.343 g/cm3, F000 = 1128, Bruker-Nonius Roper CCD camera on goniostat, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.1º, 54792 reflections collected, 12082 unique (Rint 
= 0.0477).  Final GooF = 1.005, R1 = 0.0693, wR2 = 0.1805, R indices based on 9149 reflections with 
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I >2σ (I) (refinement on F2), 681 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 
0.290 mm-1. 
 
32 Synthesis of C-(10-Bromodecane)-calix[4]pyrogallolarene 
 
OH
OH
HO OH
HCl
EtOH
HO
HO OH
OH
HO OH
C8H16Br C8H16 Br
C8H16 BrC8H16Br
OH
OH
OH
OH
HO
O
HC9H18Br
 
 
Pyrogallol (2.53 g, 20 mmol) was dissolved in ethanol (100 ml) and hydrochloric acid (25 ml) was 
added. The solution was stirred at room temperature for 10 minutes, after which, 11-bromoundecanal 
(5 g, 20 mmol) in ethanol (20 ml) was added drop-wise. The solution was stirred for 1 hour at room 
temperature and then heated to 50ºC for 144 hours. The reaction mixture was allowed to cool to room 
temperature and the crystalline precipitate was filtered to yield a colourless solid which upon analysis 
was shown to be the desired product (3.525 g, 56 % yield). Crystals suitable for single X-ray 
crystallography formed over 24 hours in the mother liquors of the filtration and were submitted to the 
EPSRC X-ray crystallography analysis service. 
 
1H (CDCl3 δppm 400 MHz) 8.70 (s, 1H), 7.40 (s, 1H), 6.81 (s, 1H), 6.76 (s, 1H), 6.76 (s, 1H), 3.46 (t, 
1H 3J = 6.60 Hz), 3.31 (t, 2H, 3J = 6.82 Hz), 1.78 (p, 2H, 3J = 7.21 Hz), 1.70 (p, 2H, 3J = 7.12 Hz), 
1.47 – 1.23 (m, 14H), 13C{1H} ((CD3)2SO δppm 400 MHz) 131.5, 127.6, 125.6, 123.9, 45.1, 34.0, 
32.8, 32.6, 29.7, 29.5, 28.9, 28.9, 28.8, 28.2, IR νmax ATR cm-1 3454, 3263, 2923, 2852, 1634, 1508, 
1479, 1338, 1280, 1239, 1083, 978, 932, 778, 721, 681, 640, 544, 390, MS m/z (ES+) 1347 (M+ -Br, 
20%), 554 (50), 392 (100) 
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Crystal data for C-(10-bromodecane)-calix[4]pyrogallolarene ethanol clathrate: C204H294Br12O36, M = 
4281.31, Colourless Rhombus, 0.2 × 0.18 × 0.14 mm3, trigonal, space group R-3 (No. 148), a =  b = 
37.2327(5), c = 27.2555(8) Å, V = 32721.5(11) Å3, Z = 6, Dc = 1.304 g/cm3, F000 = 13356, MoKα 
radiation, λ = 0.71073 Å,  T = 273(2)K, 2θmax = 55.0º, 67280 reflections collected, 16584 unique (Rint 
= 0.0804).  Final GooF = 1.650, R1 = 0.2319, wR2 = 0.5224, R indices based on 6400 reflections with 
I >2σ (I) (refinement on F2), 778 parameters, 3 restraints.  Lp and absorption corrections applied, µ = 
2.268 mm-1. 
 
Crystal data for C-(10-Bromodecane)-calix[4]pyrogallolarene methanol clathrate: C424H654Br24O92, M 
= 9141.31, colourless block, 0.4 × 0.33 × 0.08 mm3, trigonal, space group R-3 (No. 148), a =  b = 
37.2447(6), c = 27.2736(8) Å, V = 32764.4(12) Å3, Z = 3, Dc = 1.390 g/cm3, F000 = 14322, Bruker-
Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 
55.0º, 74104 reflections collected, 16693 unique (Rint = 0.0961).  Final GooF = 1.872, R1 = 0.2385, 
wR2 = 0.5355, R indices based on 7500 reflections with I >2σ (I) (refinement on F2), 815 parameters, 
99 restraints.  Lp and absorption corrections applied, µ = 2.273 mm-1. 
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33 Synthesis of C-(10-cyanodecane)-calix[4]pyrogallolarene 
 
 
 
Pyrogallol (0.905 g, 7 mmol) was dissolved in ethanol (20 ml) and hydrochloric acid was added (37 % 
5 ml). The solution was placed under nitrogen and stirred for 20 minutes at room temperature. 11-
Cyanoundecanal (1.4 g, 7 mmol) in ethanol (20 ml) was added over 6 minutes to the acidic pyrogallol 
solution. The solution was stirred at room temperature for 10 minutes and then heated to 50°C for 6 
days. After this time the solution was concentrated to approximately half its volume and then cooled 
in an ice bath. After c.2 hours crystals formed which were filtered and upon analysis were shown to be 
the desired product (0.65 g, 0.5 mmol, 30% yield) 
 
1H ((CD3)2SO δppm 400 MHz) 7.07 (s, 1H), 2.41 (m, 2H), 2.25 (m, 2H), 1.59 (m, 1H), 1.283 (m, 
16H), 13C{1H} (CDCl3 δppm 100 MHz) 40.9, 134.4, 126.2, 121.3, 114.2, 35.2, 34.6, 30.8, 30.7, 30.7, 
30.5, 30.0, 29.8, 29.2, 26.5, 17.3. MS m/z (ESI) 1213 ([M+H]+·, 10%), 1235 ([M+Na]+·, 100), IR νmax 
ATR cm-1 3313.8, 2920, 2851, 2251, 1719, 1609, 1537, 1468, 1294, 1110, 978, 931, 778, 721, 595 
 
Crystal data for C-(10-cyanodecane)-calix[4]pyrogallolarene: C149H204N8O24Cl2, M = 2559.0, 
colourless cut block, 0.35 × 0.40 × 0.3 mm3, monoclinic, space group C2/c (No. 15), a = 34.066(7), b 
= 12.568(3), c = 34.785(7) Å, β = 107.05(3)°, V = 14238(5) Å3, Z = 4, Dc = 1.195 g/cm3, F000 = 5520, 
Bruker-Nonius Roper CCD camera on goniostat, MoKα radiation, λ = 0.71073 Å,  T = 173(2)K, 2θmax 
= 46.6º, 37452 reflections collected, 10197 unique (Rint = 0.0450).  Final GooF = 1.537, R1 = 0.1179, 
wR2 = 0.3479, R indices based on 6414 reflections with I >2σ (I) (refinement on F2), 839 parameters, 
132 restraints.  Lp and absorption corrections applied, µ = 0.116 mm-1. 
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34 Synthesis of dodecyl-acetate-C-(10-Cyanodecane)-
calix[4]pyrogallolarene 
AcO OAc
AcO
AcO OAc
OAc
AcO OAc
C8H16NC C8H16 CN
C8H16 CNC8H16NC
OAc
OAc
OAc
AcO
HO OH
HO
HO OH
OH
HO OH
C8H16NC C8H16 CN
C8H16 CNC8H16NC
OH
OH
OH
HO
O
O
O
 
 
C-(10-cyanodecane)-calix[4]pyrogallolarene (0.1 g, 82 µmol) was suspended in freshly distilled acetic 
anhydride. The suspension was placed under a stream of nitrogen and stirred for 8 hours at room 
temperature until the solid starting material had dissolved into the solvent. The residual solvent was 
removed under vacuum to yield an off-white powder (0.12 g 85% yield) which upon analysis was 
shown to be the desired product. Crystals suitable for single crystal X-ray diffraction studies were 
grown by allowing the reaction mixture to slowly evaporate. 
 
1H ((CD3)2SO δppm 400 MHz) 7.29 (broad singlet, 1H), 4.08 (t, 2H, J3 = 7.7 Hz), 2.29 (t, 2H, 3J = 
7.01 Hz), 2.14 (m, 2H), 1.60 (p, 2H, 3J = 7.57 Hz), 1.37 (m, 2H), 1.21 (m, 14H), 13C{1H} ((CD3)2SO 
δppm 100 MHz) 167.4, 167.0, 166.5, 120.0, 37.1, 34.4, 29.6, 29.5, 29.4, 29.3, 28.8, 28.7, 27.9, 25.4, 
22.2, 20.0, 17.1, IR νmax ATR cm-1 2926, 2855, 1771, 1728, 1440, 1370, 1203, 1165, 1072, 1029, 899, 
868, 588, 523 
 
Crystal data for C-(10-Cyanodecyl)-calix[4]pyrogallolarene dodecyl-acetal: C96H122N4O24, M = 
1715.98, colourless block, 0.20 × 0.10 × 0.08 mm3, triclinic, space group P (No. 2), a = 12.521(6), b 
= 17.207(9), c = 24.217(12) Å, α = 96.828(6), β = 101.104(6), γ = 110.673(6)°, V = 4690(4) Å3, Z = 2, 
Dc = 1.215 g/cm3, F000 = 1836, Bruker SMART APEX2 CCD diffractometer, synchrotron radiation, λ 
= 0.6941 Å,  T = 120(2)K, 2θmax = 40.6º, 22765 reflections collected, 9743 unique (Rint = 0.0950).  
Final GooF = 0.959, R1 = 0.0739, wR2 = 0.1702, R indices based on 4635 reflections with I >2σ (I) 
(refinement on F2), 1137 parameters, 0 restraints.  Lp and absorption corrections applied, µ = 0.087 
mm-1. 
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35 Synthesis of supramolecular complex of C-(heptyl) 
calix[4]pyrogallolarene methanol solvate and 4-phenyl-terpyridine 
hydrochloride 
 
HO OH
HO
HO OH
OH
HO OH
C6H12 C6H12
C6H12C6H12
OH
OH
OH
HO
N
N NHCl
 
 
C-(Heptyl) calix[4]pyrogallolarene (0.2 g, 0.21 mmol) which was tae directly from the calixarene 
synthesis reaction without further purification was dissolved in methanol (20 ml) and 4-phenyl 
terpyridine was added (0.065 g, 0.21 mmol). The solution was sonicated for 30 minutes and then left 
to slowly evaporate. After 10 days the volume of solvent had reduced significantly (~10 mL) and 
crystals suitable for single crystal X-ray diffraction studies formed. 
 
Crystal data for C-Heptyl-calix[4]pyrogallolarene 4-phenyl-tripyridine methanol solvate: 
C59H103N3O14Cl, M = 1113.89, colourless plate, 0.20 × 0.08 × 0.01 mm3, triclinic, space group P-1 
(No. 2), a = 12.845(3), b = 13.052(3), c = 23.136(7) Å, α = 77.57(4), β = 80.22(4), γ = 71.71(3)°, V = 
3574.6(16) Å3, Z = 2, Dc = 1.035 g/cm3, F000 = 1455, Bruker SMART APEX2 CCD diffractometer, 
synchrotron radiation, λ = 0.6941 Å,  T = 120(2)K, 2θmax = 45.5º, 10241 reflections collected, 10241 
unique (Rint = 0.0000).  Final GooF = 1.064, R1 = 0.0950, wR2 = 0.2606, R indices based on 6197 
reflections with I >2σ (I) (refinement on F2), 902 parameters, 1 restraint.  Lp and absorption 
corrections applied, µ = 0.121 mm-1. 
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Appendix 
 
Please see attached CD-ROM for crystallographic data for the species reported in this thesis. 
 
Below is a list of ‘Class A’ errors generated by the online IUCR basic .CIF checking package 
(http://journals.iucr.org/services/cif/checking/checkbasic.html) with a list of explanations of the errors 
which are generated. These errors arise as a result of the unique nature of the crystallographic system 
studied in this thesis. 
 
 
C1PgEt2O 
 
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  C36A   ..  C43B    ..       2.82 Ang.  
PLAT773_ALERT_2_A 
Suspect C-C Bond in CIF:   C44A   --  C43B    ..       1.95 Ang.  
PLAT223_ALERT_4_A 
Large Solvent/Anion  H     Ueq(max)/Ueq(min) ...       5.56 Ratio 
 
The short inter-hydrogen distance and the large solvent H errors are due to the disordered nature of the 
solvent molecule which is exo to the cavity of the calixarene interacting with the ordered solvent 
molecule which resides within the cavity of the calixarene.  
 
 
C1PgMeCN 
 
PLAT414_ALERT_2_A  
Short Intra D-H..H-X       H2     ..  H7      ..       1.78 Ang.  
 
The electron density pattern suggests that hydrogen 2 forms a hydrogen bond to oxygen 3, bringing it 
into close contact with hydrogen 7 which is the bound to methine carbon of the macrocycle as a 
consequence of intramolecular hydrogen bonding. It has only been modelled in the highest electron 
density position, however it is acknowledged that there is a dynamic interchange of position between 
the two sites.  
 
 
C2RsMeCN 
 
No category A alerts were produced for this dataset. 
 
 
C2PgMeCN 
 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       5.35 Ratio 
 
This error is due to the solvent molecule exo to the cavity being disordered over two positions, despite 
successfully modelling it as a disordered entity the error persists. 
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C3OHPgAcetone1 
 
SHFSU01_ALERT_2_A 
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   2.679 
Additional refinement cycles may be required. 
 
Despite repeated cycles of refinement, the R1 remained unchanged at 0.0411 and the structure was 
stable. 
 
 
C3OHPgAcetone2 
 
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O17      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O18    
 
This error is due to the lack of hydrogen atoms on a water molecule which have been located in the 
structure. Xseed does not currently support placement of hydrogen atoms on water molecules. 
 
 
C3OHRsMeCNlowsymm 
 
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O13      
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......       O14  
 
This error is due to the lack of hydrogen atoms on two water molecules which have been located in 
the structure. Xseed does not currently support geometrical location of hydrogen atoms on water 
molecules. 
 
 
C3OHPgChairConf 
 
SHFSU01_ALERT_2_A 
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   3.411 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A 
Maximum Shift/Error ............................       3.41       
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       8.70 Ratio 
 
This structure has a network of five water molecules within the asymmetric unit which have been 
assigned hydrogen atoms empirically rather than the usual protocol of geometrical addition, which 
may be the cause of the PLAT080 error. Despite repeated cycles of refinement, the R1 remained 
unchanged at 0.0536 and the structure was stable. 
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C3RsMeCNHighSymm 
 
SHFSU01_ALERT_2_A 
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   0.449 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A  
Maximum Shift/Error ............................       0.45       
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......         O4      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......         O5 
 
The PLAT306 error is due to the lack of hydrogen atoms on two water molecules which have been 
located in the structure. Xseed does not currently support placement of hydrogen atoms on water 
molecules. The absolute parameter shift is due to the formation of a channel of solvent molecules exo 
to the cavity of the calixarene molecules, therefore the exact atomic positions could not be determined 
and were therefore modelled as oxygen atoms. 
 
 
C3OHPgTHF 
 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       6.75 Ratio 
 
The source of the error above is the free water molecule whose hydrogen atoms were located 
empirically and not geometrically. 
 
 
C3PgAcetone 
 
No class A errors were generated for this dataset 
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C3PgEt2O 
 
SHFSU01_ALERT_2_A   
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   4.997 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A 
Maximum Shift/Error ............................       5.00       
PLAT215_ALERT_3_A  
Disordered C50B    has ADP max/min Ratio .......       6.10       
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       4.76 Ratio 
PLAT220_ALERT_2_A  
Large Non-Solvent    O     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       9.55 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       5.93 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H20C   ..  H50B    ..       1.74 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  O27    ..  C85     ..       2.20 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  O29    ..  C84B    ..       2.07 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  O29    ..  C84     ..       2.40 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  C20A   ..  C50A    ..       2.79 Ang.  
PLAT221_ALERT_4_A  
Large Solvent/Anion  C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT223_ALERT_4_A  
Large Solvent/Anion  H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT780_ALERT_1_A 
Coordinates do not Form a Properly Connected Set          ? 
 
 
SHFSU01 is due to the isotropic refinement applied to the two solvent molecules causing oscillation 
within the structure. The disorder of the pendant chains contributes errors PLAT220, PLAT222 and 
PLAT432. The interdigitation of the two sets of disordered chains gives rise to the close contacts 
which produce the errors. The close contact between O27 and C85 is a result of a water molecule 
(O27) which is hydrogen bonded to the upper rim of a calixarene molecule coming into close contact 
with the methyl group of a diethyl ether molecule housed in the cavity of a calixarene. 
 
 
C3PgEtOH 
 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
 
The presence of this error is due to the inclusion of a water molecule into the crystal lattice. The 
hydrogen atoms were placed onto the oxygen by empirical methods as the geometrical placing of 
hydrogen atoms onto an isolated oxygen is not currently supported by Xseed. 
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C3PgMeCN 
 
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       7.82 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       9.13 Ratio 
 
This large Ueq is due to the formation of a small void by the interdigitation of the pendant chains, 
allowing some conformational flexibility of the terminal methyl group. 
 
 
C4ClPgEtOH 
 
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A 
Check High      Ueq as Compared to Neighbors for        C22      
PLAT242_ALERT_2_A 
Check Low       Ueq as Compared to Neighbors for       Cl2A      
PLAT242_ALERT_2_A 
Check Low       Ueq as Compared to Neighbors for       Cl2B      
PLAT242_ALERT_2_A 
Check Low       Ueq as Compared to Neighbors for        C21      
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......        O15      
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......        O16      
PLAT224_ALERT_1_A 
Ueq(Rep) and Ueq(Calc) differ by -0.010 Ang**2 .        C22     
 
The errors generated from C22 and Cl12A and Cl12B are due to the disordering of the terminal 
chlorine atom over two positions. The isolated oxygen atom are due to lack of hydrogen atoms on two 
water molecules which have been located in the structure. Xseed does not currently support 
geometrical placement of hydrogen atoms on water molecules. 
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C4ClPgEt2O 
 
PLAT215_ALERT_3_A  
Disordered C22B    has ADP max/min Ratio .......      15.60       
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT220_ALERT_2_A  
Large Non-Solvent   Cl     Ueq(max)/Ueq(min) ...       6.21 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       Cl2B      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C22A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       Cl4A      
PLAT245_ALERT_2_A  
U(iso) H22B    Smaller than U(eq) C22B    by ...       0.29 AngSq 
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O15 
 
The PLAT215, 220, 222, 242, 245 errors are generated by disorder of a pendant chain which forms 
the base of a solvent filled void within the crystal lattice. This void is bounded on three sides by the 
aryl rings of adjacent calixarene molecules which have low conformational flexibility, however the 
base of this void is completed by a pendant chain which has conformational flexibility which has been 
modelled. The PLAT306 error is due to the presence of a water molecule within the asymmetric unit. 
Currently Xseed does not support placement of hydrogen atoms in geometrical positions on isolated 
oxygen atoms. 
 
 
C4ClPgiPrOH 
 
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......        O13      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O14      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O15      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O16      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O18      
PLAT414_ALERT_2_A  
Short Intra D-H..H-X       H1     ..  H40     ..       1.72 Ang.  
PLAT414_ALERT_2_A  
Short Intra D-H..H-X       H7     ..  H18     ..       1.76 Ang.  
PLAT414_ALERT_2_A  
Short Intra D-H..H-X       H9     ..  H29     ..       1.59 Ang 
 
The PLAT306 error is due to the presence of five water molecules within the asymmetric unit. 
Currently Xseed does not support placement of hydrogen atoms in geometrical positions on isolated 
oxygen atoms. The PLAT414 error is due to the arrangement of hydrogen atoms of the upper rim into 
a intra-molecular hydrogen bonded motif. These hydrogen atoms come into close contact with the 
methine carbon. It is acknowledged that this is a dynamic system and at room temperature rotation of 
these bonds will be possible. 
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C4PgEt2O 
 
No class A errors were generated for this dataset 
 
 
C4PgMeCN 
 
RFACR01_ALERT_3_A 
The value of the weighted R factor is > 0.45 
Weighted R factor given   0.472 
SHFSU01_ALERT_2_A 
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   5.261 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A 
Maximum Shift/Error ............................       5.26       
PLAT084_ALERT_2_A 
High R2 Value ..................................       0.47       
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       7.09 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       8.83 Ratio 
PLAT242_ALERT_2_A 
Check Low       Ueq as Compared to Neighbors for        C10      
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......        O15      
PLAT430_ALERT_2_A 
Short Inter D...A Contact  O15    ..  O15     ..       2.00 Ang.  
PLAT430_ALERT_2_A 
Short Inter D...A Contact  O15    ..  O15     ..       2.00 Ang.  
PLAT430_ALERT_2_A 
Short Inter D...A Contact  O15    ..  N4      ..       2.54 Ang.  
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  N4     ..  C51     ..       2.55 Ang.  
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  N5     ..  C54     ..       2.70 Ang.  
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  C51    ..  C52     ..       1.89 Ang.  
PLAT773_ALERT_2_A 
Suspect C-C Bond in CIF:   C51    --  C52     ..       1.90 Ang. 
 
This crystal structure is a calixarene molecule arranged by R symmetry to form a nano-sphere. The 
large unit cell combined with the intrinsic difficulty in assigning the electron density within the nano 
capsule lead to a high R1 and R2 factor. The contents of the nano sphere are tentatively assigned as 18 
acetonitrile molecules, which account for the close contacts seen in the .CIF check. The isolated 
oxygen atom is an extra-capsular water molecule. Xseed does not allow geometrical assignment of 
hydrogen atoms in water molecules. 
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C5ClPgEtOH 
 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       6.67 Ratio 
 
This error is due to the empirical location of the hydroxyl hydrogen atoms around the upper rim of the 
calixarene molecule. There is an intramolecular hydrogen bonding network around each calixarene 
molecule which would cause this error as they are slightly disordered. 
 
 
C5PgMeCN 
 
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT242_ALERT_2_A 
Check Low       Ueq as Compared to Neighbors for        C23 
 
This is a false alarm generated by the .CIF checking engine, The carbon atom which has been flagged 
as erroneously assigned is the penultimate atom of a pendant chain which forms an interdigitated 
bilayer. The atom in question has larger than usual thermal ellipsoid parameters, which indicate some 
degree of freedom of positional location within the crystal lattice. On packing the structure around the 
atom in question a small void is apparent which would support the theory of conformational freedom 
of the terminal two atoms of the pendant chain. 
 
 
C6PgMeCN 
 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       4.66 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       5.50 Ratio 
 
This large Ueq is due to the formation of a small void by the interdigitation of the pendant chains, 
allowing some conformational flexibility of the terminal methyl group. 
 
 
C7PgEt2O 
 
PLAT220_ALERT_2_A Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       
9.68 Ratio 
PLAT222_ALERT_3_A Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      
10.00 Ratio 
PLAT241_ALERT_2_A Check High      Ueq as Compared to Neighbors for        
C52      
PLAT306_ALERT_2_A Isolated Oxygen Atom (H-atoms Missing ?) .......        
O10   
 
The possible cause of the PLAT220 and PLAT 222 errors is the presence of a small void below the 
pendant chain bearing C55 which may allow a small amount of conformational flexibility causing 
disorder within the structure. The PLAT306 error is due to the lack of hydrogen atoms on two water 
molecules which have been located in the structure. Xseed does not currently support placement of 
hydrogen atoms on water molecules. 
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C7PgEtOAc 
 
RFACR01_ALERT_3_A 
The value of the weighted R factor is > 0.45 
Weighted R factor given   0.465 
SHFSU01_ALERT_2_A 
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   0.958 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A 
Maximum Shift/Error ............................       0.96       
PLAT084_ALERT_2_A 
High R2 Value ..................................       0.46       
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A 
Check High      Ueq as Compared to Neighbors for        C12      
PLAT241_ALERT_2_A 
Check High      Ueq as Compared to Neighbors for        C27      
PLAT241_ALERT_2_A 
Check High      Ueq as Compared to Neighbors for        C55      
PLAT242_ALERT_2_A 
Check Low       Ueq as Compared to Neighbors for        C13      
PLAT413_ALERT_2_A 
Short Inter XH3 .. XHn     H14C   ..  H42A    ..       1.83 Ang.  
PLAT413_ALERT_2_A 
Short Inter XH3 .. XHn     H14C   ..  H42C    ..       1.57 Ang.  
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  C14    ..  C42     ..       2.87 Ang.  
PLAT601_ALERT_2_A 
Structure Contains Solvent Accessible VOIDS of .    1205.00 A**3  
PLAT224_ALERT_1_A 
Ueq(Rep) and Ueq(Calc) differ by  0.010 Ang**2 .        C14       
PLAT234_ALERT_4_A 
Large Hirshfeld Difference C13    --  C14     ..       0.37  Ang. 
 
 
This crystal structure is a calixarene molecule arranged by R symmetry to form a nano-sphere. The 
large unit cell combined with the intrinsic difficulty in assigning the electron density within the nano 
capsule lead to a high R2 factor. Despite repeated cycles of refinement the R1 remained at 0.158. 
 
The contents of the nano sphere are assigned as diffuse electron density and are modelled by the 
SQUEEZE programme. It has been shown in the literature that 6 ethyl acetate molecules may occupy 
the internal volume of the nano-sphere. The errors which refer to C14 (and corresponding hydrogen 
atoms) are due to the presence of a small void within the crystal lattice allowing the terminal methyl 
group of a pendant chain to be conformationally flexible, therefore enlarging the thermal parameters 
of this terminal group. 
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C7PgMeCN 
 
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       5.06 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       5.81 Ratio 
PLAT306_ALERT_2_A 
Isolated Oxygen Atom (H-atoms Missing ?) .......        O16      
 
 
The errors which refer to C73 (and corresponding hydrogen atoms) are due to the presence of a small 
void within the crystal lattice which is formed by the interdigitation of the pendant chains. This void 
allows the terminal methyl group of the affected pendant chain to be conformationally flexible, 
therefore enlarging the thermal parameters of this terminal group. 
 
The PLAT306 error is due to the lack of hydrogen atoms on two water molecules which have been 
located in the structure. Xseed does not currently support placement of hydrogen atoms on water 
molecules 
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C7PgEtOH 
 
THETM01_ALERT_3_A   
The value of sine(theta_max)/wavelength is less than 0.550 
Calculated sin(theta_max)/wavelength =    0.5263 
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       6.22 Ratio 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...       5.45 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C52      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C79      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C82      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C96      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for       C111      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C51      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C53      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C78      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C81      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C83      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C97      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C110      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O26      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O30      
PLAT412_ALERT_2_A  
Short Intra XH3 .. XHn     H11D   ..  H12C    ..       1.69 Ang.  
PLAT415_ALERT_2_A  
Short Inter D-H..H-X       H13    ..  H84A    ..       1.80 Ang.  
 
This dataset was collected by the EPSRC crystallography service at Daresbury synchrotron because 
despite repeated attempts to crystallise the material, only small crystal dimensions and low diffraction 
angles could be achieved. This accounts for the THETM01 error.  
 
The PLAT220, 222, 241, 242, 412 and 415 are due to the molecules forming an interdigitated bilayer. 
This bilayer arrangement allows a small degree of conformational flexibility within the crystal lattice 
and therefore accounts for the large thermal parameters observed for the atoms highlighted above. 
 
The PLAT306 error is due to the lack of hydrogen atoms on two water molecules which have been 
located in the structure. Xseed does not currently support placement of hydrogen atoms on water 
molecules 
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C7PgTerpy 
 
SHFSU01_ALERT_2_A   
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   1.207 
Additional refinement cycles may be required. 
PLAT213_ALERT_2_A 
Atom C26     has ADP max/min Ratio .............       5.30 prola 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C12      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C25      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C26      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C11      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C24      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C27      
PLAT353_ALERT_3_A  
Long    N-H Bond (0.87A)   N1     -   H80    ...       1.21 Ang.  
PLAT410_ALERT_2_A  
Short Intra H...H Contact  H58    ..  H73     ..       1.79 Ang.  
PLAT410_ALERT_2_A  
Short Intra H...H Contact  H60    ..  H63     ..       1.58 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H24A   ..  H28C    ..       1.17 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H60    ..  H79C    ..       1.81 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H63    ..  H79A    ..       1.59 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H77    ..  H79C    ..       1.61 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H78B   ..  H79A    ..       1.83 Ang.  
PLAT415_ALERT_2_A  
Short Inter D-H..H-X       H4     ..  H79B    ..       1.48 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  O5     ..  C79     ..       2.42 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  C63    ..  C79     ..       2.66 Ang.  
PLAT224_ALERT_1_A  
Ueq(Rep) and Ueq(Calc) differ by -0.010 Ang**2 .        C28       
PLAT234_ALERT_4_A  
Large Hirshfeld Difference C12    --  C13     ..       0.31  Ang. 
 
The crystal produced were very small plates which due to their size were only suitable for 
examination at a synchrotron radiation source. 
Errors PLAT241 and 242 are due to disorder within the pendant chains which form an interdigitated 
bilayer and therefore have some degree of conformational flexibility. The errors PLAT360, PLAT410 
and PLAT 413 are due to the two methanol molecules which are present within the crystal lattice. 
Refinement of these molecules was confined to isotropic refinement only as including them in the 
isotropic refinement model introduced instability into the model. With this compensation in place for 
the solvent molecules, despite repeated cycles of refinement, the R1 remained unchanged at 0.111 and 
the structure was stable. 
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C8PgMeCN 
 
SHFSU01_ALERT_2_A 
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   4.892 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A  
Maximum Shift/Error ............................       4.89       
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       9.46 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C30      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C29A      
PLAT390_ALERT_3_A  
Deviating Methyl C30     X-C-H Bond Angle ......     137.00 Deg.  
PLAT390_ALERT_3_A  
Deviating Methyl C30     X-C-H Bond Angle ......      64.00 Deg.  
PLAT410_ALERT_2_A  
Short Intra H...H Contact  H58A   ..  H60E    ..       1.61 Ang.  
PLAT410_ALERT_2_A  
Short Intra H...H Contact  H58B   ..  H60E    ..       1.45 Ang.  
PLAT411_ALERT_2_A  
Short Inter H...H Contact  H13    ..  H60D    ..       1.61 Ang.  
PLAT411_ALERT_2_A  
Short Inter H...H Contact  H14    ..  H60D    ..       1.76 Ang. 
 
Two of the pendant chains within the calixarene show significant disorder which has been modelled. 
The half occupancy model which has been written is the source of the PLAT220, 222, 241, 242, 290, 
410 and 411. This disorder is due to the increasing length of the pendant chains allowing greater 
conformational variability within the bilayer which has formed, thereby introducing disorder into the 
crystal. Despite repeated cycles of refinement, the R1 remained unchanged at 0.0859 and the structure 
was stable when the disorder was modelled. 
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C10BrPgEtOH 
 
RFACG01_ALERT_3_A 
The value of the R factor is > 0.20 
R factor given   0.229 
RFACR01_ALERT_3_A 
The value of the weighted R factor is > 0.45 
Weighted R factor given   0.548 
PLAT082_ALERT_2_A 
High R1 Value ..................................       0.23       
PLAT084_ALERT_2_A 
High R2 Value ..................................       0.55       
PLAT215_ALERT_3_A 
Disordered C16B    has ADP max/min Ratio .......       7.70       
PLAT220_ALERT_2_A 
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A 
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A 
Check High      Ueq as Compared to Neighbors for        Br1      
PLAT241_ALERT_2_A 
Check High      Ueq as Compared to Neighbors for        C62      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C67      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C16A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C17A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C17B      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C51      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C61      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C63      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C66      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C68      
PLAT245_ALERT_2_A  
U(iso) H16A    Smaller than U(eq) C16B    by ...       0.32 AngSq 
PLAT601_ALERT_2_A  
Structure Contains Solvent Accessible VOIDS of .    1178.00 A**3  
 
This structure shows a spherical arrangement of the calixarene molecules, the SQUEEZE program 
was applied to model the disordered contents of the sphere as diffuse electron density. This un-
assignable electron density is the cause of the high R1 and R2 values. PLAT215, 220, 242, 241, 245 
errors are due to the disorder of two pendant chains, and despite modelling the disorder, the errors 
persisted.  
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C10BrPgMeOH 
 
RFACG01_ALERT_3_A 
The value of the R factor is > 0.20 
R factor given   0.242 
RFACR01_ALERT_3_A 
The value of the weighted R factor is > 0.45 
Weighted R factor given   0.574 
SHFSU01_ALERT_2_A  
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   2.004 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A 
Maximum Shift/Error ............................       2.00       
PLAT082_ALERT_2_A 
High R1 Value ..................................       0.24       
PLAT084_ALERT_2_A 
High R2 Value ..................................       0.57       
PLAT213_ALERT_2_A  
Atom O1      has ADP max/min Ratio .............       6.40 prola 
PLAT213_ALERT_2_A  
Atom O2      has ADP max/min Ratio .............       6.20 prola 
PLAT213_ALERT_2_A  
Atom O5      has ADP max/min Ratio .............       5.80 oblat 
PLAT213_ALERT_2_A  
Atom O11     has ADP max/min Ratio .............       7.50 prola 
PLAT213_ALERT_2_A  
Atom C11     has ADP max/min Ratio .............       6.10 prola 
PLAT213_ALERT_2_A  
Atom C49     has ADP max/min Ratio .............       5.40 prola 
PLAT213_ALERT_2_A  
Atom C58     has ADP max/min Ratio .............       6.00 prola 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C11      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C17      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C29      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C32      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C49      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C51      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C10      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C16      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C28A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C31A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C34      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C48      
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PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C50      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C68      
PLAT410_ALERT_2_A  
Short Intra H...H Contact  H31B   ..  H33B    ..       1.72 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H69B   ..  H71B    ..       1.73 Ang.  
PLAT413_ALERT_2_A  
Short Inter XH3 .. XHn     H69C   ..  H71A    ..       1.55 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  O14    ..  C69     ..       2.70 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  C69    ..  C71     ..       2.71 Ang.  
PLAT234_ALERT_4_A  
Large Hirshfeld Difference C32    --  C33     ..       0.41  Ang. 
 
 
This structure shows a spherical arrangement of the calixarene molecules, the SQUEEZE program 
was applied to model the disordered contents of the sphere as diffuse electron density. This un-
assignable electron density is the cause of the high R1 and R2 values. PLAT213, 220, 234, 241, 242, 
245, 410, 413, 432 errors are due to the disorder of two pendant chains, and despite modelling the 
disorder, the errors persisted.  
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C10CNPg Benzene 
 
SHFSU01_ALERT_2_A   
The absolute value of parameter shift to su ratio > 0.20 
Absolute value of the parameter shift to su ratio given   6.839 
Additional refinement cycles may be required. 
PLAT080_ALERT_2_A  
Maximum Shift/Error ............................       6.84       
PLAT213_ALERT_2_A  
Atom C52     has ADP max/min Ratio .............       7.00 prola 
PLAT215_ALERT_3_A  
Disordered C64B    has ADP max/min Ratio .......       8.60       
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT220_ALERT_2_A  
Large Non-Solvent    N     Ueq(max)/Ueq(min) ...       8.95 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C17      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C35      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C50      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C52      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C65      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C68      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C16      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C18      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C34      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C36      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C49      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C51      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C53      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C54      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C63      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C64A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C66      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C69      
PLAT245_ALERT_2_A  
U(iso) H63A    Smaller than U(eq) C64B    by ...       0.37 AngSq 
PLAT331_ALERT_2_A  
Small Average Phenyl  C-C Dist.  C100   -C101_a        1.34 Ang.  
PLAT773_ALERT_2_A  
Suspect C-C Bond in CIF:   C64B   --  C65     ..       1.76 Ang.  
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PLAT224_ALERT_1_A  
Ueq(Rep) and Ueq(Calc) differ by -0.010 Ang**2 .        N1        
PLAT224_ALERT_1_A  
Ueq(Rep) and Ueq(Calc) differ by -0.010 Ang**2 .        C17       
PLAT224_ALERT_1_A  
Ueq(Rep) and Ueq(Calc) differ by -0.010 Ang**2 .        C18       
PLAT234_ALERT_4_A  
Large Hirshfeld Difference N4     --  C18     ..       0.55  Ang. 
PLAT234_ALERT_4_A  
Large Hirshfeld Difference C67    --  C68     ..       0.36  Ang. 
 
The errors generated are due to disorder of two pendant chains within the molecule. Despite modelling 
of the disorder the error persisted. This is the first dataset collected for this molecule, due to the future 
importance of this molecule as an intermediate in the synthesis of a therapeutic delivery system 
further investigations into the structural behaviour of substituted calixarene molecules. The disorder of 
pendant chains may be due to the interactions between the pendant chains preventing interdigitation, 
this would allow greater conformational flexibility of the chains and therefore disorder within the 
crystal lattice.  
 
 
C10CNPgAcetylated 
THETM01_ALERT_3_A 
The value of sine(theta_max)/wavelength is less than 0.550 
Calculated sin(theta_max)/wavelength =    0.4998 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...       5.00 Ratio 
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for       C16A      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C18 
 
Despite repeated attempts to crystallize the material, the crystals which grew were only suitable for 
synchrotron radiation due to their small size. The PLAT220 and 242 errors are due to the disorder of 
the penultimate carbon atom of one of the pendant chains. Despite modelling the disorder the error 
persists. 
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C10enePgEtOAc 
 
PLAT213_ALERT_2_A  
Atom C51     has ADP max/min Ratio .............       8.10 prola 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT220_ALERT_2_A  
Large Non-Solvent    C     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT222_ALERT_3_A  
Large Non-Solvent    H     Ueq(max)/Ueq(min) ...      10.00 Ratio 
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C44      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C47      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C49      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        O13      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C70      
PLAT241_ALERT_2_A  
Check High      Ueq as Compared to Neighbors for        C71      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C32      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C33      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C46      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C48      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C50      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        O14      
PLAT242_ALERT_2_A  
Check Low       Ueq as Compared to Neighbors for        C69      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O15      
PLAT780_ALERT_1_A  
Coordinates do not Form a Properly Connected Set          ? 
 
 
This structure shows a spherical arrangement of the calixarene molecules. The PLAT213, 220, 222, 
241 and 242 errors are due to a disordered pendant chain which, despite modelling the errors 
persisted. The PLAT306 is due to the presence of a water molecule within the crystal lattice. Xseed 
does not currently support geometric placement of hydrogen atoms on isolated oxygen atoms.  
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CpNO2C6H4Pg 
 
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O14      
PLAT306_ALERT_2_A  
Isolated Oxygen Atom (H-atoms Missing ?) .......        O15      
PLAT412_ALERT_2_A  
Short Intra XH3 .. XHn     H31B   ..  H34C    ..       1.61 Ang.  
PLAT415_ALERT_2_A  
Short Inter D-H..H-X       H3A    ..  H34A    ..       1.67 Ang.  
PLAT415_ALERT_2_A  
Short Inter D-H..H-X       H3A    ..  H34B    ..       1.63 Ang.  
PLAT430_ALERT_2_A  
Short Inter D...A Contact  O14    ..  O14     ..       1.94 Ang.  
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  O3     ..  C34     ..       2.69 Ang.  
PLAT432_ALERT_2_A  
Short Inter X...Y Contact  O4     ..  C27     ..       2.65 Ang.  
PLAT432_ALERT_2_A 
Short Inter X...Y Contact  O6     ..  C38     ..       2.66 Ang.  
 
Despite multiple attempts to crystallize CpNO2C6H4Pg from a number of different solvents under 
varying conditions, crystals only grew from a saturated solution of methyl ethyl ketone exposed to the 
atmosphere and allowed to slowly evaporate. The small crystal size and low quality required 
synchrotron radiation to collect an adequate dataset. These factors required the use of the SQUEEZE 
program to model extensively disordered solvent molecules exo to the cavity of the calixarene. The 
PLAT306 error is due to XSEED currently not supporting the geometrical placement of hydrogen 
atoms on isolated oxygen atoms. PLAT415, 430, 432 are due to the extensive disorder of the solvent 
molecules exo to the cavity of the calixarene. 
 
 
 
Phenanthrene 
 
This structure produced no class A or B alerts. 
 
 
